id	sid	tid	token	lemma	pos
dpc-2300	1	1	dermatology	dermatology	NOUN
dpc-2300	1	2	:	:	PUNCT
dpc-2300	1	3	practical	practical	ADJ
dpc-2300	1	4	and	and	CCONJ
dpc-2300	1	5	conceptual	conceptual	ADJ
dpc-2300	1	6	review	review	NOUN
dpc-2300	1	7	|	|	ADV
dpc-2300	1	8	dermatol	dermatol	ADJ
dpc-2300	1	9	pract	pract	NOUN
dpc-2300	1	10	concept	concept	NOUN
dpc-2300	1	11	.	.	PUNCT
dpc-2300	2	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	2	2	1	1	NUM
dpc-2300	2	3	atopic	atopic	NOUN
dpc-2300	2	4	dermatitis	dermatitis	NOUN
dpc-2300	2	5	pathogenesis	pathogenesis	NOUN
dpc-2300	2	6	:	:	PUNCT
dpc-2300	2	7	lessons	lesson	NOUN
dpc-2300	2	8	from	from	ADP
dpc-2300	2	9	immunology	immunology	NOUN
dpc-2300	2	10	luis	luis	PROPN
dpc-2300	2	11	f	f	PROPN
dpc-2300	2	12	santamaria	santamaria	PROPN
dpc-2300	2	13	-	-	PROPN
dpc-2300	2	14	babí1	babí1	PROPN
dpc-2300	2	15	1	1	NUM
dpc-2300	2	16	translational	translational	ADJ
dpc-2300	2	17	immunology	immunology	NOUN
dpc-2300	2	18	,	,	PUNCT
dpc-2300	2	19	department	department	NOUN
dpc-2300	2	20	of	of	ADP
dpc-2300	2	21	cellular	cellular	ADJ
dpc-2300	2	22	biology	biology	NOUN
dpc-2300	2	23	,	,	PUNCT
dpc-2300	2	24	physiology	physiology	NOUN
dpc-2300	2	25	and	and	CCONJ
dpc-2300	2	26	immunology	immunology	NOUN
dpc-2300	2	27	,	,	PUNCT
dpc-2300	2	28	faculty	faculty	NOUN
dpc-2300	2	29	of	of	ADP
dpc-2300	2	30	biology	biology	NOUN
dpc-2300	2	31	,	,	PUNCT
dpc-2300	2	32	university	university	PROPN
dpc-2300	2	33	of	of	ADP
dpc-2300	2	34	barcelona	barcelona	PROPN
dpc-2300	2	35	,	,	PUNCT
dpc-2300	2	36	parc	parc	PROPN
dpc-2300	2	37	científic	científic	PROPN
dpc-2300	2	38	de	de	PROPN
dpc-2300	2	39	barcelona	barcelona	PROPN
dpc-2300	2	40	,	,	PUNCT
dpc-2300	2	41	barcelona	barcelona	PROPN
dpc-2300	2	42	,	,	PUNCT
dpc-2300	2	43	spain	spain	PROPN
dpc-2300	2	44	key	key	ADJ
dpc-2300	2	45	words	word	NOUN
dpc-2300	2	46	:	:	PUNCT
dpc-2300	2	47	atopic	atopic	NOUN
dpc-2300	2	48	dermatitis	dermatitis	NOUN
dpc-2300	2	49	,	,	PUNCT
dpc-2300	2	50	translational	translational	ADJ
dpc-2300	2	51	research	research	NOUN
dpc-2300	2	52	,	,	PUNCT
dpc-2300	2	53	homing	homing	NOUN
dpc-2300	2	54	,	,	PUNCT
dpc-2300	2	55	cla	cla	PROPN
dpc-2300	2	56	abbreviations	abbreviation	NOUN
dpc-2300	2	57	:	:	PUNCT
dpc-2300	2	58	cla	cla	ADJ
dpc-2300	2	59	:	:	PUNCT
dpc-2300	2	60	cutaneous	cutaneous	ADJ
dpc-2300	2	61	lymphocyte	lymphocyte	NOUN
dpc-2300	2	62	-	-	PUNCT
dpc-2300	2	63	associated	associated	ADJ
dpc-2300	2	64	antigen	antigen	ADV
dpc-2300	2	65	;	;	PUNCT
dpc-2300	2	66	sa	sa	PROPN
dpc-2300	2	67	:	:	PUNCT
dpc-2300	2	68	staphylococcus	staphylococcus	NOUN
dpc-2300	2	69	aureus	aureus	NOUN
dpc-2300	2	70	;	;	PUNCT
dpc-2300	2	71	ad	ad	NOUN
dpc-2300	2	72	:	:	PUNCT
dpc-2300	2	73	atopic	atopic	NOUN
dpc-2300	2	74	dermatitis	dermatitis	NOUN
dpc-2300	2	75	citation	citation	NOUN
dpc-2300	2	76	:	:	PUNCT
dpc-2300	2	77	santamaria	santamaria	PROPN
dpc-2300	2	78	-	-	PUNCT
dpc-2300	2	79	babí	babí	NOUN
dpc-2300	2	80	l.f	l.f	PROPN
dpc-2300	2	81	.	.	PROPN
dpc-2300	2	82	atopic	atopic	PROPN
dpc-2300	2	83	dermatitis	dermatitis	NOUN
dpc-2300	2	84	pathogenesis	pathogenesis	NOUN
dpc-2300	2	85	:	:	PUNCT
dpc-2300	2	86	lessons	lesson	NOUN
dpc-2300	2	87	from	from	ADP
dpc-2300	2	88	immunology	immunology	NOUN
dpc-2300	2	89	.	.	PUNCT
dpc-2300	3	1	dermatol	dermatol	NOUN
dpc-2300	3	2	pract	pract	PROPN
dpc-2300	3	3	concept	concept	NOUN
dpc-2300	3	4	.	.	PUNCT
dpc-2300	4	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	4	2	.	.	PUNCT
dpc-2300	4	3	doi	doi	PROPN
dpc-2300	4	4	:	:	PUNCT
dpc-2300	4	5	https://doi.org/10.5826/dpc.1201a152	https://doi.org/10.5826/dpc.1201a152	PROPN
dpc-2300	4	6	accepted	accept	VERB
dpc-2300	4	7	:	:	PUNCT
dpc-2300	4	8	december	december	PROPN
dpc-2300	4	9	14	14	NUM
dpc-2300	4	10	,	,	PUNCT
dpc-2300	4	11	2021	2021	NUM
dpc-2300	4	12	;	;	PUNCT
dpc-2300	4	13	published	publish	VERB
dpc-2300	4	14	:	:	PUNCT
dpc-2300	4	15	january	january	PROPN
dpc-2300	4	16	2022	2022	NUM
dpc-2300	5	1	copyright	copyright	NOUN
dpc-2300	5	2	:	:	PUNCT
dpc-2300	5	3	©	©	PROPN
dpc-2300	5	4	2022	2022	NUM
dpc-2300	5	5	santamaria	santamaria	PROPN
dpc-2300	5	6	-	-	PUNCT
dpc-2300	5	7	babi	babi	PROPN
dpc-2300	5	8	.	.	PUNCT
dpc-2300	6	1	this	this	PRON
dpc-2300	6	2	is	be	AUX
dpc-2300	6	3	an	an	DET
dpc-2300	6	4	open	open	ADJ
dpc-2300	6	5	-	-	PUNCT
dpc-2300	6	6	access	access	NOUN
dpc-2300	6	7	article	article	NOUN
dpc-2300	6	8	distributed	distribute	VERB
dpc-2300	6	9	under	under	ADP
dpc-2300	6	10	the	the	DET
dpc-2300	6	11	terms	term	NOUN
dpc-2300	6	12	of	of	ADP
dpc-2300	6	13	the	the	DET
dpc-2300	6	14	creative	creative	ADJ
dpc-2300	6	15	commons	common	NOUN
dpc-2300	6	16	attribution	attribution	NOUN
dpc-2300	6	17	-	-	PUNCT
dpc-2300	6	18	noncommercial	noncommercial	ADJ
dpc-2300	6	19	license	license	NOUN
dpc-2300	6	20	(	(	PUNCT
dpc-2300	6	21	by	by	ADP
dpc-2300	6	22	-	-	PUNCT
dpc-2300	6	23	nc-4.0	nc-4.0	NOUN
dpc-2300	6	24	)	)	PUNCT
dpc-2300	6	25	,	,	PUNCT
dpc-2300	6	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2300	6	27	,	,	PUNCT
dpc-2300	6	28	which	which	PRON
dpc-2300	6	29	permits	permit	VERB
dpc-2300	6	30	unrestricted	unrestricted	ADJ
dpc-2300	6	31	noncommercial	noncommercial	ADJ
dpc-2300	6	32	use	use	NOUN
dpc-2300	6	33	,	,	PUNCT
dpc-2300	6	34	distribution	distribution	NOUN
dpc-2300	6	35	,	,	PUNCT
dpc-2300	6	36	and	and	CCONJ
dpc-2300	6	37	reproduction	reproduction	NOUN
dpc-2300	6	38	in	in	ADP
dpc-2300	6	39	any	any	DET
dpc-2300	6	40	medium	medium	NOUN
dpc-2300	6	41	,	,	PUNCT
dpc-2300	6	42	provided	provide	VERB
dpc-2300	6	43	the	the	DET
dpc-2300	6	44	original	original	ADJ
dpc-2300	6	45	authors	author	NOUN
dpc-2300	6	46	and	and	CCONJ
dpc-2300	6	47	source	source	NOUN
dpc-2300	6	48	are	be	AUX
dpc-2300	6	49	credited	credit	VERB
dpc-2300	6	50	.	.	PUNCT
dpc-2300	7	1	funding	funding	NOUN
dpc-2300	7	2	:	:	PUNCT
dpc-2300	7	3	none	none	NOUN
dpc-2300	7	4	.	.	PUNCT
dpc-2300	8	1	competing	compete	VERB
dpc-2300	8	2	interests	interest	NOUN
dpc-2300	8	3	:	:	PUNCT
dpc-2300	8	4	none	none	NOUN
dpc-2300	8	5	.	.	PUNCT
dpc-2300	9	1	corresponding	correspond	VERB
dpc-2300	9	2	author	author	NOUN
dpc-2300	9	3	:	:	PUNCT
dpc-2300	9	4	luis	luis	PROPN
dpc-2300	9	5	f	f	PROPN
dpc-2300	9	6	santamaria	santamaria	PROPN
dpc-2300	9	7	-	-	PUNCT
dpc-2300	9	8	babí	babí	NOUN
dpc-2300	9	9	,	,	PUNCT
dpc-2300	9	10	phd	phd	NOUN
dpc-2300	9	11	,	,	PUNCT
dpc-2300	9	12	professor	professor	NOUN
dpc-2300	9	13	of	of	ADP
dpc-2300	9	14	clinical	clinical	ADJ
dpc-2300	9	15	and	and	CCONJ
dpc-2300	9	16	translational	translational	ADJ
dpc-2300	9	17	immunology	immunology	NOUN
dpc-2300	9	18	.	.	PUNCT
dpc-2300	10	1	translational	translational	ADJ
dpc-2300	10	2	immunology	immunology	NOUN
dpc-2300	10	3	.	.	PUNCT
dpc-2300	11	1	parc	parc	PROPN
dpc-2300	11	2	científic	científic	PROPN
dpc-2300	11	3	de	de	PROPN
dpc-2300	11	4	barcelona	barcelona	PROPN
dpc-2300	11	5	,	,	PUNCT
dpc-2300	11	6	barcelona	barcelona	PROPN
dpc-2300	11	7	,	,	PUNCT
dpc-2300	11	8	spain	spain	PROPN
dpc-2300	11	9	.	.	PUNCT
dpc-2300	12	1	e	e	X
dpc-2300	12	2	-	-	NOUN
dpc-2300	12	3	mail	mail	NOUN
dpc-2300	12	4	:	:	PUNCT
dpc-2300	12	5	luis.santamaria@ub.edu	luis.santamaria@ub.edu	X
dpc-2300	12	6	translational	translational	ADJ
dpc-2300	12	7	research	research	NOUN
dpc-2300	12	8	has	have	AUX
dpc-2300	12	9	changed	change	VERB
dpc-2300	12	10	the	the	DET
dpc-2300	12	11	understanding	understanding	NOUN
dpc-2300	12	12	of	of	ADP
dpc-2300	12	13	atopic	atopic	NOUN
dpc-2300	12	14	dermatitis	dermatitis	NOUN
dpc-2300	12	15	(	(	PUNCT
dpc-2300	12	16	ad	ad	NOUN
dpc-2300	12	17	)	)	PUNCT
dpc-2300	12	18	pathogenesis	pathogenesis	NOUN
dpc-2300	12	19	beyond	beyond	ADP
dpc-2300	12	20	the	the	DET
dpc-2300	12	21	basic	basic	ADJ
dpc-2300	12	22	mechanisms	mechanism	NOUN
dpc-2300	12	23	of	of	ADP
dpc-2300	12	24	immunology	immunology	NOUN
dpc-2300	12	25	.	.	PUNCT
dpc-2300	13	1	the	the	DET
dpc-2300	13	2	study	study	NOUN
dpc-2300	13	3	in	in	ADP
dpc-2300	13	4	patients	patient	NOUN
dpc-2300	13	5	of	of	ADP
dpc-2300	13	6	rational	rational	ADJ
dpc-2300	13	7	therapies	therapy	NOUN
dpc-2300	13	8	based	base	VERB
dpc-2300	13	9	on	on	ADP
dpc-2300	13	10	targeted	target	VERB
dpc-2300	13	11	therapies	therapy	NOUN
dpc-2300	13	12	(	(	PUNCT
dpc-2300	13	13	biologicals	biological	NOUN
dpc-2300	13	14	)	)	PUNCT
dpc-2300	13	15	provides	provide	VERB
dpc-2300	13	16	valuable	valuable	ADJ
dpc-2300	13	17	information	information	NOUN
dpc-2300	13	18	from	from	ADP
dpc-2300	13	19	the	the	DET
dpc-2300	13	20	patient	patient	NOUN
dpc-2300	13	21	and	and	CCONJ
dpc-2300	13	22	provides	provide	VERB
dpc-2300	13	23	lessons	lesson	NOUN
dpc-2300	13	24	of	of	ADP
dpc-2300	13	25	clinical	clinical	ADJ
dpc-2300	13	26	immunology	immunology	NOUN
dpc-2300	13	27	on	on	ADP
dpc-2300	13	28	clinically	clinically	ADV
dpc-2300	13	29	relevant	relevant	ADJ
dpc-2300	13	30	mechanism	mechanism	NOUN
dpc-2300	13	31	of	of	ADP
dpc-2300	13	32	ad	ad	NOUN
dpc-2300	13	33	pathogenesis	pathogenesis	NOUN
dpc-2300	13	34	.	.	PUNCT
dpc-2300	14	1	ad	ad	NOUN
dpc-2300	14	2	features	feature	VERB
dpc-2300	14	3	such	such	ADJ
dpc-2300	14	4	as	as	ADP
dpc-2300	14	5	skin	skin	NOUN
dpc-2300	14	6	barrier	barrier	NOUN
dpc-2300	14	7	defect	defect	NOUN
dpc-2300	14	8	,	,	PUNCT
dpc-2300	14	9	skin	skin	NOUN
dpc-2300	14	10	dysbiosis	dysbiosis	NOUN
dpc-2300	14	11	,	,	PUNCT
dpc-2300	14	12	and	and	CCONJ
dpc-2300	14	13	pruritus	pruritus	PROPN
dpc-2300	14	14	share	share	VERB
dpc-2300	14	15	a	a	DET
dpc-2300	14	16	common	common	ADJ
dpc-2300	14	17	abnormal	abnormal	ADJ
dpc-2300	14	18	adaptive	adaptive	ADJ
dpc-2300	14	19	immune	immune	ADJ
dpc-2300	14	20	response	response	NOUN
dpc-2300	14	21	process	process	NOUN
dpc-2300	14	22	.	.	PUNCT
dpc-2300	15	1	skin	skin	NOUN
dpc-2300	15	2	-	-	PUNCT
dpc-2300	15	3	homing	home	VERB
dpc-2300	15	4	cla+cd4	cla+cd4	NOUN
dpc-2300	15	5	+	+	CCONJ
dpc-2300	15	6	memory	memory	NOUN
dpc-2300	15	7	t	t	PROPN
dpc-2300	15	8	-	-	PUNCT
dpc-2300	15	9	cells	cell	NOUN
dpc-2300	15	10	produce	produce	VERB
dpc-2300	15	11	il-4	il-4	NOUN
dpc-2300	15	12	,	,	PUNCT
dpc-2300	15	13	il-13	il-13	ADV
dpc-2300	15	14	,	,	PUNCT
dpc-2300	15	15	and	and	CCONJ
dpc-2300	15	16	il-31	il-31	PRON
dpc-2300	15	17	which	which	PRON
dpc-2300	15	18	are	be	AUX
dpc-2300	15	19	key	key	ADJ
dpc-2300	15	20	mediators	mediator	NOUN
dpc-2300	15	21	in	in	ADP
dpc-2300	15	22	ad	ad	NOUN
dpc-2300	15	23	pathogenesis	pathogenesis	NOUN
dpc-2300	15	24	.	.	PUNCT
dpc-2300	16	1	lessons	lesson	NOUN
dpc-2300	16	2	learned	learn	VERB
dpc-2300	16	3	from	from	ADP
dpc-2300	16	4	ad	ad	NOUN
dpc-2300	16	5	show	show	NOUN
dpc-2300	16	6	that	that	SCONJ
dpc-2300	16	7	translational	translational	ADJ
dpc-2300	16	8	immunology	immunology	NOUN
dpc-2300	16	9	allows	allow	VERB
dpc-2300	16	10	generating	generate	VERB
dpc-2300	16	11	rational	rational	ADJ
dpc-2300	16	12	therapies	therapy	NOUN
dpc-2300	16	13	for	for	ADP
dpc-2300	16	14	ad	ad	NOUN
dpc-2300	16	15	and	and	CCONJ
dpc-2300	16	16	learning	learn	VERB
dpc-2300	16	17	its	its	PRON
dpc-2300	16	18	immunopathogenesis	immunopathogenesis	NOUN
dpc-2300	16	19	in	in	ADP
dpc-2300	16	20	the	the	DET
dpc-2300	16	21	patient	patient	NOUN
dpc-2300	16	22	.	.	PUNCT
dpc-2300	17	1	abstract	abstract	ADJ
dpc-2300	17	2	this	this	DET
dpc-2300	17	3	article	article	NOUN
dpc-2300	17	4	is	be	AUX
dpc-2300	17	5	part	part	NOUN
dpc-2300	17	6	of	of	ADP
dpc-2300	17	7	a	a	DET
dpc-2300	17	8	series	series	NOUN
dpc-2300	17	9	of	of	ADP
dpc-2300	17	10	reviews	review	NOUN
dpc-2300	17	11	dedicated	dedicate	VERB
dpc-2300	17	12	to	to	ADP
dpc-2300	17	13	atopic	atopic	NOUN
dpc-2300	17	14	dermatitis	dermatitis	NOUN
dpc-2300	17	15	,	,	PUNCT
dpc-2300	17	16	guest	guest	NOUN
dpc-2300	17	17	edited	edit	VERB
dpc-2300	17	18	by	by	ADP
dpc-2300	17	19	prof	prof	PROPN
dpc-2300	17	20	anna	anna	PROPN
dpc-2300	17	21	balato	balato	PROPN
dpc-2300	17	22	.	.	PUNCT
dpc-2300	18	1	guest	guest	PROPN
dpc-2300	18	2	editor	editor	PROPN
dpc-2300	18	3	prof	prof	PROPN
dpc-2300	18	4	.	.	PROPN
dpc-2300	19	1	anna	anna	PROPN
dpc-2300	19	2	balato	balato	PROPN
dpc-2300	19	3	,	,	PUNCT
dpc-2300	19	4	md	md	PROPN
dpc-2300	19	5	,	,	PUNCT
dpc-2300	19	6	phd	phd	NOUN
dpc-2300	19	7	associate	associate	NOUN
dpc-2300	19	8	professor	professor	NOUN
dpc-2300	19	9	of	of	ADP
dpc-2300	19	10	dermatology	dermatology	NOUN
dpc-2300	19	11	,	,	PUNCT
dpc-2300	19	12	dermatology	dermatology	NOUN
dpc-2300	19	13	unit	unit	NOUN
dpc-2300	19	14	,	,	PUNCT
dpc-2300	19	15	university	university	PROPN
dpc-2300	19	16	of	of	ADP
dpc-2300	19	17	campania	campania	PROPN
dpc-2300	19	18	,	,	PUNCT
dpc-2300	19	19	naples	naples	PROPN
dpc-2300	19	20	,	,	PUNCT
dpc-2300	19	21	italy	italy	PROPN
dpc-2300	19	22	2	2	NUM
dpc-2300	19	23	review	review	NOUN
dpc-2300	19	24	|	|	ADV
dpc-2300	19	25	dermatol	dermatol	ADJ
dpc-2300	19	26	pract	pract	NOUN
dpc-2300	19	27	concept	concept	NOUN
dpc-2300	19	28	.	.	PUNCT
dpc-2300	20	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	20	2	introduction	introduction	NOUN
dpc-2300	20	3	atopic	atopic	NOUN
dpc-2300	20	4	dermatitis	dermatitis	NOUN
dpc-2300	20	5	(	(	PUNCT
dpc-2300	20	6	ad	ad	NOUN
dpc-2300	20	7	)	)	PUNCT
dpc-2300	20	8	is	be	AUX
dpc-2300	20	9	a	a	DET
dpc-2300	20	10	chronic	chronic	ADJ
dpc-2300	20	11	inflammatory	inflammatory	ADJ
dpc-2300	20	12	skin	skin	NOUN
dpc-2300	20	13	disease	disease	NOUN
dpc-2300	20	14	characterized	characterize	VERB
dpc-2300	20	15	by	by	ADP
dpc-2300	20	16	a	a	DET
dpc-2300	20	17	defective	defective	ADJ
dpc-2300	20	18	epidermal	epidermal	ADJ
dpc-2300	20	19	barrier	barrier	NOUN
dpc-2300	20	20	,	,	PUNCT
dpc-2300	20	21	cutaneous	cutaneous	ADJ
dpc-2300	20	22	dysbiosis	dysbiosis	NOUN
dpc-2300	20	23	,	,	PUNCT
dpc-2300	20	24	pruritus	pruritus	PROPN
dpc-2300	20	25	,	,	PUNCT
dpc-2300	20	26	in	in	ADP
dpc-2300	20	27	a	a	DET
dpc-2300	20	28	context	context	NOUN
dpc-2300	20	29	of	of	ADP
dpc-2300	20	30	abnormal	abnormal	ADJ
dpc-2300	20	31	immune	immune	ADJ
dpc-2300	20	32	response	response	NOUN
dpc-2300	20	33	[	[	X
dpc-2300	20	34	1	1	NUM
dpc-2300	20	35	]	]	PUNCT
dpc-2300	20	36	.	.	PUNCT
dpc-2300	21	1	the	the	DET
dpc-2300	21	2	translational	translational	ADJ
dpc-2300	21	3	research	research	NOUN
dpc-2300	21	4	model	model	NOUN
dpc-2300	21	5	,	,	PUNCT
dpc-2300	21	6	originally	originally	ADV
dpc-2300	21	7	applied	apply	VERB
dpc-2300	21	8	to	to	ADP
dpc-2300	21	9	plaque	plaque	NOUN
dpc-2300	21	10	psoriasis	psoriasis	NOUN
dpc-2300	21	11	,	,	PUNCT
dpc-2300	21	12	has	have	AUX
dpc-2300	21	13	revolutionized	revolutionize	VERB
dpc-2300	21	14	the	the	DET
dpc-2300	21	15	concepts	concept	NOUN
dpc-2300	21	16	of	of	ADP
dpc-2300	21	17	moderate	moderate	ADJ
dpc-2300	21	18	to	to	ADP
dpc-2300	21	19	severe	severe	ADJ
dpc-2300	21	20	ad	ad	NOUN
dpc-2300	21	21	pathogenesis	pathogenesis	NOUN
dpc-2300	21	22	and	and	CCONJ
dpc-2300	21	23	has	have	AUX
dpc-2300	21	24	provided	provide	VERB
dpc-2300	21	25	relevant	relevant	ADJ
dpc-2300	21	26	clinical	clinical	ADJ
dpc-2300	21	27	information	information	NOUN
dpc-2300	21	28	on	on	ADP
dpc-2300	21	29	the	the	DET
dpc-2300	21	30	important	important	ADJ
dpc-2300	21	31	immunological	immunological	ADJ
dpc-2300	21	32	mechanisms	mechanism	NOUN
dpc-2300	21	33	of	of	ADP
dpc-2300	21	34	ad	ad	NOUN
dpc-2300	21	35	[	[	X
dpc-2300	21	36	2	2	NUM
dpc-2300	21	37	]	]	PUNCT
dpc-2300	21	38	.	.	PUNCT
dpc-2300	22	1	translational	translational	ADJ
dpc-2300	22	2	research	research	NOUN
dpc-2300	22	3	allows	allow	VERB
dpc-2300	22	4	validating	validate	VERB
dpc-2300	22	5	in	in	ADP
dpc-2300	22	6	the	the	DET
dpc-2300	22	7	patient	patient	ADJ
dpc-2300	22	8	new	new	ADJ
dpc-2300	22	9	pathological	pathological	ADJ
dpc-2300	22	10	mechanisms	mechanism	NOUN
dpc-2300	22	11	proposed	propose	VERB
dpc-2300	22	12	in	in	ADP
dpc-2300	22	13	basic	basic	ADJ
dpc-2300	22	14	research	research	NOUN
dpc-2300	22	15	.	.	PUNCT
dpc-2300	23	1	the	the	DET
dpc-2300	23	2	use	use	NOUN
dpc-2300	23	3	of	of	ADP
dpc-2300	23	4	targeted	target	VERB
dpc-2300	23	5	therapies	therapy	NOUN
dpc-2300	23	6	such	such	ADJ
dpc-2300	23	7	as	as	ADP
dpc-2300	23	8	humanized	humanize	VERB
dpc-2300	23	9	monoclonal	monoclonal	NOUN
dpc-2300	23	10	antibodies	antibody	NOUN
dpc-2300	23	11	directed	direct	VERB
dpc-2300	23	12	to	to	ADP
dpc-2300	23	13	human	human	ADJ
dpc-2300	23	14	targets	target	NOUN
dpc-2300	23	15	(	(	PUNCT
dpc-2300	23	16	cytokines	cytokine	NOUN
dpc-2300	23	17	,	,	PUNCT
dpc-2300	23	18	receptors	receptor	NOUN
dpc-2300	23	19	,	,	PUNCT
dpc-2300	23	20	cells	cell	NOUN
dpc-2300	23	21	.	.	PUNCT
dpc-2300	23	22	.	.	PUNCT
dpc-2300	23	23	.	.	PUNCT
dpc-2300	23	24	)	)	PUNCT
dpc-2300	24	1	in	in	ADP
dpc-2300	24	2	clinical	clinical	ADJ
dpc-2300	24	3	trials	trial	NOUN
dpc-2300	24	4	,	,	PUNCT
dpc-2300	24	5	together	together	ADV
dpc-2300	24	6	with	with	ADP
dpc-2300	24	7	advanced	advanced	ADJ
dpc-2300	24	8	technologies	technology	NOUN
dpc-2300	24	9	analyzing	analyze	VERB
dpc-2300	24	10	molecular	molecular	ADJ
dpc-2300	24	11	mechanisms	mechanism	NOUN
dpc-2300	24	12	in	in	ADP
dpc-2300	24	13	patients	patient	NOUN
dpc-2300	24	14	(	(	PUNCT
dpc-2300	24	15	transcriptomics	transcriptomic	NOUN
dpc-2300	24	16	,	,	PUNCT
dpc-2300	24	17	proteomics	proteomic	NOUN
dpc-2300	24	18	.	.	PUNCT
dpc-2300	24	19	.	.	PUNCT
dpc-2300	24	20	.	.	PUNCT
dpc-2300	24	21	)	)	PUNCT
dpc-2300	24	22	,	,	PUNCT
dpc-2300	24	23	has	have	AUX
dpc-2300	24	24	demonstrated	demonstrate	VERB
dpc-2300	24	25	that	that	SCONJ
dpc-2300	24	26	ad	ad	NOUN
dpc-2300	24	27	is	be	AUX
dpc-2300	24	28	a	a	DET
dpc-2300	24	29	complex	complex	ADJ
dpc-2300	24	30	and	and	CCONJ
dpc-2300	24	31	heterogeneous	heterogeneous	ADJ
dpc-2300	24	32	condition	condition	NOUN
dpc-2300	24	33	that	that	PRON
dpc-2300	24	34	can	can	AUX
dpc-2300	24	35	now	now	ADV
dpc-2300	24	36	be	be	AUX
dpc-2300	24	37	treated	treat	VERB
dpc-2300	24	38	more	more	ADV
dpc-2300	24	39	effectively	effectively	ADV
dpc-2300	24	40	with	with	ADP
dpc-2300	24	41	rational	rational	ADJ
dpc-2300	24	42	therapies	therapy	NOUN
dpc-2300	24	43	directed	direct	VERB
dpc-2300	24	44	to	to	ADP
dpc-2300	24	45	the	the	DET
dpc-2300	24	46	pathogenic	pathogenic	ADJ
dpc-2300	24	47	basis	basis	NOUN
dpc-2300	24	48	of	of	ADP
dpc-2300	24	49	the	the	DET
dpc-2300	24	50	disease	disease	NOUN
dpc-2300	24	51	.	.	PUNCT
dpc-2300	25	1	the	the	DET
dpc-2300	25	2	“	"	PUNCT
dpc-2300	25	3	omics	omics	PROPN
dpc-2300	25	4	”	"	PUNCT
dpc-2300	25	5	revolution	revolution	NOUN
dpc-2300	25	6	facilitated	facilitate	VERB
dpc-2300	25	7	the	the	DET
dpc-2300	25	8	understanding	understanding	NOUN
dpc-2300	25	9	of	of	ADP
dpc-2300	25	10	ad	ad	NOUN
dpc-2300	25	11	pathogenesis	pathogenesis	NOUN
dpc-2300	25	12	at	at	ADP
dpc-2300	25	13	molecular	molecular	ADJ
dpc-2300	25	14	lever	lever	NOUN
dpc-2300	25	15	beyond	beyond	ADP
dpc-2300	25	16	clinical	clinical	ADJ
dpc-2300	25	17	scores	score	NOUN
dpc-2300	25	18	.	.	PUNCT
dpc-2300	26	1	now	now	ADV
dpc-2300	26	2	all	all	DET
dpc-2300	26	3	clinical	clinical	ADJ
dpc-2300	26	4	studies	study	NOUN
dpc-2300	26	5	with	with	ADP
dpc-2300	26	6	innovative	innovative	ADJ
dpc-2300	26	7	drug	drug	NOUN
dpc-2300	26	8	therapies	therapy	NOUN
dpc-2300	26	9	incorporate	incorporate	VERB
dpc-2300	26	10	this	this	DET
dpc-2300	26	11	molecular	molecular	ADJ
dpc-2300	26	12	phenotyping	phenotyping	NOUN
dpc-2300	26	13	of	of	ADP
dpc-2300	26	14	patients	patient	NOUN
dpc-2300	26	15	[	[	X
dpc-2300	26	16	3	3	NUM
dpc-2300	26	17	]	]	PUNCT
dpc-2300	26	18	.	.	PUNCT
dpc-2300	27	1	this	this	DET
dpc-2300	27	2	review	review	NOUN
dpc-2300	27	3	highlights	highlight	NOUN
dpc-2300	27	4	,	,	PUNCT
dpc-2300	27	5	from	from	ADP
dpc-2300	27	6	a	a	DET
dpc-2300	27	7	translational	translational	ADJ
dpc-2300	27	8	immunology	immunology	NOUN
dpc-2300	27	9	perspective	perspective	NOUN
dpc-2300	27	10	,	,	PUNCT
dpc-2300	27	11	recently	recently	ADV
dpc-2300	27	12	identified	identify	VERB
dpc-2300	27	13	immunological	immunological	ADJ
dpc-2300	27	14	mechanisms	mechanism	NOUN
dpc-2300	27	15	involved	involve	VERB
dpc-2300	27	16	in	in	ADP
dpc-2300	27	17	moderate	moderate	ADJ
dpc-2300	27	18	to	to	ADP
dpc-2300	27	19	severe	severe	ADJ
dpc-2300	27	20	ad	ad	NOUN
dpc-2300	27	21	pathogenesis	pathogenesis	NOUN
dpc-2300	27	22	that	that	PRON
dpc-2300	27	23	are	be	AUX
dpc-2300	27	24	clinically	clinically	ADV
dpc-2300	27	25	relevant	relevant	ADJ
dpc-2300	27	26	(	(	PUNCT
dpc-2300	27	27	table	table	NOUN
dpc-2300	27	28	1	1	NUM
dpc-2300	27	29	)	)	PUNCT
dpc-2300	27	30	.	.	PUNCT
dpc-2300	28	1	type	type	NOUN
dpc-2300	28	2	2	2	NUM
dpc-2300	28	3	(	(	PUNCT
dpc-2300	28	4	t2	t2	NOUN
dpc-2300	28	5	)	)	PUNCT
dpc-2300	28	6	immune	immune	ADJ
dpc-2300	28	7	response	response	NOUN
dpc-2300	28	8	in	in	ADP
dpc-2300	28	9	ad	ad	NOUN
dpc-2300	28	10	many	many	ADJ
dpc-2300	28	11	ad	ad	NOUN
dpc-2300	28	12	patients	patient	NOUN
dpc-2300	28	13	exhibit	exhibit	VERB
dpc-2300	28	14	an	an	DET
dpc-2300	28	15	exaggerated	exaggerated	ADJ
dpc-2300	28	16	immune	immune	ADJ
dpc-2300	28	17	t2	t2	NOUN
dpc-2300	28	18	response	response	NOUN
dpc-2300	28	19	that	that	PRON
dpc-2300	28	20	leads	lead	VERB
dpc-2300	28	21	to	to	ADP
dpc-2300	28	22	increased	increase	VERB
dpc-2300	28	23	ige	ige	PROPN
dpc-2300	28	24	levels	level	NOUN
dpc-2300	28	25	.	.	PUNCT
dpc-2300	29	1	the	the	DET
dpc-2300	29	2	t2	t2	PROPN
dpc-2300	29	3	immune	immune	ADJ
dpc-2300	29	4	response	response	NOUN
dpc-2300	29	5	consists	consist	VERB
dpc-2300	29	6	of	of	ADP
dpc-2300	29	7	the	the	DET
dpc-2300	29	8	production	production	NOUN
dpc-2300	29	9	of	of	ADP
dpc-2300	29	10	il-4	il-4	NOUN
dpc-2300	29	11	,	,	PUNCT
dpc-2300	29	12	il-13	il-13	ADV
dpc-2300	29	13	,	,	PUNCT
dpc-2300	29	14	and	and	CCONJ
dpc-2300	29	15	il-5	il-5	PUNCT
dpc-2300	29	16	by	by	ADP
dpc-2300	29	17	memory	memory	NOUN
dpc-2300	29	18	cd4	cd4	PROPN
dpc-2300	29	19	+	+	PROPN
dpc-2300	29	20	th2	th2	PROPN
dpc-2300	29	21	cells	cell	NOUN
dpc-2300	29	22	,	,	PUNCT
dpc-2300	29	23	type-2	type-2	NUM
dpc-2300	29	24	innate	innate	ADJ
dpc-2300	29	25	lymphoid	lymphoid	NOUN
dpc-2300	29	26	cells	cell	NOUN
dpc-2300	29	27	(	(	PUNCT
dpc-2300	29	28	ilc2	ilc2	NOUN
dpc-2300	29	29	)	)	PUNCT
dpc-2300	29	30	,	,	PUNCT
dpc-2300	29	31	mast	mast	NOUN
dpc-2300	29	32	cells	cell	NOUN
dpc-2300	29	33	,	,	PUNCT
dpc-2300	29	34	and	and	CCONJ
dpc-2300	29	35	basophils	basophil	NOUN
dpc-2300	29	36	[	[	X
dpc-2300	29	37	4	4	NUM
dpc-2300	29	38	]	]	PUNCT
dpc-2300	29	39	.	.	PUNCT
dpc-2300	30	1	thus	thus	ADV
dpc-2300	30	2	,	,	PUNCT
dpc-2300	30	3	t2	t2	PROPN
dpc-2300	30	4	immune	immune	ADJ
dpc-2300	30	5	response	response	NOUN
dpc-2300	30	6	includes	include	VERB
dpc-2300	30	7	adaptive	adaptive	ADJ
dpc-2300	30	8	and	and	CCONJ
dpc-2300	30	9	innate	innate	ADJ
dpc-2300	30	10	mechanisms	mechanism	NOUN
dpc-2300	30	11	.	.	PUNCT
dpc-2300	31	1	the	the	DET
dpc-2300	31	2	adaptive	adaptive	ADJ
dpc-2300	31	3	response	response	NOUN
dpc-2300	31	4	is	be	AUX
dpc-2300	31	5	based	base	VERB
dpc-2300	31	6	on	on	ADP
dpc-2300	31	7	the	the	DET
dpc-2300	31	8	capture	capture	NOUN
dpc-2300	31	9	of	of	ADP
dpc-2300	31	10	allergens	allergen	NOUN
dpc-2300	31	11	,	,	PUNCT
dpc-2300	31	12	antigens	antigen	NOUN
dpc-2300	31	13	,	,	PUNCT
dpc-2300	31	14	and	and	CCONJ
dpc-2300	31	15	superantigens	superantigen	NOUN
dpc-2300	31	16	by	by	ADP
dpc-2300	31	17	antigen	antigen	NOUN
dpc-2300	31	18	presenting	present	VERB
dpc-2300	31	19	cells	cell	NOUN
dpc-2300	31	20	and	and	CCONJ
dpc-2300	31	21	presentation	presentation	NOUN
dpc-2300	31	22	to	to	ADP
dpc-2300	31	23	specific	specific	ADJ
dpc-2300	31	24	cd4	cd4	PROPN
dpc-2300	31	25	memory	memory	NOUN
dpc-2300	31	26	t	t	PROPN
dpc-2300	31	27	-	-	PUNCT
dpc-2300	31	28	cells	cell	NOUN
dpc-2300	31	29	that	that	PRON
dpc-2300	31	30	are	be	AUX
dpc-2300	31	31	activated	activate	VERB
dpc-2300	31	32	and	and	CCONJ
dpc-2300	31	33	secrete	secrete	NOUN
dpc-2300	31	34	il-13	il-13	ADP
dpc-2300	31	35	,	,	PUNCT
dpc-2300	31	36	il-4	il-4	PRON
dpc-2300	31	37	,	,	PUNCT
dpc-2300	31	38	il-31	il-31	X
dpc-2300	31	39	,	,	PUNCT
dpc-2300	31	40	and	and	CCONJ
dpc-2300	31	41	il-22	il-22	NOUN
dpc-2300	31	42	(	(	PUNCT
dpc-2300	31	43	figure	figure	NOUN
dpc-2300	31	44	1	1	NUM
dpc-2300	31	45	)	)	PUNCT
dpc-2300	31	46	.	.	PUNCT
dpc-2300	32	1	on	on	ADP
dpc-2300	32	2	the	the	DET
dpc-2300	32	3	other	other	ADJ
dpc-2300	32	4	hand	hand	NOUN
dpc-2300	32	5	,	,	PUNCT
dpc-2300	32	6	the	the	DET
dpc-2300	32	7	innate	innate	ADJ
dpc-2300	32	8	response	response	NOUN
dpc-2300	32	9	is	be	AUX
dpc-2300	32	10	based	base	VERB
dpc-2300	32	11	on	on	ADP
dpc-2300	32	12	ilc2	ilc2	NOUN
dpc-2300	32	13	cells	cell	NOUN
dpc-2300	32	14	that	that	PRON
dpc-2300	32	15	are	be	AUX
dpc-2300	32	16	tissue	tissue	NOUN
dpc-2300	32	17	-	-	PUNCT
dpc-2300	32	18	resident	resident	NOUN
dpc-2300	32	19	and	and	CCONJ
dpc-2300	32	20	produce	produce	VERB
dpc-2300	32	21	il-5	il-5	PROPN
dpc-2300	32	22	and	and	CCONJ
dpc-2300	32	23	il-13	il-13	X
dpc-2300	32	24	.	.	PUNCT
dpc-2300	33	1	to	to	PART
dpc-2300	33	2	secrete	secrete	VERB
dpc-2300	33	3	cytokines	cytokine	NOUN
dpc-2300	33	4	,	,	PUNCT
dpc-2300	33	5	ilc2	ilc2	NOUN
dpc-2300	33	6	lymphocytes	lymphocyte	NOUN
dpc-2300	33	7	need	need	VERB
dpc-2300	33	8	to	to	PART
dpc-2300	33	9	be	be	AUX
dpc-2300	33	10	activated	activate	VERB
dpc-2300	33	11	by	by	ADP
dpc-2300	33	12	epithelial	epithelial	ADJ
dpc-2300	33	13	cytokines	cytokine	NOUN
dpc-2300	33	14	,	,	PUNCT
dpc-2300	33	15	also	also	ADV
dpc-2300	33	16	termed	term	VERB
dpc-2300	33	17	alarmins	alarmin	NOUN
dpc-2300	33	18	,	,	PUNCT
dpc-2300	33	19	produced	produce	VERB
dpc-2300	33	20	by	by	ADP
dpc-2300	33	21	keratinocytes	keratinocyte	NOUN
dpc-2300	33	22	.	.	PUNCT
dpc-2300	34	1	the	the	DET
dpc-2300	34	2	best	good	ADJ
dpc-2300	34	3	characterized	characterize	VERB
dpc-2300	34	4	alarmins	alarmin	NOUN
dpc-2300	34	5	are	be	AUX
dpc-2300	34	6	tlsp	tlsp	NOUN
dpc-2300	34	7	(	(	PUNCT
dpc-2300	34	8	thymic	thymic	ADJ
dpc-2300	34	9	stromal	stromal	ADJ
dpc-2300	34	10	lymphopoietin	lymphopoietin	NOUN
dpc-2300	34	11	,	,	PUNCT
dpc-2300	34	12	il-25	il-25	NOUN
dpc-2300	34	13	,	,	PUNCT
dpc-2300	34	14	il-33	il-33	X
dpc-2300	34	15	,	,	PUNCT
dpc-2300	34	16	and	and	CCONJ
dpc-2300	34	17	il-1α	il-1α	PROPN
dpc-2300	34	18	[	[	X
dpc-2300	34	19	1	1	NUM
dpc-2300	34	20	]	]	PUNCT
dpc-2300	34	21	.	.	PUNCT
dpc-2300	35	1	they	they	PRON
dpc-2300	35	2	have	have	AUX
dpc-2300	35	3	been	be	AUX
dpc-2300	35	4	very	very	ADV
dpc-2300	35	5	well	well	ADV
dpc-2300	35	6	studied	study	VERB
dpc-2300	35	7	also	also	ADV
dpc-2300	35	8	in	in	ADP
dpc-2300	35	9	ad	ad	NOUN
dpc-2300	35	10	[	[	X
dpc-2300	35	11	5,6	5,6	NUM
dpc-2300	35	12	]	]	PUNCT
dpc-2300	35	13	.	.	PUNCT
dpc-2300	36	1	th2	th2	PROPN
dpc-2300	36	2	response	response	NOUN
dpc-2300	36	3	and	and	CCONJ
dpc-2300	36	4	translational	translational	ADJ
dpc-2300	36	5	research	research	NOUN
dpc-2300	36	6	in	in	ADP
dpc-2300	36	7	ad	ad	NOUN
dpc-2300	36	8	il-13	il-13	PUNCT
dpc-2300	36	9	and	and	CCONJ
dpc-2300	36	10	il4	il4	NOUN
dpc-2300	36	11	have	have	AUX
dpc-2300	36	12	been	be	AUX
dpc-2300	36	13	demonstrated	demonstrate	VERB
dpc-2300	36	14	to	to	PART
dpc-2300	36	15	be	be	AUX
dpc-2300	36	16	clinically	clinically	ADV
dpc-2300	36	17	relevant	relevant	ADJ
dpc-2300	36	18	in	in	ADP
dpc-2300	36	19	ad	ad	NOUN
dpc-2300	36	20	by	by	ADP
dpc-2300	36	21	targeted	target	VERB
dpc-2300	36	22	therapeutic	therapeutic	ADJ
dpc-2300	36	23	strategies	strategy	NOUN
dpc-2300	36	24	since	since	SCONJ
dpc-2300	36	25	neutralization	neutralization	NOUN
dpc-2300	36	26	of	of	ADP
dpc-2300	36	27	il-4rα	il-4rα	PROPN
dpc-2300	36	28	and	and	CCONJ
dpc-2300	36	29	il-13	il-13	CCONJ
dpc-2300	36	30	clearly	clearly	ADV
dpc-2300	36	31	improved	improve	VERB
dpc-2300	36	32	ad	ad	NOUN
dpc-2300	36	33	by	by	ADP
dpc-2300	36	34	inhibiting	inhibit	VERB
dpc-2300	36	35	il4	il4	NOUN
dpc-2300	36	36	/	/	SYM
dpc-2300	36	37	il-13	il-13	NOUN
dpc-2300	36	38	and	and	CCONJ
dpc-2300	36	39	il-13	il-13	ADP
dpc-2300	36	40	biological	biological	ADJ
dpc-2300	36	41	activities	activity	NOUN
dpc-2300	36	42	,	,	PUNCT
dpc-2300	36	43	respectively	respectively	ADV
dpc-2300	36	44	[	[	X
dpc-2300	36	45	7	7	NUM
dpc-2300	36	46	]	]	PUNCT
dpc-2300	36	47	.	.	PUNCT
dpc-2300	37	1	in	in	ADP
dpc-2300	37	2	recent	recent	ADJ
dpc-2300	37	3	years	year	NOUN
dpc-2300	37	4	,	,	PUNCT
dpc-2300	37	5	several	several	ADJ
dpc-2300	37	6	clinical	clinical	ADJ
dpc-2300	37	7	trials	trial	NOUN
dpc-2300	37	8	with	with	ADP
dpc-2300	37	9	biological	biological	ADJ
dpc-2300	37	10	therapies	therapy	NOUN
dpc-2300	37	11	have	have	AUX
dpc-2300	37	12	sought	seek	VERB
dpc-2300	37	13	to	to	PART
dpc-2300	37	14	explore	explore	VERB
dpc-2300	37	15	the	the	DET
dpc-2300	37	16	relevance	relevance	NOUN
dpc-2300	37	17	of	of	ADP
dpc-2300	37	18	thymic	thymic	ADJ
dpc-2300	37	19	stromal	stromal	ADJ
dpc-2300	37	20	lymphoietin	lymphoietin	NOUN
dpc-2300	37	21	(	(	PUNCT
dpc-2300	37	22	tslp	tslp	PROPN
dpc-2300	37	23	)	)	PUNCT
dpc-2300	37	24	,	,	PUNCT
dpc-2300	37	25	il-25	il-25	NOUN
dpc-2300	37	26	,	,	PUNCT
dpc-2300	37	27	il-33	il-33	VERB
dpc-2300	37	28	as	as	ADP
dpc-2300	37	29	possible	possible	ADJ
dpc-2300	37	30	new	new	ADJ
dpc-2300	37	31	therapeutic	therapeutic	ADJ
dpc-2300	37	32	targets	target	NOUN
dpc-2300	37	33	for	for	ADP
dpc-2300	37	34	ad	ad	NOUN
dpc-2300	37	35	since	since	SCONJ
dpc-2300	37	36	they	they	PRON
dpc-2300	37	37	induce	induce	VERB
dpc-2300	37	38	t2	t2	NOUN
dpc-2300	37	39	response	response	NOUN
dpc-2300	37	40	in	in	ADP
dpc-2300	37	41	ilc2	ilc2	NOUN
dpc-2300	37	42	.	.	PUNCT
dpc-2300	38	1	lessons	lesson	NOUN
dpc-2300	38	2	from	from	ADP
dpc-2300	38	3	these	these	DET
dpc-2300	38	4	clinical	clinical	ADJ
dpc-2300	38	5	trials	trial	NOUN
dpc-2300	38	6	that	that	PRON
dpc-2300	38	7	explore	explore	VERB
dpc-2300	38	8	the	the	DET
dpc-2300	38	9	roles	role	NOUN
dpc-2300	38	10	of	of	ADP
dpc-2300	38	11	those	those	DET
dpc-2300	38	12	alarmins	alarmin	NOUN
dpc-2300	38	13	in	in	ADP
dpc-2300	38	14	ad	ad	NOUN
dpc-2300	38	15	patients	patient	NOUN
dpc-2300	38	16	indicate	indicate	VERB
dpc-2300	38	17	that	that	SCONJ
dpc-2300	38	18	the	the	DET
dpc-2300	38	19	neutralization	neutralization	NOUN
dpc-2300	38	20	of	of	ADP
dpc-2300	38	21	tslp	tslp	NOUN
dpc-2300	38	22	,	,	PUNCT
dpc-2300	38	23	il-25	il-25	X
dpc-2300	38	24	and	and	CCONJ
dpc-2300	38	25	il-33	il-33	ADJ
dpc-2300	38	26	is	be	AUX
dpc-2300	38	27	not	not	PART
dpc-2300	38	28	effective	effective	ADJ
dpc-2300	38	29	in	in	ADP
dpc-2300	38	30	improving	improve	VERB
dpc-2300	38	31	disease	disease	NOUN
dpc-2300	38	32	[	[	X
dpc-2300	38	33	8	8	NUM
dpc-2300	38	34	]	]	PUNCT
dpc-2300	38	35	.	.	PUNCT
dpc-2300	39	1	in	in	ADP
dpc-2300	39	2	contrast	contrast	NOUN
dpc-2300	39	3	to	to	ADP
dpc-2300	39	4	ad	ad	NOUN
dpc-2300	39	5	,	,	PUNCT
dpc-2300	39	6	in	in	ADP
dpc-2300	39	7	asthma	asthma	NOUN
dpc-2300	39	8	the	the	DET
dpc-2300	39	9	clinical	clinical	ADJ
dpc-2300	39	10	importance	importance	NOUN
dpc-2300	39	11	of	of	ADP
dpc-2300	39	12	il-33	il-33	VERB
dpc-2300	39	13	and	and	CCONJ
dpc-2300	39	14	tslp	tslp	NOUN
dpc-2300	39	15	is	be	AUX
dpc-2300	39	16	well	well	ADV
dpc-2300	39	17	demonstrated	demonstrate	VERB
dpc-2300	39	18	[	[	PUNCT
dpc-2300	39	19	9	9	NUM
dpc-2300	39	20	]	]	PUNCT
dpc-2300	39	21	.	.	PUNCT
dpc-2300	40	1	since	since	SCONJ
dpc-2300	40	2	t2	t2	NOUN
dpc-2300	40	3	cytokines	cytokine	NOUN
dpc-2300	40	4	can	can	AUX
dpc-2300	40	5	also	also	ADV
dpc-2300	40	6	be	be	AUX
dpc-2300	40	7	produced	produce	VERB
dpc-2300	40	8	by	by	ADP
dpc-2300	40	9	cd4	cd4	PROPN
dpc-2300	40	10	+	+	PROPN
dpc-2300	40	11	memory	memory	NOUN
dpc-2300	40	12	t	t	PROPN
dpc-2300	40	13	-	-	PUNCT
dpc-2300	40	14	cells	cell	NOUN
dpc-2300	40	15	,	,	PUNCT
dpc-2300	40	16	at	at	ADP
dpc-2300	40	17	the	the	DET
dpc-2300	40	18	present	present	ADJ
dpc-2300	40	19	time	time	NOUN
dpc-2300	40	20	,	,	PUNCT
dpc-2300	40	21	clinical	clinical	ADJ
dpc-2300	40	22	efficacy	efficacy	NOUN
dpc-2300	40	23	in	in	ADP
dpc-2300	40	24	patients	patient	NOUN
dpc-2300	40	25	supports	support	VERB
dpc-2300	40	26	more	more	ADV
dpc-2300	40	27	strongly	strongly	ADV
dpc-2300	40	28	the	the	DET
dpc-2300	40	29	relevance	relevance	NOUN
dpc-2300	40	30	of	of	ADP
dpc-2300	40	31	the	the	DET
dpc-2300	40	32	adaptive	adaptive	ADJ
dpc-2300	40	33	immune	immune	ADJ
dpc-2300	40	34	response	response	NOUN
dpc-2300	40	35	in	in	ADP
dpc-2300	40	36	contrast	contrast	NOUN
dpc-2300	40	37	to	to	ADP
dpc-2300	40	38	the	the	DET
dpc-2300	40	39	innate	innate	ADJ
dpc-2300	40	40	response	response	NOUN
dpc-2300	40	41	.	.	PUNCT
dpc-2300	41	1	in	in	ADP
dpc-2300	41	2	fact	fact	NOUN
dpc-2300	41	3	,	,	PUNCT
dpc-2300	41	4	cd4	cd4	PROPN
dpc-2300	41	5	+	+	NOUN
dpc-2300	41	6	memory	memory	NOUN
dpc-2300	41	7	th2	th2	PROPN
dpc-2300	41	8	cells	cell	NOUN
dpc-2300	41	9	are	be	AUX
dpc-2300	41	10	the	the	DET
dpc-2300	41	11	most	most	ADV
dpc-2300	41	12	abundant	abundant	ADJ
dpc-2300	41	13	in	in	ADP
dpc-2300	41	14	inflamed	inflamed	ADJ
dpc-2300	41	15	lesions	lesion	NOUN
dpc-2300	41	16	and	and	CCONJ
dpc-2300	41	17	considered	consider	VERB
dpc-2300	41	18	the	the	DET
dpc-2300	41	19	most	most	ADV
dpc-2300	41	20	important	important	ADJ
dpc-2300	41	21	[	[	X
dpc-2300	41	22	1	1	NUM
dpc-2300	41	23	]	]	PUNCT
dpc-2300	41	24	.	.	PUNCT
dpc-2300	42	1	interestingly	interestingly	ADV
dpc-2300	42	2	,	,	PUNCT
dpc-2300	42	3	blockage	blockage	NOUN
dpc-2300	42	4	of	of	ADP
dpc-2300	42	5	antigen	antigen	ADJ
dpc-2300	42	6	presentation	presentation	NOUN
dpc-2300	42	7	to	to	ADP
dpc-2300	42	8	table	table	NOUN
dpc-2300	42	9	1	1	NUM
dpc-2300	42	10	.	.	PUNCT
dpc-2300	42	11	targeted	target	VERB
dpc-2300	42	12	therapies	therapy	NOUN
dpc-2300	42	13	in	in	ADP
dpc-2300	42	14	moderate	moderate	ADJ
dpc-2300	42	15	-	-	PUNCT
dpc-2300	42	16	to	to	ADP
dpc-2300	42	17	-	-	PUNCT
dpc-2300	42	18	severe	severe	ADJ
dpc-2300	42	19	atopic	atopic	NOUN
dpc-2300	42	20	dermatitis	dermatitis	NOUN
dpc-2300	42	21	.	.	PUNCT
dpc-2300	43	1	target	target	NOUN
dpc-2300	43	2	mechanism	mechanism	NOUN
dpc-2300	43	3	therapy	therapy	NOUN
dpc-2300	43	4	clinical	clinical	ADJ
dpc-2300	43	5	evidence	evidence	NOUN
dpc-2300	43	6	in	in	ADP
dpc-2300	43	7	ad	ad	NOUN
dpc-2300	43	8	il-4ra	il-4ra	NUM
dpc-2300	43	9	th2	th2	PROPN
dpc-2300	43	10	(	(	PUNCT
dpc-2300	43	11	il-4	il-4	X
dpc-2300	43	12	,	,	PUNCT
dpc-2300	43	13	il-13	il-13	NUM
dpc-2300	43	14	)	)	PUNCT
dpc-2300	43	15	anti	anti	ADJ
dpc-2300	43	16	-	-	ADJ
dpc-2300	43	17	il-4rα	il-4rα	ADJ
dpc-2300	43	18	+	+	X
dpc-2300	43	19	il-13	il-13	PUNCT
dpc-2300	43	20	il-13	il-13	ADP
dpc-2300	43	21	anti	anti	ADJ
dpc-2300	43	22	-	-	ADJ
dpc-2300	43	23	il-13	il-13	PUNCT
dpc-2300	43	24	+	+	PUNCT
dpc-2300	43	25	il-31	il-31	ADJ
dpc-2300	43	26	il-31	il-31	PUNCT
dpc-2300	43	27	anti	anti	ADJ
dpc-2300	43	28	-	-	ADJ
dpc-2300	43	29	il-31ra	il-31ra	ADJ
dpc-2300	43	30	+	+	X
dpc-2300	43	31	il-22	il-22	NOUN
dpc-2300	43	32	il-22	il-22	PRON
dpc-2300	43	33	anti	anti	ADJ
dpc-2300	43	34	-	-	NOUN
dpc-2300	43	35	il-22	il-22	ADJ
dpc-2300	43	36	+	+	CCONJ
dpc-2300	43	37	ox40l	ox40l	CCONJ
dpc-2300	43	38	antigen	antigen	ADJ
dpc-2300	43	39	presentation	presentation	NOUN
dpc-2300	43	40	anti	anti	ADJ
dpc-2300	43	41	-	-	ADJ
dpc-2300	43	42	ox40l	ox40l	ADJ
dpc-2300	43	43	+	+	NUM
dpc-2300	43	44	ccr4	ccr4	PROPN
dpc-2300	43	45	ccr4	ccr4	NOUN
dpc-2300	43	46	mediated	mediate	VERB
dpc-2300	43	47	cla+	cla+	PROPN
dpc-2300	43	48	t	t	NOUN
dpc-2300	43	49	-	-	PUNCT
dpc-2300	43	50	cell	cell	NOUN
dpc-2300	43	51	chemotaxis	chemotaxis	NOUN
dpc-2300	43	52	by	by	ADP
dpc-2300	43	53	ccl17	ccl17	PROPN
dpc-2300	43	54	and	and	CCONJ
dpc-2300	43	55	ccl22	ccl22	PROPN
dpc-2300	43	56	ccr4	ccr4	NOUN
dpc-2300	43	57	antagonist	antagonist	NOUN
dpc-2300	43	58	small	small	ADJ
dpc-2300	43	59	molecule	molecule	NOUN
dpc-2300	43	60	+	+	CCONJ
dpc-2300	43	61	il-17a	il-17a	PROPN
dpc-2300	43	62	il-17a	il-17a	PROPN
dpc-2300	43	63	anti	anti	ADJ
dpc-2300	43	64	-	-	ADJ
dpc-2300	43	65	il-17a	il-17a	ADJ
dpc-2300	43	66	il-5	il-5	NOUN
dpc-2300	43	67	eosinophil	eosinophil	ADJ
dpc-2300	43	68	biology	biology	NOUN
dpc-2300	43	69	anti	anti	ADJ
dpc-2300	43	70	-	-	ADJ
dpc-2300	43	71	il-5	il-5	ADJ
dpc-2300	43	72	tslp	tslp	ADJ
dpc-2300	43	73	innate	innate	ADJ
dpc-2300	43	74	t2	t2	NOUN
dpc-2300	43	75	response	response	NOUN
dpc-2300	43	76	.	.	PUNCT
dpc-2300	44	1	tslp	tslp	ADJ
dpc-2300	44	2	activation	activation	NOUN
dpc-2300	44	3	of	of	ADP
dpc-2300	44	4	ilc2	ilc2	NOUN
dpc-2300	44	5	anti	anti	ADJ
dpc-2300	44	6	-	-	ADJ
dpc-2300	44	7	tslp	tslp	ADJ
dpc-2300	44	8	il-33	il-33	ADJ
dpc-2300	44	9	innate	innate	ADJ
dpc-2300	44	10	t2	t2	NOUN
dpc-2300	44	11	response	response	NOUN
dpc-2300	44	12	.	.	PUNCT
dpc-2300	45	1	il-33	il-33	VERB
dpc-2300	45	2	activation	activation	NOUN
dpc-2300	45	3	of	of	ADP
dpc-2300	45	4	ilc2	ilc2	NOUN
dpc-2300	45	5	anti	anti	ADJ
dpc-2300	45	6	-	-	ADJ
dpc-2300	45	7	il-33	il-33	ADJ
dpc-2300	45	8	il-25	il-25	NOUN
dpc-2300	45	9	innate	innate	VERB
dpc-2300	45	10	t2	t2	NOUN
dpc-2300	45	11	response	response	NOUN
dpc-2300	45	12	.	.	PUNCT
dpc-2300	46	1	il-25	il-25	NOUN
dpc-2300	46	2	activation	activation	NOUN
dpc-2300	46	3	of	of	ADP
dpc-2300	46	4	ilc2	ilc2	NOUN
dpc-2300	46	5	anti	anti	NOUN
dpc-2300	46	6	-	-	NOUN
dpc-2300	46	7	il-25	il-25	NOUN
dpc-2300	46	8	il-23	il-23	NOUN
dpc-2300	46	9	il-23	il-23	NOUN
dpc-2300	46	10	/	/	SYM
dpc-2300	46	11	th17	th17	PROPN
dpc-2300	46	12	axis	axis	ADJ
dpc-2300	46	13	anti	anti	ADJ
dpc-2300	46	14	-	-	ADJ
dpc-2300	46	15	il-23p19	il-23p19	ADJ
dpc-2300	46	16	tslp	tslp	ADJ
dpc-2300	46	17	=	=	PUNCT
dpc-2300	46	18	thymic	thymic	ADJ
dpc-2300	46	19	stromal	stromal	ADJ
dpc-2300	46	20	lymphopoietin	lymphopoietin	NOUN
dpc-2300	46	21	.	.	PUNCT
dpc-2300	47	1	review	review	NOUN
dpc-2300	47	2	|	|	ADV
dpc-2300	47	3	dermatol	dermatol	ADJ
dpc-2300	47	4	pract	pract	NOUN
dpc-2300	47	5	concept	concept	NOUN
dpc-2300	47	6	.	.	PUNCT
dpc-2300	48	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	48	2	3	3	NUM
dpc-2300	48	3	cd4	cd4	PROPN
dpc-2300	48	4	+	+	PROPN
dpc-2300	48	5	memory	memory	NOUN
dpc-2300	48	6	t	t	PROPN
dpc-2300	48	7	-	-	PUNCT
dpc-2300	48	8	cells	cell	NOUN
dpc-2300	48	9	by	by	ADP
dpc-2300	48	10	a	a	DET
dpc-2300	48	11	humanized	humanize	VERB
dpc-2300	48	12	monoclonal	monoclonal	NOUN
dpc-2300	48	13	antibody	antibody	NOUN
dpc-2300	48	14	that	that	PRON
dpc-2300	48	15	inhibits	inhibit	VERB
dpc-2300	48	16	the	the	DET
dpc-2300	48	17	ox	ox	ADJ
dpc-2300	48	18	-	-	PUNCT
dpc-2300	48	19	ox40l	ox40l	NUM
dpc-2300	48	20	interaction	interaction	NOUN
dpc-2300	48	21	has	have	AUX
dpc-2300	48	22	demonstrated	demonstrate	VERB
dpc-2300	48	23	to	to	PART
dpc-2300	48	24	be	be	AUX
dpc-2300	48	25	effective	effective	ADJ
dpc-2300	48	26	in	in	ADP
dpc-2300	48	27	the	the	DET
dpc-2300	48	28	clinic	clinic	NOUN
dpc-2300	48	29	(	(	PUNCT
dpc-2300	48	30	figure	figure	NOUN
dpc-2300	48	31	1	1	NUM
dpc-2300	48	32	)	)	PUNCT
dpc-2300	49	1	[	[	X
dpc-2300	49	2	10	10	NUM
dpc-2300	49	3	]	]	NUM
dpc-2300	49	4	)	)	PUNCT
dpc-2300	49	5	.	.	PUNCT
dpc-2300	50	1	il-5	il-5	PROPN
dpc-2300	50	2	constitutes	constitute	VERB
dpc-2300	50	3	another	another	DET
dpc-2300	50	4	t2	t2	NOUN
dpc-2300	50	5	cytokine	cytokine	NOUN
dpc-2300	50	6	that	that	PRON
dpc-2300	50	7	regulates	regulate	VERB
dpc-2300	50	8	eosinophil	eosinophil	ADJ
dpc-2300	50	9	generation	generation	NOUN
dpc-2300	50	10	and	and	CCONJ
dpc-2300	50	11	survival	survival	NOUN
dpc-2300	50	12	.	.	PUNCT
dpc-2300	51	1	in	in	ADP
dpc-2300	51	2	ad	ad	NOUN
dpc-2300	51	3	,	,	PUNCT
dpc-2300	51	4	neutralization	neutralization	NOUN
dpc-2300	51	5	of	of	ADP
dpc-2300	51	6	il-5	il-5	PROPN
dpc-2300	51	7	has	have	AUX
dpc-2300	51	8	not	not	PART
dpc-2300	51	9	provided	provide	VERB
dpc-2300	51	10	clinical	clinical	ADJ
dpc-2300	51	11	improvement	improvement	NOUN
dpc-2300	51	12	in	in	ADP
dpc-2300	51	13	patients	patient	NOUN
dpc-2300	51	14	,	,	PUNCT
dpc-2300	51	15	whereas	whereas	SCONJ
dpc-2300	51	16	in	in	ADP
dpc-2300	51	17	asthma	asthma	NOUN
dpc-2300	51	18	,	,	PUNCT
dpc-2300	51	19	it	it	PRON
dpc-2300	51	20	constitutes	constitute	VERB
dpc-2300	51	21	a	a	DET
dpc-2300	51	22	biological	biological	ADJ
dpc-2300	51	23	therapy	therapy	NOUN
dpc-2300	51	24	already	already	ADV
dpc-2300	51	25	approved	approve	VERB
dpc-2300	51	26	[	[	X
dpc-2300	51	27	8	8	NUM
dpc-2300	51	28	]	]	PUNCT
dpc-2300	51	29	.	.	PUNCT
dpc-2300	52	1	novel	novel	ADJ
dpc-2300	52	2	insights	insight	NOUN
dpc-2300	52	3	on	on	ADP
dpc-2300	52	4	il-13	il-13	ADP
dpc-2300	52	5	relevance	relevance	NOUN
dpc-2300	52	6	in	in	ADP
dpc-2300	52	7	ad	ad	NOUN
dpc-2300	52	8	il-4	il-4	X
dpc-2300	53	1	and	and	CCONJ
dpc-2300	53	2	il-13	il-13	CCONJ
dpc-2300	53	3	represent	represent	VERB
dpc-2300	53	4	the	the	DET
dpc-2300	53	5	best	well	ADV
dpc-2300	53	6	clinically	clinically	ADV
dpc-2300	53	7	validated	validate	VERB
dpc-2300	53	8	cytokines	cytokine	NOUN
dpc-2300	53	9	in	in	ADP
dpc-2300	53	10	ad	ad	NOUN
dpc-2300	53	11	due	due	ADP
dpc-2300	53	12	to	to	ADP
dpc-2300	53	13	the	the	DET
dpc-2300	53	14	efficacy	efficacy	NOUN
dpc-2300	53	15	of	of	ADP
dpc-2300	53	16	biologicals	biological	NOUN
dpc-2300	53	17	targeting	target	VERB
dpc-2300	53	18	il-4ra	il-4ra	NOUN
dpc-2300	53	19	and	and	CCONJ
dpc-2300	53	20	il-13	il-13	NUM
dpc-2300	53	21	.	.	PUNCT
dpc-2300	54	1	recent	recent	ADJ
dpc-2300	54	2	studies	study	NOUN
dpc-2300	54	3	in	in	ADP
dpc-2300	54	4	ad	ad	NOUN
dpc-2300	54	5	lesional	lesional	ADJ
dpc-2300	54	6	skin	skin	NOUN
dpc-2300	54	7	indicate	indicate	VERB
dpc-2300	54	8	that	that	SCONJ
dpc-2300	54	9	il-13	il-13	PUNCT
dpc-2300	54	10	may	may	AUX
dpc-2300	54	11	have	have	VERB
dpc-2300	54	12	more	more	ADJ
dpc-2300	54	13	relevance	relevance	NOUN
dpc-2300	54	14	in	in	ADP
dpc-2300	54	15	the	the	DET
dpc-2300	54	16	inflammatory	inflammatory	ADJ
dpc-2300	54	17	processes	process	NOUN
dpc-2300	54	18	that	that	PRON
dpc-2300	54	19	take	take	VERB
dpc-2300	54	20	place	place	NOUN
dpc-2300	54	21	in	in	ADP
dpc-2300	54	22	the	the	DET
dpc-2300	54	23	skin	skin	NOUN
dpc-2300	54	24	than	than	ADP
dpc-2300	54	25	il-4	il-4	NOUN
dpc-2300	55	1	[	[	X
dpc-2300	55	2	7	7	NUM
dpc-2300	55	3	]	]	PUNCT
dpc-2300	55	4	.	.	PUNCT
dpc-2300	56	1	il-13	il-13	ADP
dpc-2300	56	2	receptors	receptor	NOUN
dpc-2300	56	3	,	,	PUNCT
dpc-2300	56	4	il-13ra1	il-13ra1	PROPN
dpc-2300	56	5	and	and	CCONJ
dpc-2300	56	6	il-13ra2	il-13ra2	NOUN
dpc-2300	56	7	,	,	PUNCT
dpc-2300	56	8	are	be	AUX
dpc-2300	56	9	preferentially	preferentially	ADV
dpc-2300	56	10	found	find	VERB
dpc-2300	56	11	in	in	ADP
dpc-2300	56	12	non	non	ADJ
dpc-2300	56	13	-	-	ADJ
dpc-2300	56	14	hematopoietic	hematopoietic	ADJ
dpc-2300	56	15	cells	cell	NOUN
dpc-2300	56	16	such	such	ADJ
dpc-2300	56	17	as	as	ADP
dpc-2300	56	18	keratinocytes	keratinocyte	NOUN
dpc-2300	56	19	and	and	CCONJ
dpc-2300	56	20	fibroblasts	fibroblast	NOUN
dpc-2300	56	21	.	.	PUNCT
dpc-2300	57	1	in	in	ADP
dpc-2300	57	2	addition	addition	NOUN
dpc-2300	57	3	,	,	PUNCT
dpc-2300	57	4	il-13	il-13	PUNCT
dpc-2300	57	5	it	it	PRON
dpc-2300	57	6	is	be	AUX
dpc-2300	57	7	expressed	express	VERB
dpc-2300	57	8	in	in	ADP
dpc-2300	57	9	higher	high	ADJ
dpc-2300	57	10	level	level	NOUN
dpc-2300	57	11	in	in	ADP
dpc-2300	57	12	ad	ad	NOUN
dpc-2300	57	13	lesions	lesion	NOUN
dpc-2300	57	14	compared	compare	VERB
dpc-2300	57	15	to	to	ADP
dpc-2300	57	16	il-4	il-4	NOUN
dpc-2300	57	17	,	,	PUNCT
dpc-2300	57	18	and	and	CCONJ
dpc-2300	57	19	transcriptomic	transcriptomic	ADJ
dpc-2300	57	20	analyses	analysis	NOUN
dpc-2300	57	21	have	have	AUX
dpc-2300	57	22	demonstrated	demonstrate	VERB
dpc-2300	57	23	a	a	DET
dpc-2300	57	24	dominant	dominant	ADJ
dpc-2300	57	25	il-13	il-13	CCONJ
dpc-2300	57	26	molecular	molecular	ADJ
dpc-2300	57	27	signature	signature	NOUN
dpc-2300	58	1	[	[	X
dpc-2300	58	2	11	11	NUM
dpc-2300	58	3	]	]	PUNCT
dpc-2300	58	4	.	.	PUNCT
dpc-2300	59	1	interestingly	interestingly	ADV
dpc-2300	59	2	,	,	PUNCT
dpc-2300	59	3	jak1	jak1	PROPN
dpc-2300	59	4	is	be	AUX
dpc-2300	59	5	the	the	DET
dpc-2300	59	6	most	most	ADV
dpc-2300	59	7	highly	highly	ADV
dpc-2300	59	8	expressed	express	VERB
dpc-2300	59	9	member	member	NOUN
dpc-2300	59	10	of	of	ADP
dpc-2300	59	11	the	the	DET
dpc-2300	59	12	jak	jak	PROPN
dpc-2300	59	13	family	family	PROPN
dpc-2300	59	14	in	in	ADP
dpc-2300	59	15	lesional	lesional	ADJ
dpc-2300	59	16	ad	ad	NOUN
dpc-2300	59	17	biopsies	biopsy	NOUN
dpc-2300	59	18	and	and	CCONJ
dpc-2300	59	19	is	be	AUX
dpc-2300	59	20	involved	involve	VERB
dpc-2300	59	21	in	in	ADP
dpc-2300	59	22	il-13	il-13	CCONJ
dpc-2300	59	23	signal	signal	ADJ
dpc-2300	59	24	transduction	transduction	NOUN
dpc-2300	60	1	[	[	X
dpc-2300	60	2	12	12	NUM
dpc-2300	60	3	]	]	PUNCT
dpc-2300	60	4	.	.	PUNCT
dpc-2300	61	1	besides	besides	SCONJ
dpc-2300	61	2	this	this	PRON
dpc-2300	61	3	,	,	PUNCT
dpc-2300	61	4	il-13	il-13	VERB
dpc-2300	61	5	also	also	ADV
dpc-2300	61	6	plays	play	VERB
dpc-2300	61	7	a	a	DET
dpc-2300	61	8	relevant	relevant	ADJ
dpc-2300	61	9	role	role	NOUN
dpc-2300	61	10	in	in	ADP
dpc-2300	61	11	the	the	DET
dpc-2300	61	12	recruitment	recruitment	NOUN
dpc-2300	61	13	of	of	ADP
dpc-2300	61	14	pathogenic	pathogenic	ADJ
dpc-2300	61	15	skin	skin	NOUN
dpc-2300	61	16	-	-	PUNCT
dpc-2300	61	17	homing	home	VERB
dpc-2300	61	18	memory	memory	NOUN
dpc-2300	61	19	t	t	PROPN
dpc-2300	61	20	-	-	PUNCT
dpc-2300	61	21	cells	cell	NOUN
dpc-2300	61	22	that	that	PRON
dpc-2300	61	23	express	express	VERB
dpc-2300	61	24	the	the	DET
dpc-2300	61	25	cutaneous	cutaneous	ADJ
dpc-2300	61	26	lymphocyte	lymphocyte	NOUN
dpc-2300	61	27	-	-	PUNCT
dpc-2300	61	28	associated	associate	VERB
dpc-2300	61	29	antigen	antigen	NOUN
dpc-2300	61	30	(	(	PUNCT
dpc-2300	61	31	cla	cla	NOUN
dpc-2300	61	32	)	)	PUNCT
dpc-2300	61	33	positive	positive	ADJ
dpc-2300	61	34	on	on	ADP
dpc-2300	61	35	their	their	PRON
dpc-2300	61	36	surface	surface	NOUN
dpc-2300	61	37	[	[	X
dpc-2300	61	38	1,13	1,13	NUM
dpc-2300	61	39	]	]	PUNCT
dpc-2300	61	40	.	.	PUNCT
dpc-2300	62	1	il-13	il-13	PUNCT
dpc-2300	62	2	and	and	CCONJ
dpc-2300	62	3	ccr4	ccr4	NOUN
dpc-2300	62	4	are	be	AUX
dpc-2300	62	5	closely	closely	ADV
dpc-2300	62	6	related	relate	VERB
dpc-2300	62	7	in	in	ADP
dpc-2300	62	8	ad	ad	NOUN
dpc-2300	62	9	inflammation	inflammation	NOUN
dpc-2300	62	10	.	.	PUNCT
dpc-2300	63	1	the	the	DET
dpc-2300	63	2	ccr4	ccr4	NOUN
dpc-2300	63	3	is	be	AUX
dpc-2300	63	4	a	a	DET
dpc-2300	63	5	chemokine	chemokine	ADJ
dpc-2300	63	6	receptor	receptor	NOUN
dpc-2300	63	7	preferentially	preferentially	ADV
dpc-2300	63	8	expressed	express	VERB
dpc-2300	63	9	by	by	ADP
dpc-2300	63	10	cla+cd4	cla+cd4	PROPN
dpc-2300	63	11	+	+	CCONJ
dpc-2300	63	12	t	t	PROPN
dpc-2300	63	13	-	-	PUNCT
dpc-2300	63	14	cells	cell	NOUN
dpc-2300	64	1	[	[	X
dpc-2300	64	2	14	14	NUM
dpc-2300	64	3	]	]	X
dpc-2300	64	4	whose	whose	DET
dpc-2300	64	5	ligands	ligand	NOUN
dpc-2300	64	6	are	be	AUX
dpc-2300	64	7	ccl17	ccl17	ADJ
dpc-2300	64	8	and	and	CCONJ
dpc-2300	64	9	ccl22	ccl22	PROPN
dpc-2300	64	10	and	and	CCONJ
dpc-2300	64	11	are	be	AUX
dpc-2300	64	12	induced	induce	VERB
dpc-2300	64	13	in	in	ADP
dpc-2300	64	14	keratinocytes	keratinocyte	NOUN
dpc-2300	64	15	upon	upon	SCONJ
dpc-2300	64	16	il-13	il-13	CCONJ
dpc-2300	64	17	activation	activation	NOUN
dpc-2300	64	18	and	and	CCONJ
dpc-2300	64	19	preferentially	preferentially	ADV
dpc-2300	64	20	attract	attract	VERB
dpc-2300	65	1	cla+	cla+	NOUN
dpc-2300	65	2	cd4	cd4	PROPN
dpc-2300	65	3	+	+	PROPN
dpc-2300	65	4	lymphocytes	lymphocyte	NOUN
dpc-2300	65	5	[	[	X
dpc-2300	65	6	15	15	NUM
dpc-2300	65	7	]	]	PUNCT
dpc-2300	65	8	.	.	PUNCT
dpc-2300	66	1	interestingly	interestingly	ADV
dpc-2300	66	2	,	,	PUNCT
dpc-2300	66	3	ccl17	ccl17	PROPN
dpc-2300	66	4	is	be	AUX
dpc-2300	66	5	considered	consider	VERB
dpc-2300	66	6	a	a	DET
dpc-2300	66	7	relevant	relevant	ADJ
dpc-2300	66	8	biomarker	biomarker	NOUN
dpc-2300	66	9	for	for	ADP
dpc-2300	66	10	ad	ad	NOUN
dpc-2300	66	11	[	[	X
dpc-2300	66	12	16	16	NUM
dpc-2300	66	13	]	]	PUNCT
dpc-2300	66	14	and	and	CCONJ
dpc-2300	66	15	a	a	DET
dpc-2300	66	16	recent	recent	ADJ
dpc-2300	66	17	study	study	NOUN
dpc-2300	66	18	has	have	AUX
dpc-2300	66	19	shown	show	VERB
dpc-2300	66	20	that	that	SCONJ
dpc-2300	66	21	a	a	DET
dpc-2300	66	22	small	small	ADJ
dpc-2300	66	23	molecule	molecule	NOUN
dpc-2300	66	24	antagonist	antagonist	NOUN
dpc-2300	66	25	of	of	ADP
dpc-2300	66	26	the	the	DET
dpc-2300	66	27	ccr4	ccr4	NOUN
dpc-2300	66	28	receptor	receptor	NOUN
dpc-2300	66	29	can	can	AUX
dpc-2300	66	30	improve	improve	VERB
dpc-2300	66	31	ad	ad	NOUN
dpc-2300	66	32	[	[	X
dpc-2300	66	33	17	17	NUM
dpc-2300	66	34	]	]	PUNCT
dpc-2300	66	35	.	.	PUNCT
dpc-2300	67	1	il-13	il-13	PUNCT
dpc-2300	67	2	and	and	CCONJ
dpc-2300	67	3	il-4	il-4	PRON
dpc-2300	67	4	affect	affect	VERB
dpc-2300	67	5	the	the	DET
dpc-2300	67	6	skin	skin	NOUN
dpc-2300	67	7	barrier	barrier	NOUN
dpc-2300	67	8	function	function	NOUN
dpc-2300	67	9	and	and	CCONJ
dpc-2300	67	10	the	the	DET
dpc-2300	67	11	microbial	microbial	ADJ
dpc-2300	67	12	cutaneous	cutaneous	ADJ
dpc-2300	67	13	colonization	colonization	NOUN
dpc-2300	67	14	by	by	ADP
dpc-2300	67	15	staphyloccocus	staphyloccocus	NOUN
dpc-2300	67	16	aureus	aureus	PROPN
dpc-2300	67	17	in	in	ADP
dpc-2300	67	18	ad	ad	NOUN
dpc-2300	67	19	the	the	DET
dpc-2300	67	20	skin	skin	NOUN
dpc-2300	67	21	barrier	barrier	NOUN
dpc-2300	67	22	integrity	integrity	NOUN
dpc-2300	67	23	is	be	AUX
dpc-2300	67	24	damaged	damage	VERB
dpc-2300	67	25	in	in	ADP
dpc-2300	67	26	ad	ad	NOUN
dpc-2300	67	27	cutaneous	cutaneous	ADJ
dpc-2300	67	28	lesions	lesion	NOUN
dpc-2300	67	29	making	make	VERB
dpc-2300	67	30	the	the	DET
dpc-2300	67	31	stratum	stratum	NOUN
dpc-2300	67	32	corneum	corneum	VERB
dpc-2300	67	33	permeable	permeable	ADJ
dpc-2300	67	34	to	to	ADP
dpc-2300	67	35	allergens	allergen	NOUN
dpc-2300	67	36	,	,	PUNCT
dpc-2300	67	37	microbes	microbe	NOUN
dpc-2300	67	38	,	,	PUNCT
dpc-2300	67	39	and	and	CCONJ
dpc-2300	67	40	their	their	PRON
dpc-2300	67	41	toxins	toxin	NOUN
dpc-2300	67	42	.	.	PUNCT
dpc-2300	68	1	besides	besides	SCONJ
dpc-2300	68	2	genetic	genetic	ADJ
dpc-2300	68	3	structural	structural	ADJ
dpc-2300	68	4	defects	defect	NOUN
dpc-2300	68	5	,	,	PUNCT
dpc-2300	68	6	such	such	ADJ
dpc-2300	68	7	as	as	ADP
dpc-2300	68	8	filaggrin	filaggrin	ADJ
dpc-2300	68	9	mutations	mutation	NOUN
dpc-2300	68	10	,	,	PUNCT
dpc-2300	68	11	which	which	PRON
dpc-2300	68	12	are	be	AUX
dpc-2300	68	13	present	present	ADJ
dpc-2300	68	14	in	in	ADP
dpc-2300	68	15	some	some	DET
dpc-2300	68	16	ad	ad	NOUN
dpc-2300	68	17	patients	patient	NOUN
dpc-2300	68	18	,	,	PUNCT
dpc-2300	68	19	il-13	il-13	PUNCT
dpc-2300	68	20	and	and	CCONJ
dpc-2300	68	21	il-4	il-4	PRON
dpc-2300	68	22	reduce	reduce	VERB
dpc-2300	68	23	the	the	DET
dpc-2300	68	24	expression	expression	NOUN
dpc-2300	68	25	of	of	ADP
dpc-2300	68	26	relevant	relevant	ADJ
dpc-2300	68	27	skin	skin	NOUN
dpc-2300	68	28	elements	element	NOUN
dpc-2300	68	29	involved	involve	VERB
dpc-2300	68	30	in	in	ADP
dpc-2300	68	31	the	the	DET
dpc-2300	68	32	skin	skin	NOUN
dpc-2300	68	33	barrier	barrier	NOUN
dpc-2300	68	34	such	such	ADJ
dpc-2300	68	35	as	as	ADP
dpc-2300	68	36	filaggrin	filaggrin	NOUN
dpc-2300	68	37	,	,	PUNCT
dpc-2300	68	38	loricrin	loricrin	NOUN
dpc-2300	68	39	,	,	PUNCT
dpc-2300	68	40	involucrin	involucrin	ADJ
dpc-2300	68	41	and	and	CCONJ
dpc-2300	68	42	important	important	ADJ
dpc-2300	68	43	lipid	lipid	NOUN
dpc-2300	68	44	components	component	NOUN
dpc-2300	68	45	[	[	X
dpc-2300	68	46	18,19	18,19	NUM
dpc-2300	68	47	]	]	PUNCT
dpc-2300	68	48	.	.	PUNCT
dpc-2300	69	1	by	by	ADP
dpc-2300	69	2	far	far	ADV
dpc-2300	69	3	,	,	PUNCT
dpc-2300	69	4	staphylococcus	staphylococcus	NOUN
dpc-2300	69	5	aureus	aureus	NOUN
dpc-2300	69	6	(	(	PUNCT
dpc-2300	69	7	sa	sa	PROPN
dpc-2300	69	8	)	)	PUNCT
dpc-2300	69	9	is	be	AUX
dpc-2300	69	10	the	the	DET
dpc-2300	69	11	best	well	ADV
dpc-2300	69	12	characterized	characterize	VERB
dpc-2300	69	13	microorganism	microorganism	NOUN
dpc-2300	69	14	in	in	ADP
dpc-2300	69	15	ad	ad	NOUN
dpc-2300	69	16	because	because	SCONJ
dpc-2300	69	17	it	it	PRON
dpc-2300	69	18	is	be	AUX
dpc-2300	69	19	present	present	ADJ
dpc-2300	69	20	on	on	ADP
dpc-2300	69	21	the	the	DET
dpc-2300	69	22	skin	skin	NOUN
dpc-2300	69	23	of	of	ADP
dpc-2300	69	24	ad	ad	NOUN
dpc-2300	69	25	patients	patient	NOUN
dpc-2300	69	26	[	[	X
dpc-2300	69	27	20	20	NUM
dpc-2300	69	28	]	]	PUNCT
dpc-2300	69	29	.	.	PUNCT
dpc-2300	70	1	in	in	ADP
dpc-2300	70	2	fact	fact	NOUN
dpc-2300	70	3	,	,	PUNCT
dpc-2300	70	4	sa	sa	PROPN
dpc-2300	70	5	skin	skin	NOUN
dpc-2300	70	6	-	-	PUNCT
dpc-2300	70	7	colonized	colonize	VERB
dpc-2300	70	8	ad	ad	NOUN
dpc-2300	70	9	patients	patient	NOUN
dpc-2300	70	10	have	have	AUX
dpc-2300	70	11	been	be	AUX
dpc-2300	70	12	recently	recently	ADV
dpc-2300	70	13	shown	show	VERB
dpc-2300	70	14	to	to	PART
dpc-2300	70	15	present	present	VERB
dpc-2300	70	16	a	a	DET
dpc-2300	70	17	more	more	ADV
dpc-2300	70	18	severe	severe	ADJ
dpc-2300	70	19	form	form	NOUN
dpc-2300	70	20	of	of	ADP
dpc-2300	70	21	disease	disease	NOUN
dpc-2300	70	22	than	than	ADP
dpc-2300	70	23	figure	figure	NOUN
dpc-2300	70	24	1	1	NUM
dpc-2300	70	25	.	.	PUNCT
dpc-2300	71	1	lesson	lesson	NOUN
dpc-2300	71	2	learned	learn	VERB
dpc-2300	71	3	from	from	ADP
dpc-2300	71	4	translational	translational	ADJ
dpc-2300	71	5	immunology	immunology	NOUN
dpc-2300	71	6	in	in	ADP
dpc-2300	71	7	atopic	atopic	NOUN
dpc-2300	71	8	dermatitis	dermatitis	NOUN
dpc-2300	71	9	(	(	PUNCT
dpc-2300	71	10	ad	ad	NOUN
dpc-2300	71	11	)	)	PUNCT
dpc-2300	71	12	.	.	PUNCT
dpc-2300	72	1	the	the	DET
dpc-2300	72	2	skin	skin	NOUN
dpc-2300	72	3	barrier	barrier	NOUN
dpc-2300	72	4	abnormality	abnormality	NOUN
dpc-2300	72	5	,	,	PUNCT
dpc-2300	72	6	together	together	ADV
dpc-2300	72	7	with	with	ADP
dpc-2300	72	8	the	the	DET
dpc-2300	72	9	itch	itch	NOUN
dpc-2300	72	10	-	-	PUNCT
dpc-2300	72	11	scratching	scratch	VERB
dpc-2300	72	12	cycle	cycle	NOUN
dpc-2300	72	13	in	in	ADP
dpc-2300	72	14	ad	ad	NOUN
dpc-2300	72	15	,	,	PUNCT
dpc-2300	72	16	facilitate	facilitate	VERB
dpc-2300	72	17	skin	skin	NOUN
dpc-2300	72	18	entry	entry	NOUN
dpc-2300	72	19	of	of	ADP
dpc-2300	72	20	allergens	allergen	NOUN
dpc-2300	72	21	and	and	CCONJ
dpc-2300	72	22	staphylococcus	staphylococcus	NOUN
dpc-2300	72	23	aureus	aureus	PROPN
dpc-2300	72	24	that	that	SCONJ
dpc-2300	72	25	active	active	ADJ
dpc-2300	72	26	pathogenic	pathogenic	ADJ
dpc-2300	72	27	skin	skin	NOUN
dpc-2300	72	28	-	-	PUNCT
dpc-2300	72	29	homing	home	VERB
dpc-2300	72	30	cla+	cla+	NOUN
dpc-2300	72	31	cd4+ccr4	cd4+ccr4	PROPN
dpc-2300	72	32	+	+	SYM
dpc-2300	72	33	memory	memory	NOUN
dpc-2300	72	34	t	t	PROPN
dpc-2300	72	35	-	-	PUNCT
dpc-2300	72	36	cells	cell	NOUN
dpc-2300	72	37	leading	lead	VERB
dpc-2300	72	38	to	to	ADP
dpc-2300	72	39	production	production	NOUN
dpc-2300	72	40	of	of	ADP
dpc-2300	72	41	il-13	il-13	PRON
dpc-2300	72	42	,	,	PUNCT
dpc-2300	72	43	il-4	il-4	PRON
dpc-2300	72	44	,	,	PUNCT
dpc-2300	72	45	il-31	il-31	X
dpc-2300	72	46	,	,	PUNCT
dpc-2300	72	47	and	and	CCONJ
dpc-2300	72	48	il-22	il-22	NOUN
dpc-2300	72	49	.	.	PUNCT
dpc-2300	73	1	th2	th2	PROPN
dpc-2300	73	2	cytokines	cytokine	VERB
dpc-2300	73	3	further	far	ADV
dpc-2300	73	4	alter	alter	VERB
dpc-2300	73	5	the	the	DET
dpc-2300	73	6	skin	skin	NOUN
dpc-2300	73	7	barrier	barrier	NOUN
dpc-2300	73	8	,	,	PUNCT
dpc-2300	73	9	decreasing	decrease	VERB
dpc-2300	73	10	natural	natural	ADJ
dpc-2300	73	11	antimicrobial	antimicrobial	ADJ
dpc-2300	73	12	peptides	peptide	NOUN
dpc-2300	73	13	that	that	PRON
dpc-2300	73	14	promote	promote	VERB
dpc-2300	73	15	staphylococcus	staphylococcus	NOUN
dpc-2300	73	16	aureus	aureus	NOUN
dpc-2300	73	17	colonization	colonization	NOUN
dpc-2300	73	18	.	.	PUNCT
dpc-2300	74	1	cytokines	cytokine	NOUN
dpc-2300	74	2	il-4	il-4	PRON
dpc-2300	74	3	,	,	PUNCT
dpc-2300	74	4	il-13	il-13	ADV
dpc-2300	74	5	,	,	PUNCT
dpc-2300	74	6	and	and	CCONJ
dpc-2300	74	7	il-31	il-31	PUNCT
dpc-2300	74	8	bind	bind	VERB
dpc-2300	74	9	to	to	ADP
dpc-2300	74	10	their	their	PRON
dpc-2300	74	11	respective	respective	ADJ
dpc-2300	74	12	receptors	receptor	NOUN
dpc-2300	74	13	present	present	ADJ
dpc-2300	74	14	in	in	ADP
dpc-2300	74	15	sensitive	sensitive	ADJ
dpc-2300	74	16	neurons	neuron	NOUN
dpc-2300	74	17	in	in	ADP
dpc-2300	74	18	the	the	DET
dpc-2300	74	19	skin	skin	NOUN
dpc-2300	74	20	that	that	PRON
dpc-2300	74	21	transmit	transmit	VERB
dpc-2300	74	22	pruritus	pruritus	PROPN
dpc-2300	74	23	to	to	ADP
dpc-2300	74	24	the	the	DET
dpc-2300	74	25	central	central	ADJ
dpc-2300	74	26	nervous	nervous	ADJ
dpc-2300	74	27	system	system	NOUN
dpc-2300	74	28	.	.	PUNCT
dpc-2300	75	1	inflammation	inflammation	NOUN
dpc-2300	75	2	is	be	AUX
dpc-2300	75	3	amplified	amplify	VERB
dpc-2300	75	4	by	by	ADP
dpc-2300	75	5	il-13	il-13	ADV
dpc-2300	75	6	-	-	PUNCT
dpc-2300	75	7	mediated	mediate	VERB
dpc-2300	75	8	infiltration	infiltration	NOUN
dpc-2300	75	9	of	of	ADP
dpc-2300	75	10	cla+cd4+ccr4	cla+cd4+ccr4	NOUN
dpc-2300	75	11	+	+	PROPN
dpc-2300	75	12	t	t	NOUN
dpc-2300	75	13	cells	cell	NOUN
dpc-2300	75	14	attracted	attract	VERB
dpc-2300	75	15	by	by	ADP
dpc-2300	75	16	il-13	il-13	ADV
dpc-2300	75	17	-	-	PUNCT
dpc-2300	75	18	induced	induce	VERB
dpc-2300	75	19	ccl17	ccl17	ADJ
dpc-2300	75	20	production	production	NOUN
dpc-2300	75	21	by	by	ADP
dpc-2300	75	22	keratinocytes	keratinocyte	NOUN
dpc-2300	75	23	.	.	PUNCT
dpc-2300	76	1	4	4	NUM
dpc-2300	76	2	review	review	NOUN
dpc-2300	76	3	|	|	ADV
dpc-2300	76	4	dermatol	dermatol	ADJ
dpc-2300	76	5	pract	pract	NOUN
dpc-2300	76	6	concept	concept	NOUN
dpc-2300	76	7	.	.	PUNCT
dpc-2300	77	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	77	2	non	non	ADJ
dpc-2300	77	3	-	-	ADJ
dpc-2300	77	4	colonized	colonized	ADJ
dpc-2300	77	5	ones	one	NOUN
dpc-2300	77	6	[	[	X
dpc-2300	77	7	21	21	NUM
dpc-2300	77	8	]	]	PUNCT
dpc-2300	77	9	.	.	PUNCT
dpc-2300	78	1	th2	th2	PROPN
dpc-2300	78	2	cytokines	cytokine	NOUN
dpc-2300	78	3	have	have	AUX
dpc-2300	78	4	been	be	AUX
dpc-2300	78	5	shown	show	VERB
dpc-2300	78	6	to	to	PART
dpc-2300	78	7	facilitate	facilitate	VERB
dpc-2300	78	8	skin	skin	NOUN
dpc-2300	78	9	colonization	colonization	NOUN
dpc-2300	78	10	by	by	ADP
dpc-2300	78	11	sa	sa	PROPN
dpc-2300	78	12	since	since	SCONJ
dpc-2300	78	13	they	they	PRON
dpc-2300	78	14	reduce	reduce	VERB
dpc-2300	78	15	the	the	DET
dpc-2300	78	16	expression	expression	NOUN
dpc-2300	78	17	of	of	ADP
dpc-2300	78	18	natural	natural	ADJ
dpc-2300	78	19	antimicrobial	antimicrobial	ADJ
dpc-2300	78	20	peptides	peptide	NOUN
dpc-2300	78	21	,	,	PUNCT
dpc-2300	78	22	thus	thus	ADV
dpc-2300	78	23	reducing	reduce	VERB
dpc-2300	78	24	defenses	defense	NOUN
dpc-2300	78	25	against	against	ADP
dpc-2300	78	26	sa	sa	NOUN
dpc-2300	78	27	infection	infection	NOUN
dpc-2300	78	28	,	,	PUNCT
dpc-2300	78	29	favoring	favor	VERB
dpc-2300	78	30	sa	sa	NOUN
dpc-2300	78	31	skin	skin	NOUN
dpc-2300	78	32	adherence	adherence	NOUN
dpc-2300	78	33	by	by	ADP
dpc-2300	78	34	promoting	promote	VERB
dpc-2300	78	35	fibronectin	fibronectin	NOUN
dpc-2300	78	36	production	production	NOUN
dpc-2300	78	37	[	[	X
dpc-2300	78	38	20	20	NUM
dpc-2300	78	39	]	]	PUNCT
dpc-2300	78	40	.	.	PUNCT
dpc-2300	79	1	immunological	immunological	ADJ
dpc-2300	79	2	mechanisms	mechanism	NOUN
dpc-2300	79	3	of	of	ADP
dpc-2300	79	4	pruritus	pruritus	PROPN
dpc-2300	79	5	itch	itch	NOUN
dpc-2300	79	6	is	be	AUX
dpc-2300	79	7	probably	probably	ADV
dpc-2300	79	8	the	the	DET
dpc-2300	79	9	symptom	symptom	NOUN
dpc-2300	79	10	that	that	PRON
dpc-2300	79	11	most	most	ADV
dpc-2300	79	12	affects	affect	VERB
dpc-2300	79	13	the	the	DET
dpc-2300	79	14	quality	quality	NOUN
dpc-2300	79	15	of	of	ADP
dpc-2300	79	16	life	life	NOUN
dpc-2300	79	17	of	of	ADP
dpc-2300	79	18	ad	ad	NOUN
dpc-2300	79	19	patients	patient	NOUN
dpc-2300	79	20	,	,	PUNCT
dpc-2300	79	21	and	and	CCONJ
dpc-2300	79	22	it	it	PRON
dpc-2300	79	23	is	be	AUX
dpc-2300	79	24	part	part	NOUN
dpc-2300	79	25	of	of	ADP
dpc-2300	79	26	the	the	DET
dpc-2300	79	27	itch	itch	NOUN
dpc-2300	79	28	-	-	PUNCT
dpc-2300	79	29	scratching	scratch	VERB
dpc-2300	79	30	cycle	cycle	NOUN
dpc-2300	79	31	that	that	PRON
dpc-2300	79	32	most	most	ADJ
dpc-2300	79	33	patients	patient	NOUN
dpc-2300	79	34	suffer	suffer	VERB
dpc-2300	79	35	from	from	ADP
dpc-2300	79	36	[	[	X
dpc-2300	79	37	22	22	NUM
dpc-2300	79	38	]	]	PUNCT
dpc-2300	79	39	.	.	PUNCT
dpc-2300	80	1	the	the	DET
dpc-2300	80	2	adaptive	adaptive	ADJ
dpc-2300	80	3	immune	immune	ADJ
dpc-2300	80	4	response	response	NOUN
dpc-2300	80	5	is	be	AUX
dpc-2300	80	6	responsible	responsible	ADJ
dpc-2300	80	7	to	to	ADP
dpc-2300	80	8	a	a	DET
dpc-2300	80	9	great	great	ADJ
dpc-2300	80	10	extent	extent	NOUN
dpc-2300	80	11	of	of	ADP
dpc-2300	80	12	the	the	DET
dpc-2300	80	13	pruritus	pruritus	NOUN
dpc-2300	80	14	present	present	ADJ
dpc-2300	80	15	in	in	ADP
dpc-2300	80	16	ad	ad	NOUN
dpc-2300	80	17	as	as	SCONJ
dpc-2300	80	18	demonstrated	demonstrate	VERB
dpc-2300	80	19	by	by	ADP
dpc-2300	80	20	biological	biological	ADJ
dpc-2300	80	21	therapies	therapy	NOUN
dpc-2300	80	22	and	and	CCONJ
dpc-2300	80	23	small	small	ADJ
dpc-2300	80	24	molecules	molecule	NOUN
dpc-2300	80	25	that	that	PRON
dpc-2300	80	26	inhibit	inhibit	VERB
dpc-2300	80	27	key	key	ADJ
dpc-2300	80	28	signaling	signal	VERB
dpc-2300	80	29	pathways	pathway	NOUN
dpc-2300	80	30	involved	involve	VERB
dpc-2300	80	31	in	in	ADP
dpc-2300	80	32	pruritus	pruritus	PROPN
dpc-2300	80	33	.	.	PUNCT
dpc-2300	81	1	there	there	PRON
dpc-2300	81	2	are	be	VERB
dpc-2300	81	3	2	2	NUM
dpc-2300	81	4	different	different	ADJ
dpc-2300	81	5	immunological	immunological	ADJ
dpc-2300	81	6	mechanisms	mechanism	NOUN
dpc-2300	81	7	behind	behind	ADP
dpc-2300	81	8	the	the	DET
dpc-2300	81	9	adaptive	adaptive	ADJ
dpc-2300	81	10	immune	immune	ADJ
dpc-2300	81	11	response	response	NOUN
dpc-2300	81	12	and	and	CCONJ
dpc-2300	81	13	signal	signal	ADJ
dpc-2300	81	14	transduction	transduction	NOUN
dpc-2300	81	15	of	of	ADP
dpc-2300	81	16	itch	itch	NOUN
dpc-2300	81	17	by	by	ADP
dpc-2300	81	18	sensitive	sensitive	ADJ
dpc-2300	81	19	nervous	nervous	ADJ
dpc-2300	81	20	fibers	fiber	NOUN
dpc-2300	81	21	in	in	ADP
dpc-2300	81	22	the	the	DET
dpc-2300	81	23	skin	skin	NOUN
dpc-2300	81	24	.	.	PUNCT
dpc-2300	82	1	cd4	cd4	PROPN
dpc-2300	82	2	+	+	PROPN
dpc-2300	82	3	th2	th2	PROPN
dpc-2300	82	4	cells	cell	NOUN
dpc-2300	82	5	producing	produce	VERB
dpc-2300	82	6	il-4	il-4	X
dpc-2300	82	7	and	and	CCONJ
dpc-2300	82	8	il-13	il-13	NUM
dpc-2300	82	9	,	,	PUNCT
dpc-2300	82	10	and	and	CCONJ
dpc-2300	82	11	the	the	DET
dpc-2300	82	12	th2	th2	PROPN
dpc-2300	82	13	related	relate	VERB
dpc-2300	82	14	il-31	il-31	ADP
dpc-2300	82	15	.	.	PUNCT
dpc-2300	83	1	these	these	DET
dpc-2300	83	2	3	3	NUM
dpc-2300	83	3	cytokines	cytokine	NOUN
dpc-2300	83	4	stimulate	stimulate	VERB
dpc-2300	83	5	sensitive	sensitive	ADJ
dpc-2300	83	6	cutaneous	cutaneous	ADJ
dpc-2300	83	7	fibers	fiber	NOUN
dpc-2300	83	8	that	that	PRON
dpc-2300	83	9	express	express	VERB
dpc-2300	83	10	their	their	PRON
dpc-2300	83	11	specific	specific	ADJ
dpc-2300	83	12	receptors	receptor	NOUN
dpc-2300	83	13	to	to	PART
dpc-2300	83	14	transmit	transmit	VERB
dpc-2300	83	15	pruritus	pruritus	PROPN
dpc-2300	83	16	to	to	ADP
dpc-2300	83	17	the	the	DET
dpc-2300	83	18	central	central	ADJ
dpc-2300	83	19	nervous	nervous	ADJ
dpc-2300	83	20	system	system	NOUN
dpc-2300	83	21	through	through	ADP
dpc-2300	83	22	jak1	jak1	PROPN
dpc-2300	83	23	kinase	kinase	NOUN
dpc-2300	83	24	signaling	signal	VERB
dpc-2300	83	25	[	[	X
dpc-2300	83	26	23	23	NUM
dpc-2300	83	27	]	]	PUNCT
dpc-2300	83	28	.	.	PUNCT
dpc-2300	84	1	the	the	DET
dpc-2300	84	2	relevance	relevance	NOUN
dpc-2300	84	3	of	of	ADP
dpc-2300	84	4	il-4	il-4	NOUN
dpc-2300	84	5	and	and	CCONJ
dpc-2300	84	6	il-13	il-13	X
dpc-2300	84	7	in	in	ADP
dpc-2300	84	8	pruritus	pruritus	PROPN
dpc-2300	84	9	is	be	AUX
dpc-2300	84	10	supported	support	VERB
dpc-2300	84	11	by	by	ADP
dpc-2300	84	12	the	the	DET
dpc-2300	84	13	important	important	ADJ
dpc-2300	84	14	release	release	NOUN
dpc-2300	84	15	of	of	ADP
dpc-2300	84	16	itch	itch	NOUN
dpc-2300	84	17	by	by	ADP
dpc-2300	84	18	neutralizing	neutralize	VERB
dpc-2300	84	19	antibodies	antibody	NOUN
dpc-2300	84	20	to	to	ADP
dpc-2300	84	21	il-4ra	il-4ra	NOUN
dpc-2300	84	22	and	and	CCONJ
dpc-2300	84	23	il-13	il-13	X
dpc-2300	84	24	in	in	ADP
dpc-2300	84	25	moderate	moderate	ADJ
dpc-2300	84	26	to	to	ADP
dpc-2300	84	27	severe	severe	ADJ
dpc-2300	84	28	patients	patient	NOUN
dpc-2300	84	29	.	.	PUNCT
dpc-2300	85	1	in	in	ADP
dpc-2300	85	2	addition	addition	NOUN
dpc-2300	85	3	,	,	PUNCT
dpc-2300	85	4	small	small	ADJ
dpc-2300	85	5	molecules	molecule	NOUN
dpc-2300	85	6	that	that	PRON
dpc-2300	85	7	act	act	VERB
dpc-2300	85	8	as	as	ADP
dpc-2300	85	9	jak	jak	PROPN
dpc-2300	85	10	inhibitors	inhibitor	NOUN
dpc-2300	85	11	and	and	CCONJ
dpc-2300	85	12	block	block	VERB
dpc-2300	85	13	jak1	jak1	NOUN
dpc-2300	85	14	signaling	signal	VERB
dpc-2300	85	15	of	of	ADP
dpc-2300	85	16	il-4	il-4	NOUN
dpc-2300	85	17	and	and	CCONJ
dpc-2300	85	18	il-13	il-13	ADP
dpc-2300	85	19	receptors	receptor	NOUN
dpc-2300	85	20	,	,	PUNCT
dpc-2300	85	21	are	be	AUX
dpc-2300	85	22	also	also	ADV
dpc-2300	85	23	potent	potent	ADJ
dpc-2300	85	24	therapies	therapy	NOUN
dpc-2300	85	25	that	that	PRON
dpc-2300	85	26	act	act	VERB
dpc-2300	85	27	on	on	ADP
dpc-2300	85	28	immune	immune	NOUN
dpc-2300	85	29	-	-	PUNCT
dpc-2300	85	30	mediated	mediate	VERB
dpc-2300	85	31	itch	itch	NOUN
dpc-2300	85	32	.	.	PUNCT
dpc-2300	86	1	il-31	il-31	PUNCT
dpc-2300	86	2	is	be	AUX
dpc-2300	86	3	a	a	DET
dpc-2300	86	4	unique	unique	ADJ
dpc-2300	86	5	cytokine	cytokine	NOUN
dpc-2300	86	6	since	since	SCONJ
dpc-2300	86	7	it	it	PRON
dpc-2300	86	8	is	be	AUX
dpc-2300	86	9	mainly	mainly	ADV
dpc-2300	86	10	involved	involve	VERB
dpc-2300	86	11	in	in	ADP
dpc-2300	86	12	pruritus	pruritus	PROPN
dpc-2300	86	13	generation	generation	NOUN
dpc-2300	86	14	.	.	PUNCT
dpc-2300	87	1	cla+cd4	cla+cd4	NOUN
dpc-2300	88	1	+	+	NUM
dpc-2300	88	2	memory	memory	NOUN
dpc-2300	88	3	t	t	PROPN
dpc-2300	88	4	-	-	PUNCT
dpc-2300	88	5	cells	cell	NOUN
dpc-2300	88	6	constitute	constitute	VERB
dpc-2300	88	7	the	the	DET
dpc-2300	88	8	main	main	ADJ
dpc-2300	88	9	source	source	NOUN
dpc-2300	88	10	of	of	ADP
dpc-2300	88	11	il-31	il-31	NOUN
dpc-2300	88	12	[	[	X
dpc-2300	88	13	24	24	NUM
dpc-2300	88	14	]	]	PUNCT
dpc-2300	88	15	.	.	PUNCT
dpc-2300	89	1	il-31	il-31	PUNCT
dpc-2300	89	2	binds	bind	VERB
dpc-2300	89	3	to	to	ADP
dpc-2300	89	4	the	the	DET
dpc-2300	89	5	il-31ra	il-31ra	NOUN
dpc-2300	89	6	that	that	SCONJ
dpc-2300	89	7	it	it	PRON
dpc-2300	89	8	is	be	AUX
dpc-2300	89	9	expressed	express	VERB
dpc-2300	89	10	in	in	ADP
dpc-2300	89	11	cutaneous	cutaneous	ADJ
dpc-2300	89	12	sensitive	sensitive	ADJ
dpc-2300	89	13	neurons	neuron	NOUN
dpc-2300	89	14	and	and	CCONJ
dpc-2300	89	15	transduces	transduce	NOUN
dpc-2300	89	16	signaling	signal	VERB
dpc-2300	89	17	through	through	ADP
dpc-2300	89	18	jak1	jak1	NOUN
dpc-2300	89	19	signaling	signal	VERB
dpc-2300	89	20	.	.	PUNCT
dpc-2300	90	1	the	the	DET
dpc-2300	90	2	relevance	relevance	NOUN
dpc-2300	90	3	of	of	ADP
dpc-2300	90	4	il-31	il-31	ADJ
dpc-2300	90	5	in	in	ADP
dpc-2300	90	6	itch	itch	NOUN
dpc-2300	90	7	in	in	ADP
dpc-2300	90	8	ad	ad	NOUN
dpc-2300	90	9	patients	patient	NOUN
dpc-2300	90	10	is	be	AUX
dpc-2300	90	11	supported	support	VERB
dpc-2300	90	12	by	by	ADP
dpc-2300	90	13	the	the	DET
dpc-2300	90	14	antipruritic	antipruritic	ADJ
dpc-2300	90	15	activity	activity	NOUN
dpc-2300	90	16	of	of	ADP
dpc-2300	90	17	anti	anti	ADJ
dpc-2300	90	18	-	-	ADJ
dpc-2300	90	19	il-31ra	il-31ra	NOUN
dpc-2300	90	20	which	which	PRON
dpc-2300	90	21	is	be	AUX
dpc-2300	90	22	currently	currently	ADV
dpc-2300	90	23	in	in	ADP
dpc-2300	90	24	phase	phase	NOUN
dpc-2300	90	25	iii	iii	NUM
dpc-2300	90	26	trials	trial	NOUN
dpc-2300	90	27	[	[	X
dpc-2300	90	28	25	25	NUM
dpc-2300	90	29	]	]	PUNCT
dpc-2300	90	30	.	.	PUNCT
dpc-2300	91	1	immunological	immunological	ADJ
dpc-2300	91	2	response	response	NOUN
dpc-2300	91	3	in	in	ADP
dpc-2300	91	4	ad	ad	NOUN
dpc-2300	91	5	:	:	PUNCT
dpc-2300	91	6	beyond	beyond	ADP
dpc-2300	91	7	th2	th2	PROPN
dpc-2300	91	8	and	and	CCONJ
dpc-2300	91	9	th1	th1	X
dpc-2300	91	10	the	the	DET
dpc-2300	91	11	classical	classical	ADJ
dpc-2300	91	12	model	model	NOUN
dpc-2300	91	13	of	of	ADP
dpc-2300	91	14	ad	ad	NOUN
dpc-2300	91	15	pathogenesis	pathogenesis	NOUN
dpc-2300	91	16	where	where	SCONJ
dpc-2300	91	17	the	the	DET
dpc-2300	91	18	acute	acute	ADJ
dpc-2300	91	19	phase	phase	NOUN
dpc-2300	91	20	is	be	AUX
dpc-2300	91	21	th2	th2	PROPN
dpc-2300	91	22	and	and	CCONJ
dpc-2300	91	23	the	the	DET
dpc-2300	91	24	chronic	chronic	ADJ
dpc-2300	91	25	stage	stage	NOUN
dpc-2300	91	26	is	be	AUX
dpc-2300	91	27	th1	th1	NOUN
dpc-2300	91	28	has	have	AUX
dpc-2300	91	29	evolved	evolve	VERB
dpc-2300	91	30	to	to	ADP
dpc-2300	91	31	more	more	ADJ
dpc-2300	91	32	a	a	DET
dpc-2300	91	33	complex	complex	ADJ
dpc-2300	91	34	scenario	scenario	NOUN
dpc-2300	91	35	including	include	VERB
dpc-2300	91	36	th1	th1	PROPN
dpc-2300	91	37	,	,	PUNCT
dpc-2300	91	38	th2	th2	PROPN
dpc-2300	91	39	,	,	PUNCT
dpc-2300	91	40	th17	th17	PROPN
dpc-2300	91	41	,	,	PUNCT
dpc-2300	91	42	and	and	CCONJ
dpc-2300	91	43	th22	th22	PROPN
dpc-2300	91	44	cytokines	cytokine	VERB
dpc-2300	92	1	[	[	X
dpc-2300	92	2	26	26	NUM
dpc-2300	92	3	]	]	PUNCT
dpc-2300	92	4	.	.	PUNCT
dpc-2300	93	1	however	however	ADV
dpc-2300	93	2	,	,	PUNCT
dpc-2300	93	3	the	the	DET
dpc-2300	93	4	presence	presence	NOUN
dpc-2300	93	5	of	of	ADP
dpc-2300	93	6	all	all	DET
dpc-2300	93	7	those	those	DET
dpc-2300	93	8	t	t	NOUN
dpc-2300	93	9	-	-	PUNCT
dpc-2300	93	10	cell	cell	NOUN
dpc-2300	93	11	subtypes	subtype	NOUN
dpc-2300	93	12	in	in	ADP
dpc-2300	93	13	ad	ad	NOUN
dpc-2300	93	14	does	do	AUX
dpc-2300	93	15	not	not	PART
dpc-2300	93	16	imply	imply	VERB
dpc-2300	93	17	they	they	PRON
dpc-2300	93	18	are	be	AUX
dpc-2300	93	19	clinically	clinically	ADV
dpc-2300	93	20	relevant	relevant	ADJ
dpc-2300	93	21	players	player	NOUN
dpc-2300	93	22	.	.	PUNCT
dpc-2300	94	1	at	at	ADP
dpc-2300	94	2	present	present	ADJ
dpc-2300	94	3	,	,	PUNCT
dpc-2300	94	4	translational	translational	ADJ
dpc-2300	94	5	research	research	NOUN
dpc-2300	94	6	has	have	AUX
dpc-2300	94	7	demonstrated	demonstrate	VERB
dpc-2300	94	8	that	that	SCONJ
dpc-2300	94	9	only	only	ADV
dpc-2300	94	10	some	some	PRON
dpc-2300	94	11	of	of	ADP
dpc-2300	94	12	them	they	PRON
dpc-2300	94	13	are	be	AUX
dpc-2300	94	14	important	important	ADJ
dpc-2300	94	15	,	,	PUNCT
dpc-2300	94	16	although	although	SCONJ
dpc-2300	94	17	it	it	PRON
dpc-2300	94	18	can	can	AUX
dpc-2300	94	19	not	not	PART
dpc-2300	94	20	be	be	AUX
dpc-2300	94	21	discarded	discard	VERB
dpc-2300	94	22	that	that	SCONJ
dpc-2300	94	23	in	in	ADP
dpc-2300	94	24	different	different	ADJ
dpc-2300	94	25	ad	ad	NOUN
dpc-2300	94	26	phenotypes	phenotype	NOUN
dpc-2300	94	27	,	,	PUNCT
dpc-2300	94	28	endotypes	endotype	NOUN
dpc-2300	94	29	,	,	PUNCT
dpc-2300	94	30	or	or	CCONJ
dpc-2300	94	31	ethnicities	ethnicity	NOUN
dpc-2300	94	32	these	these	DET
dpc-2300	94	33	cytokines	cytokine	NOUN
dpc-2300	94	34	may	may	AUX
dpc-2300	94	35	be	be	AUX
dpc-2300	94	36	relevant	relevant	ADJ
dpc-2300	94	37	.	.	PUNCT
dpc-2300	95	1	il-22	il-22	NOUN
dpc-2300	95	2	,	,	PUNCT
dpc-2300	95	3	il-17a	il-17a	PROPN
dpc-2300	95	4	and	and	CCONJ
dpc-2300	95	5	il-23	il-23	NOUN
dpc-2300	95	6	are	be	AUX
dpc-2300	95	7	well	well	ADV
dpc-2300	95	8	characterized	characterized	ADJ
dpc-2300	95	9	mediators	mediator	NOUN
dpc-2300	95	10	of	of	ADP
dpc-2300	95	11	inflammation	inflammation	NOUN
dpc-2300	95	12	in	in	ADP
dpc-2300	95	13	psoriasis	psoriasis	NOUN
dpc-2300	95	14	;	;	PUNCT
dpc-2300	95	15	however	however	ADV
dpc-2300	95	16	,	,	PUNCT
dpc-2300	95	17	they	they	PRON
dpc-2300	95	18	are	be	AUX
dpc-2300	95	19	also	also	ADV
dpc-2300	95	20	present	present	ADJ
dpc-2300	95	21	in	in	ADP
dpc-2300	95	22	ad	ad	NOUN
dpc-2300	95	23	inflammation	inflammation	NOUN
dpc-2300	95	24	.	.	PUNCT
dpc-2300	96	1	the	the	DET
dpc-2300	96	2	study	study	NOUN
dpc-2300	96	3	of	of	ADP
dpc-2300	96	4	specific	specific	ADJ
dpc-2300	96	5	antibodies	antibody	NOUN
dpc-2300	96	6	for	for	ADP
dpc-2300	96	7	these	these	DET
dpc-2300	96	8	cytokines	cytokine	NOUN
dpc-2300	96	9	in	in	ADP
dpc-2300	96	10	ad	ad	NOUN
dpc-2300	96	11	patients	patient	NOUN
dpc-2300	96	12	has	have	AUX
dpc-2300	96	13	clarified	clarify	VERB
dpc-2300	96	14	their	their	PRON
dpc-2300	96	15	role	role	NOUN
dpc-2300	96	16	in	in	ADP
dpc-2300	96	17	this	this	DET
dpc-2300	96	18	disease	disease	NOUN
dpc-2300	96	19	.	.	PUNCT
dpc-2300	97	1	neutralization	neutralization	NOUN
dpc-2300	97	2	of	of	ADP
dpc-2300	97	3	il-22	il-22	NUM
dpc-2300	97	4	improved	improve	VERB
dpc-2300	97	5	ad	ad	NOUN
dpc-2300	97	6	preferentially	preferentially	ADV
dpc-2300	97	7	in	in	ADP
dpc-2300	97	8	patients	patient	NOUN
dpc-2300	97	9	with	with	ADP
dpc-2300	97	10	increased	increase	VERB
dpc-2300	97	11	lesional	lesional	ADJ
dpc-2300	97	12	expression	expression	NOUN
dpc-2300	97	13	of	of	ADP
dpc-2300	97	14	il-22	il-22	NOUN
dpc-2300	97	15	at	at	ADP
dpc-2300	97	16	baseline	baseline	NOUN
dpc-2300	97	17	[	[	X
dpc-2300	97	18	27	27	NUM
dpc-2300	97	19	]	]	PUNCT
dpc-2300	97	20	.	.	PUNCT
dpc-2300	98	1	current	current	ADJ
dpc-2300	98	2	efforts	effort	NOUN
dpc-2300	98	3	to	to	PART
dpc-2300	98	4	demonstrate	demonstrate	VERB
dpc-2300	98	5	the	the	DET
dpc-2300	98	6	clinical	clinical	ADJ
dpc-2300	98	7	relevance	relevance	NOUN
dpc-2300	98	8	of	of	ADP
dpc-2300	98	9	il-17a	il-17a	PROPN
dpc-2300	98	10	and	and	CCONJ
dpc-2300	98	11	il-23	il-23	NOUN
dpc-2300	98	12	have	have	AUX
dpc-2300	98	13	failed	fail	VERB
dpc-2300	98	14	since	since	SCONJ
dpc-2300	98	15	neutralization	neutralization	NOUN
dpc-2300	98	16	of	of	ADP
dpc-2300	98	17	those	those	DET
dpc-2300	98	18	cytokines	cytokine	NOUN
dpc-2300	98	19	in	in	ADP
dpc-2300	98	20	patients	patient	NOUN
dpc-2300	98	21	has	have	AUX
dpc-2300	98	22	not	not	PART
dpc-2300	98	23	provided	provide	VERB
dpc-2300	98	24	any	any	DET
dpc-2300	98	25	clinical	clinical	ADJ
dpc-2300	98	26	benefit	benefit	NOUN
dpc-2300	98	27	[	[	X
dpc-2300	98	28	8	8	NUM
dpc-2300	98	29	]	]	PUNCT
dpc-2300	98	30	.	.	PUNCT
dpc-2300	99	1	in	in	ADP
dpc-2300	99	2	relation	relation	NOUN
dpc-2300	99	3	to	to	ADP
dpc-2300	99	4	the	the	DET
dpc-2300	99	5	immune	immune	ADJ
dpc-2300	99	6	response	response	NOUN
dpc-2300	99	7	,	,	PUNCT
dpc-2300	99	8	new	new	ADJ
dpc-2300	99	9	technologies	technology	NOUN
dpc-2300	99	10	in	in	ADP
dpc-2300	99	11	simultaneous	simultaneous	ADJ
dpc-2300	99	12	quantification	quantification	NOUN
dpc-2300	99	13	of	of	ADP
dpc-2300	99	14	serum	serum	NOUN
dpc-2300	99	15	biomarkers	biomarker	NOUN
dpc-2300	99	16	of	of	ADP
dpc-2300	99	17	immune	immune	ADJ
dpc-2300	99	18	response	response	NOUN
dpc-2300	99	19	have	have	AUX
dpc-2300	99	20	allowed	allow	VERB
dpc-2300	99	21	to	to	PART
dpc-2300	99	22	classify	classify	VERB
dpc-2300	99	23	moderate	moderate	ADJ
dpc-2300	99	24	to	to	ADP
dpc-2300	99	25	severe	severe	ADJ
dpc-2300	99	26	ad	ad	NOUN
dpc-2300	99	27	patients	patient	NOUN
dpc-2300	99	28	into	into	ADP
dpc-2300	99	29	4	4	NUM
dpc-2300	99	30	endotypes	endotype	NOUN
dpc-2300	99	31	which	which	PRON
dpc-2300	99	32	demonstrate	demonstrate	VERB
dpc-2300	99	33	patients	patient	NOUN
dpc-2300	99	34	heterogeneity	heterogeneity	NOUN
dpc-2300	99	35	.	.	PUNCT
dpc-2300	100	1	these	these	PRON
dpc-2300	100	2	are	be	AUX
dpc-2300	100	3	il-1r1	il-1r1	ADJ
dpc-2300	100	4	and	and	CCONJ
dpc-2300	100	5	skin	skin	NOUN
dpc-2300	100	6	-	-	PUNCT
dpc-2300	100	7	homing	home	VERB
dpc-2300	100	8	tropism	tropism	NOUN
dpc-2300	100	9	,	,	PUNCT
dpc-2300	100	10	dominant	dominant	ADJ
dpc-2300	100	11	th1	th1	PROPN
dpc-2300	100	12	/	/	SYM
dpc-2300	100	13	th2	th2	PROPN
dpc-2300	100	14	/	/	SYM
dpc-2300	100	15	th17	th17	PROPN
dpc-2300	100	16	response	response	NOUN
dpc-2300	100	17	,	,	PUNCT
dpc-2300	100	18	th2	th2	PROPN
dpc-2300	100	19	/	/	SYM
dpc-2300	100	20	th22	th22	PROPN
dpc-2300	100	21	/	/	SYM
dpc-2300	100	22	ccl18	ccl18	NOUN
dpc-2300	100	23	response	response	NOUN
dpc-2300	100	24	,	,	PUNCT
dpc-2300	100	25	and	and	CCONJ
dpc-2300	100	26	low	low	ADJ
dpc-2300	100	27	levels	level	NOUN
dpc-2300	100	28	of	of	ADP
dpc-2300	100	29	th2	th2	PROPN
dpc-2300	100	30	cytokines	cytokine	NOUN
dpc-2300	100	31	and	and	CCONJ
dpc-2300	100	32	eosinophilia	eosinophilia	PROPN
dpc-2300	101	1	[	[	X
dpc-2300	101	2	28	28	NUM
dpc-2300	101	3	]	]	PUNCT
dpc-2300	101	4	.	.	PUNCT
dpc-2300	102	1	circulating	circulate	VERB
dpc-2300	102	2	cla+	cla+	NOUN
dpc-2300	102	3	memory	memory	NOUN
dpc-2300	102	4	t	t	NOUN
dpc-2300	102	5	cells	cell	NOUN
dpc-2300	102	6	and	and	CCONJ
dpc-2300	102	7	ad	ad	NOUN
dpc-2300	102	8	circulating	circulate	VERB
dpc-2300	102	9	t	t	PROPN
dpc-2300	102	10	-	-	PUNCT
dpc-2300	102	11	cells	cell	NOUN
dpc-2300	102	12	expressing	express	VERB
dpc-2300	102	13	the	the	DET
dpc-2300	102	14	cla	cla	NOUN
dpc-2300	102	15	antigen	antigen	NOUN
dpc-2300	102	16	represent	represent	VERB
dpc-2300	102	17	a	a	DET
dpc-2300	102	18	subset	subset	NOUN
dpc-2300	102	19	of	of	ADP
dpc-2300	102	20	memory	memory	NOUN
dpc-2300	102	21	t	t	PROPN
dpc-2300	102	22	-	-	PUNCT
dpc-2300	102	23	cells	cell	NOUN
dpc-2300	102	24	that	that	PRON
dpc-2300	102	25	reflect	reflect	VERB
dpc-2300	102	26	cutaneous	cutaneous	ADJ
dpc-2300	102	27	immunological	immunological	ADJ
dpc-2300	102	28	abnormalities	abnormality	NOUN
dpc-2300	102	29	taking	take	VERB
dpc-2300	102	30	place	place	NOUN
dpc-2300	102	31	in	in	ADP
dpc-2300	102	32	the	the	DET
dpc-2300	102	33	skin	skin	NOUN
dpc-2300	102	34	[	[	X
dpc-2300	102	35	29	29	NUM
dpc-2300	102	36	]	]	PUNCT
dpc-2300	102	37	.	.	PUNCT
dpc-2300	103	1	they	they	PRON
dpc-2300	103	2	are	be	AUX
dpc-2300	103	3	used	use	VERB
dpc-2300	103	4	to	to	PART
dpc-2300	103	5	understand	understand	VERB
dpc-2300	103	6	atopic	atopic	NOUN
dpc-2300	103	7	dermatitis	dermatitis	NOUN
dpc-2300	103	8	phenotypes	phenotype	NOUN
dpc-2300	103	9	as	as	ADP
dpc-2300	103	10	possible	possible	ADJ
dpc-2300	103	11	cell	cell	NOUN
dpc-2300	103	12	biomarkers	biomarker	NOUN
dpc-2300	103	13	of	of	ADP
dpc-2300	103	14	disease	disease	NOUN
dpc-2300	104	1	[	[	X
dpc-2300	104	2	30,31	30,31	NOUN
dpc-2300	104	3	]	]	PUNCT
dpc-2300	104	4	.	.	PUNCT
dpc-2300	105	1	the	the	DET
dpc-2300	105	2	translational	translational	ADJ
dpc-2300	105	3	relevance	relevance	NOUN
dpc-2300	105	4	of	of	ADP
dpc-2300	105	5	this	this	DET
dpc-2300	105	6	subset	subset	NOUN
dpc-2300	105	7	in	in	ADP
dpc-2300	105	8	ad	ad	NOUN
dpc-2300	105	9	,	,	PUNCT
dpc-2300	105	10	which	which	PRON
dpc-2300	105	11	also	also	ADV
dpc-2300	105	12	exists	exist	VERB
dpc-2300	105	13	in	in	ADP
dpc-2300	105	14	human	human	ADJ
dpc-2300	105	15	circulation	circulation	NOUN
dpc-2300	105	16	as	as	ADP
dpc-2300	105	17	resident	resident	ADJ
dpc-2300	105	18	memory	memory	NOUN
dpc-2300	105	19	th2	th2	PROPN
dpc-2300	105	20	cells	cell	NOUN
dpc-2300	105	21	,	,	PUNCT
dpc-2300	105	22	as	as	ADV
dpc-2300	105	23	well	well	ADV
dpc-2300	105	24	as	as	ADP
dpc-2300	105	25	in	in	ADP
dpc-2300	105	26	the	the	DET
dpc-2300	105	27	skin	skin	NOUN
dpc-2300	105	28	[	[	X
dpc-2300	105	29	32	32	NUM
dpc-2300	105	30	]	]	PUNCT
dpc-2300	105	31	,	,	PUNCT
dpc-2300	105	32	has	have	AUX
dpc-2300	105	33	been	be	AUX
dpc-2300	105	34	further	far	ADV
dpc-2300	105	35	studied	study	VERB
dpc-2300	105	36	during	during	ADP
dpc-2300	105	37	dupilumab	dupilumab	NOUN
dpc-2300	105	38	treatment	treatment	NOUN
dpc-2300	105	39	of	of	ADP
dpc-2300	105	40	moderate	moderate	ADJ
dpc-2300	105	41	to	to	ADP
dpc-2300	105	42	severe	severe	ADJ
dpc-2300	105	43	ad	ad	NOUN
dpc-2300	105	44	patients	patient	NOUN
dpc-2300	105	45	.	.	PUNCT
dpc-2300	106	1	at	at	ADP
dpc-2300	106	2	week	week	NOUN
dpc-2300	106	3	4	4	NUM
dpc-2300	106	4	of	of	ADP
dpc-2300	106	5	treatment	treatment	NOUN
dpc-2300	106	6	,	,	PUNCT
dpc-2300	106	7	dupilumab	dupilumab	NOUN
dpc-2300	106	8	decreased	decrease	VERB
dpc-2300	106	9	il-4	il-4	PROPN
dpc-2300	106	10	,	,	PUNCT
dpc-2300	106	11	il-13	il-13	PUNCT
dpc-2300	106	12	and	and	CCONJ
dpc-2300	106	13	il-22	il-22	ADP
dpc-2300	106	14	production	production	NOUN
dpc-2300	106	15	in	in	ADP
dpc-2300	106	16	cla+cd4+ccr4	cla+cd4+ccr4	NOUN
dpc-2300	106	17	+	+	PROPN
dpc-2300	106	18	,	,	PUNCT
dpc-2300	106	19	but	but	CCONJ
dpc-2300	106	20	not	not	PART
dpc-2300	106	21	in	in	ADP
dpc-2300	106	22	the	the	DET
dpc-2300	106	23	clamemory	clamemory	ADJ
dpc-2300	106	24	t	t	NOUN
dpc-2300	106	25	cells	cell	NOUN
dpc-2300	106	26	subset	subset	VERB
dpc-2300	107	1	[	[	X
dpc-2300	107	2	33,34	33,34	NOUN
dpc-2300	107	3	]	]	PUNCT
dpc-2300	107	4	.	.	PUNCT
dpc-2300	108	1	these	these	DET
dpc-2300	108	2	results	result	NOUN
dpc-2300	108	3	indicate	indicate	VERB
dpc-2300	108	4	that	that	SCONJ
dpc-2300	108	5	circulating	circulate	VERB
dpc-2300	108	6	skin	skin	NOUN
dpc-2300	108	7	homing	homing	NOUN
dpc-2300	108	8	lymphocytes	lymphocyte	NOUN
dpc-2300	108	9	preferentially	preferentially	ADV
dpc-2300	108	10	respond	respond	VERB
dpc-2300	108	11	to	to	ADP
dpc-2300	108	12	il4ra	il4ra	NUM
dpc-2300	108	13	blockage	blockage	NOUN
dpc-2300	108	14	in	in	ADP
dpc-2300	108	15	ad	ad	NOUN
dpc-2300	108	16	patients	patient	NOUN
dpc-2300	108	17	and	and	CCONJ
dpc-2300	108	18	are	be	AUX
dpc-2300	108	19	in	in	ADP
dpc-2300	108	20	line	line	NOUN
dpc-2300	108	21	with	with	ADP
dpc-2300	108	22	the	the	DET
dpc-2300	108	23	relevance	relevance	NOUN
dpc-2300	108	24	of	of	ADP
dpc-2300	108	25	adaptive	adaptive	ADJ
dpc-2300	108	26	immune	immune	ADJ
dpc-2300	108	27	response	response	NOUN
dpc-2300	108	28	in	in	ADP
dpc-2300	108	29	ad	ad	NOUN
dpc-2300	108	30	in	in	ADP
dpc-2300	108	31	the	the	DET
dpc-2300	108	32	current	current	ADJ
dpc-2300	108	33	model	model	NOUN
dpc-2300	108	34	of	of	ADP
dpc-2300	108	35	ad	ad	NOUN
dpc-2300	108	36	[	[	X
dpc-2300	108	37	1	1	NUM
dpc-2300	108	38	]	]	PUNCT
dpc-2300	108	39	.	.	PUNCT
dpc-2300	109	1	conclusions	conclusion	NOUN
dpc-2300	109	2	current	current	ADJ
dpc-2300	109	3	translational	translational	ADJ
dpc-2300	109	4	immunology	immunology	NOUN
dpc-2300	109	5	results	result	NOUN
dpc-2300	109	6	support	support	VERB
dpc-2300	109	7	a	a	DET
dpc-2300	109	8	simplified	simplified	ADJ
dpc-2300	109	9	model	model	NOUN
dpc-2300	109	10	of	of	ADP
dpc-2300	109	11	ad	ad	NOUN
dpc-2300	109	12	pathogenesis	pathogenesis	NOUN
dpc-2300	109	13	(	(	PUNCT
dpc-2300	109	14	figure	figure	NOUN
dpc-2300	109	15	1	1	NUM
dpc-2300	109	16	)	)	PUNCT
dpc-2300	109	17	,	,	PUNCT
dpc-2300	109	18	where	where	SCONJ
dpc-2300	109	19	patients	patient	NOUN
dpc-2300	109	20	carry	carry	VERB
dpc-2300	109	21	an	an	DET
dpc-2300	109	22	abnormal	abnormal	ADJ
dpc-2300	109	23	immune	immune	ADJ
dpc-2300	109	24	response	response	NOUN
dpc-2300	109	25	that	that	PRON
dpc-2300	109	26	reacts	react	VERB
dpc-2300	109	27	to	to	ADP
dpc-2300	109	28	agents	agent	NOUN
dpc-2300	109	29	accessing	access	VERB
dpc-2300	109	30	the	the	DET
dpc-2300	109	31	skin	skin	NOUN
dpc-2300	109	32	trough	trough	NOUN
dpc-2300	109	33	a	a	DET
dpc-2300	109	34	permeable	permeable	ADJ
dpc-2300	109	35	skin	skin	NOUN
dpc-2300	109	36	barrier	barrier	NOUN
dpc-2300	109	37	,	,	PUNCT
dpc-2300	109	38	in	in	ADP
dpc-2300	109	39	the	the	DET
dpc-2300	109	40	context	context	NOUN
dpc-2300	109	41	of	of	ADP
dpc-2300	109	42	the	the	DET
dpc-2300	109	43	itch	itch	NOUN
dpc-2300	109	44	-	-	PUNCT
dpc-2300	109	45	scratching	scratching	NOUN
dpc-2300	109	46	circle	circle	NOUN
dpc-2300	109	47	.	.	PUNCT
dpc-2300	110	1	circulating	circulate	VERB
dpc-2300	110	2	cla+cd4+ccr4	cla+cd4+ccr4	NOUN
dpc-2300	110	3	+	+	NOUN
dpc-2300	110	4	memory	memory	NOUN
dpc-2300	110	5	t	t	PROPN
dpc-2300	110	6	-	-	PUNCT
dpc-2300	110	7	cells	cell	NOUN
dpc-2300	110	8	infiltrate	infiltrate	VERB
dpc-2300	110	9	non	non	ADJ
dpc-2300	110	10	-	-	ADJ
dpc-2300	110	11	lesional	lesional	ADJ
dpc-2300	110	12	skin	skin	NOUN
dpc-2300	110	13	and	and	CCONJ
dpc-2300	110	14	become	become	VERB
dpc-2300	110	15	activated	activate	VERB
dpc-2300	110	16	by	by	ADP
dpc-2300	110	17	antigen	antigen	NOUN
dpc-2300	110	18	presenting	present	VERB
dpc-2300	110	19	cells	cell	NOUN
dpc-2300	110	20	and	and	CCONJ
dpc-2300	110	21	secrete	secrete	NOUN
dpc-2300	110	22	il-4	il-4	NOUN
dpc-2300	110	23	,	,	PUNCT
dpc-2300	110	24	il-13	il-13	ADV
dpc-2300	110	25	,	,	PUNCT
dpc-2300	110	26	and	and	CCONJ
dpc-2300	110	27	il-31	il-31	PUNCT
dpc-2300	110	28	among	among	ADP
dpc-2300	110	29	other	other	ADJ
dpc-2300	110	30	cytokines	cytokine	NOUN
dpc-2300	110	31	.	.	PUNCT
dpc-2300	111	1	il-4	il-4	NOUN
dpc-2300	112	1	and	and	CCONJ
dpc-2300	112	2	il-13	il-13	NUM
dpc-2300	112	3	,	,	PUNCT
dpc-2300	112	4	and	and	CCONJ
dpc-2300	112	5	in	in	ADP
dpc-2300	112	6	particular	particular	ADJ
dpc-2300	112	7	il-13	il-13	PUNCT
dpc-2300	112	8	due	due	ADP
dpc-2300	112	9	to	to	ADP
dpc-2300	112	10	the	the	DET
dpc-2300	112	11	presence	presence	NOUN
dpc-2300	112	12	of	of	ADP
dpc-2300	112	13	the	the	DET
dpc-2300	112	14	il-13	il-13	ADJ
dpc-2300	112	15	receptor	receptor	NOUN
dpc-2300	112	16	in	in	ADP
dpc-2300	112	17	the	the	DET
dpc-2300	112	18	skin	skin	NOUN
dpc-2300	112	19	and	and	CCONJ
dpc-2300	112	20	greater	great	ADJ
dpc-2300	112	21	amount	amount	NOUN
dpc-2300	112	22	of	of	ADP
dpc-2300	112	23	il-13	il-13	PUNCT
dpc-2300	112	24	than	than	ADP
dpc-2300	112	25	il-4	il-4	PROPN
dpc-2300	112	26	,	,	PUNCT
dpc-2300	112	27	alter	alter	VERB
dpc-2300	112	28	skin	skin	NOUN
dpc-2300	112	29	barrier	barrier	NOUN
dpc-2300	112	30	function	function	NOUN
dpc-2300	112	31	.	.	PUNCT
dpc-2300	113	1	in	in	ADP
dpc-2300	113	2	addition	addition	NOUN
dpc-2300	113	3	,	,	PUNCT
dpc-2300	113	4	il-13	il-13	PUNCT
dpc-2300	113	5	would	would	AUX
dpc-2300	113	6	promote	promote	VERB
dpc-2300	113	7	sa	sa	VERB
dpc-2300	113	8	colonization	colonization	NOUN
dpc-2300	113	9	by	by	ADP
dpc-2300	113	10	decreasing	decrease	VERB
dpc-2300	113	11	natural	natural	ADJ
dpc-2300	113	12	antimicrobial	antimicrobial	ADJ
dpc-2300	113	13	peptides	peptide	NOUN
dpc-2300	113	14	and	and	CCONJ
dpc-2300	113	15	adherence	adherence	NOUN
dpc-2300	113	16	through	through	ADP
dpc-2300	113	17	increased	increase	VERB
dpc-2300	113	18	production	production	NOUN
dpc-2300	113	19	of	of	ADP
dpc-2300	113	20	fibronectin	fibronectin	NOUN
dpc-2300	113	21	.	.	PUNCT
dpc-2300	114	1	those	those	DET
dpc-2300	114	2	3	3	NUM
dpc-2300	114	3	cytokines	cytokine	NOUN
dpc-2300	114	4	mediate	mediate	VERB
dpc-2300	114	5	pruritus	pruritus	NOUN
dpc-2300	114	6	by	by	ADP
dpc-2300	114	7	binding	bind	VERB
dpc-2300	114	8	to	to	ADP
dpc-2300	114	9	their	their	PRON
dpc-2300	114	10	specific	specific	ADJ
dpc-2300	114	11	receptors	receptor	NOUN
dpc-2300	114	12	in	in	ADP
dpc-2300	114	13	sensitive	sensitive	ADJ
dpc-2300	114	14	neurons	neuron	NOUN
dpc-2300	114	15	that	that	PRON
dpc-2300	114	16	transmit	transmit	VERB
dpc-2300	114	17	pruritus	pruritus	PROPN
dpc-2300	114	18	to	to	ADP
dpc-2300	114	19	central	central	ADJ
dpc-2300	114	20	nervous	nervous	ADJ
dpc-2300	114	21	system	system	NOUN
dpc-2300	114	22	.	.	PUNCT
dpc-2300	115	1	il-13	il-13	PUNCT
dpc-2300	115	2	would	would	AUX
dpc-2300	115	3	promote	promote	VERB
dpc-2300	115	4	inflammation	inflammation	NOUN
dpc-2300	115	5	by	by	ADP
dpc-2300	115	6	the	the	DET
dpc-2300	115	7	recruitment	recruitment	NOUN
dpc-2300	115	8	of	of	ADP
dpc-2300	115	9	skin	skin	NOUN
dpc-2300	115	10	-	-	PUNCT
dpc-2300	115	11	homing	home	VERB
dpc-2300	115	12	cla+cd4+ccr4	cla+cd4+ccr4	NOUN
dpc-2300	115	13	+	+	NOUN
dpc-2300	115	14	that	that	PRON
dpc-2300	115	15	are	be	AUX
dpc-2300	115	16	attracted	attract	VERB
dpc-2300	115	17	by	by	ADP
dpc-2300	115	18	il-13	il-13	ADV
dpc-2300	115	19	-	-	PUNCT
dpc-2300	115	20	activated	activate	VERB
dpc-2300	115	21	keratinocytes	keratinocyte	NOUN
dpc-2300	115	22	that	that	PRON
dpc-2300	115	23	produce	produce	VERB
dpc-2300	115	24	ccl17	ccl17	PROPN
dpc-2300	115	25	.	.	PUNCT
dpc-2300	116	1	review	review	NOUN
dpc-2300	116	2	|	|	ADV
dpc-2300	116	3	dermatol	dermatol	ADJ
dpc-2300	116	4	pract	pract	NOUN
dpc-2300	116	5	concept	concept	NOUN
dpc-2300	116	6	.	.	PUNCT
dpc-2300	117	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	117	2	5	5	NUM
dpc-2300	117	3	references	reference	NOUN
dpc-2300	117	4	1	1	NUM
dpc-2300	117	5	.	.	PUNCT
dpc-2300	118	1	langan	langan	PROPN
dpc-2300	118	2	sm	sm	PROPN
dpc-2300	118	3	,	,	PUNCT
dpc-2300	118	4	irvine	irvine	PROPN
dpc-2300	118	5	ad	ad	NOUN
dpc-2300	118	6	,	,	PUNCT
dpc-2300	118	7	weidinger	weidinger	NOUN
dpc-2300	118	8	s.	s.	PROPN
dpc-2300	118	9	atopic	atopic	PROPN
dpc-2300	118	10	dermatitis	dermatitis	PROPN
dpc-2300	118	11	.	.	PUNCT
dpc-2300	119	1	lancet	lancet	PROPN
dpc-2300	119	2	.	.	PUNCT
dpc-2300	120	1	2020;396(10247):345	2020;396(10247):345	NUM
dpc-2300	120	2	-	-	SYM
dpc-2300	120	3	360	360	NUM
dpc-2300	120	4	.	.	PUNCT
dpc-2300	120	5	doi	doi	NOUN
dpc-2300	120	6	:	:	PUNCT
dpc-2300	120	7	10.1016	10.1016	NUM
dpc-2300	120	8	/	/	SYM
dpc-2300	120	9	s01406736(20)31286	s01406736(20)31286	PROPN
dpc-2300	120	10	-	-	PUNCT
dpc-2300	120	11	1	1	NUM
dpc-2300	120	12	.	.	PUNCT
dpc-2300	121	1	pmid	pmid	NOUN
dpc-2300	121	2	:	:	PUNCT
dpc-2300	121	3	32738956	32738956	NUM
dpc-2300	121	4	.	.	PUNCT
dpc-2300	122	1	2	2	X
dpc-2300	122	2	.	.	X
dpc-2300	122	3	noda	noda	PROPN
dpc-2300	122	4	s	s	PROPN
dpc-2300	122	5	,	,	PUNCT
dpc-2300	122	6	krueger	krueger	PROPN
dpc-2300	122	7	jg	jg	PROPN
dpc-2300	122	8	,	,	PUNCT
dpc-2300	122	9	guttman	guttman	ADJ
dpc-2300	122	10	-	-	PUNCT
dpc-2300	122	11	yassky	yassky	NOUN
dpc-2300	122	12	e.	e.	PROPN
dpc-2300	123	1	the	the	DET
dpc-2300	123	2	translational	translational	PROPN
dpc-2300	123	3	revolution	revolution	NOUN
dpc-2300	123	4	and	and	CCONJ
dpc-2300	123	5	use	use	NOUN
dpc-2300	123	6	of	of	ADP
dpc-2300	123	7	biologics	biologic	NOUN
dpc-2300	123	8	in	in	ADP
dpc-2300	123	9	patients	patient	NOUN
dpc-2300	123	10	with	with	ADP
dpc-2300	123	11	inflammatory	inflammatory	ADJ
dpc-2300	123	12	skin	skin	NOUN
dpc-2300	123	13	diseases	disease	NOUN
dpc-2300	123	14	.	.	PUNCT
dpc-2300	124	1	j	j	PROPN
dpc-2300	124	2	allergy	allergy	PROPN
dpc-2300	124	3	clin	clin	PROPN
dpc-2300	124	4	immunol	immunol	NOUN
dpc-2300	124	5	.	.	PUNCT
dpc-2300	125	1	2015;135(2):324	2015;135(2):324	NUM
dpc-2300	125	2	-	-	SYM
dpc-2300	125	3	336	336	NUM
dpc-2300	125	4	.	.	PUNCT
dpc-2300	126	1	doi	doi	NOUN
dpc-2300	126	2	:	:	PUNCT
dpc-2300	126	3	10.1016	10.1016	NUM
dpc-2300	126	4	/	/	SYM
dpc-2300	126	5	j.jaci.2014.11.015	j.jaci.2014.11.015	PROPN
dpc-2300	126	6	.	.	PUNCT
dpc-2300	127	1	pmid	pmid	NOUN
dpc-2300	127	2	:	:	PUNCT
dpc-2300	127	3	25541257	25541257	NUM
dpc-2300	127	4	.	.	PUNCT
dpc-2300	128	1	3	3	X
dpc-2300	128	2	.	.	X
dpc-2300	128	3	oliva	oliva	PROPN
dpc-2300	128	4	m	m	PROPN
dpc-2300	128	5	,	,	PUNCT
dpc-2300	128	6	renert	renert	NOUN
dpc-2300	128	7	-	-	PUNCT
dpc-2300	128	8	yuval	yuval	PROPN
dpc-2300	128	9	y	y	PROPN
dpc-2300	128	10	,	,	PUNCT
dpc-2300	128	11	guttman	guttman	ADJ
dpc-2300	128	12	-	-	PUNCT
dpc-2300	128	13	yassky	yassky	NOUN
dpc-2300	128	14	e.	e.	PROPN
dpc-2300	128	15	the	the	DET
dpc-2300	128	16	“	"	PUNCT
dpc-2300	128	17	omics	omics	PROPN
dpc-2300	128	18	”	"	PUNCT
dpc-2300	128	19	revolution	revolution	NOUN
dpc-2300	128	20	:	:	PUNCT
dpc-2300	128	21	redefining	redefine	VERB
dpc-2300	128	22	the	the	DET
dpc-2300	128	23	understanding	understanding	NOUN
dpc-2300	128	24	and	and	CCONJ
dpc-2300	128	25	treatment	treatment	NOUN
dpc-2300	128	26	of	of	ADP
dpc-2300	128	27	allergic	allergic	ADJ
dpc-2300	128	28	skin	skin	NOUN
dpc-2300	128	29	diseases	disease	NOUN
dpc-2300	128	30	.	.	PUNCT
dpc-2300	129	1	curr	curr	PROPN
dpc-2300	129	2	opin	opin	PROPN
dpc-2300	129	3	allergy	allergy	PROPN
dpc-2300	129	4	clin	clin	PROPN
dpc-2300	129	5	immunol	immunol	NOUN
dpc-2300	129	6	.	.	PUNCT
dpc-2300	130	1	2016;16(5):469476	2016;16(5):469476	NUM
dpc-2300	130	2	.	.	PUNCT
dpc-2300	130	3	doi	doi	NOUN
dpc-2300	130	4	:	:	PUNCT
dpc-2300	130	5	10.1097	10.1097	NUM
dpc-2300	130	6	/	/	SYM
dpc-2300	130	7	aci.0000000000000306	aci.0000000000000306	NOUN
dpc-2300	130	8	.	.	PUNCT
dpc-2300	131	1	pmid	pmid	NOUN
dpc-2300	131	2	:	:	PUNCT
dpc-2300	131	3	27490125	27490125	NUM
dpc-2300	131	4	.	.	PUNCT
dpc-2300	132	1	4	4	X
dpc-2300	132	2	.	.	X
dpc-2300	132	3	lloyd	lloyd	PROPN
dpc-2300	132	4	cm	cm	PROPN
dpc-2300	132	5	,	,	PUNCT
dpc-2300	132	6	snelgrove	snelgrove	PROPN
dpc-2300	132	7	rj	rj	PROPN
dpc-2300	132	8	.	.	PUNCT
dpc-2300	132	9	type	type	NOUN
dpc-2300	132	10	2	2	NUM
dpc-2300	132	11	immunity	immunity	NOUN
dpc-2300	132	12	:	:	PUNCT
dpc-2300	132	13	expanding	expand	VERB
dpc-2300	132	14	our	our	PRON
dpc-2300	132	15	view	view	NOUN
dpc-2300	132	16	.	.	PUNCT
dpc-2300	133	1	sci	sci	PROPN
dpc-2300	133	2	immunol	immunol	NOUN
dpc-2300	133	3	.	.	PUNCT
dpc-2300	133	4	2018	2018	NUM
dpc-2300	133	5	;	;	PUNCT
dpc-2300	133	6	3(25):eaat1604	3(25):eaat1604	NUM
dpc-2300	133	7	.	.	PUNCT
dpc-2300	134	1	doi	doi	NOUN
dpc-2300	134	2	:	:	PUNCT
dpc-2300	134	3	10.1126	10.1126	NUM
dpc-2300	134	4	/	/	SYM
dpc-2300	134	5	sciimmunol	sciimmunol	NOUN
dpc-2300	134	6	.	.	PUNCT
dpc-2300	135	1	aat1604	aat1604	PROPN
dpc-2300	135	2	.	.	PUNCT
dpc-2300	136	1	pmid	pmid	NOUN
dpc-2300	136	2	:	:	PUNCT
dpc-2300	136	3	29980619	29980619	NUM
dpc-2300	136	4	.	.	PUNCT
dpc-2300	137	1	5	5	X
dpc-2300	137	2	.	.	X
dpc-2300	137	3	saunders	saunders	PROPN
dpc-2300	137	4	sp	sp	PROPN
dpc-2300	137	5	,	,	PUNCT
dpc-2300	137	6	moran	moran	PROPN
dpc-2300	137	7	t	t	PROPN
dpc-2300	137	8	,	,	PUNCT
dpc-2300	137	9	floudas	flouda	VERB
dpc-2300	137	10	a	a	PRON
dpc-2300	137	11	,	,	PUNCT
dpc-2300	137	12	et	et	PROPN
dpc-2300	137	13	al	al	PROPN
dpc-2300	137	14	.	.	PUNCT
dpc-2300	138	1	spontaneous	spontaneous	ADJ
dpc-2300	138	2	atopic	atopic	NOUN
dpc-2300	138	3	dermatitis	dermatitis	NOUN
dpc-2300	138	4	is	be	AUX
dpc-2300	138	5	mediated	mediate	VERB
dpc-2300	138	6	by	by	ADP
dpc-2300	138	7	innate	innate	ADJ
dpc-2300	138	8	immunity	immunity	NOUN
dpc-2300	138	9	,	,	PUNCT
dpc-2300	138	10	with	with	ADP
dpc-2300	138	11	the	the	DET
dpc-2300	138	12	secondary	secondary	ADJ
dpc-2300	138	13	lung	lung	NOUN
dpc-2300	138	14	inflammation	inflammation	NOUN
dpc-2300	138	15	of	of	ADP
dpc-2300	138	16	the	the	DET
dpc-2300	138	17	atopic	atopic	NOUN
dpc-2300	138	18	march	march	NOUN
dpc-2300	138	19	requiring	require	VERB
dpc-2300	138	20	adaptive	adaptive	ADJ
dpc-2300	138	21	immunity	immunity	NOUN
dpc-2300	138	22	.	.	PUNCT
dpc-2300	139	1	j	j	PROPN
dpc-2300	139	2	allergy	allergy	PROPN
dpc-2300	139	3	clin	clin	PROPN
dpc-2300	139	4	immunol	immunol	PROPN
dpc-2300	139	5	.	.	PUNCT
dpc-2300	140	1	2016;137(2):482	2016;137(2):482	NUM
dpc-2300	140	2	-	-	SYM
dpc-2300	140	3	491	491	NUM
dpc-2300	140	4	.	.	PUNCT
dpc-2300	141	1	doi	doi	NOUN
dpc-2300	141	2	:	:	PUNCT
dpc-2300	141	3	10.1016	10.1016	NUM
dpc-2300	141	4	/	/	SYM
dpc-2300	141	5	j.	j.	PROPN
dpc-2300	141	6	jaci.2015.06.045	jaci.2015.06.045	PROPN
dpc-2300	141	7	.	.	PUNCT
dpc-2300	142	1	pmid	pmid	NOUN
dpc-2300	142	2	:	:	PUNCT
dpc-2300	142	3	26299987	26299987	NUM
dpc-2300	142	4	.	.	PUNCT
dpc-2300	143	1	pmcid	pmcid	NOUN
dpc-2300	143	2	:	:	PUNCT
dpc-2300	143	3	pmc4735016	pmc4735016	PROPN
dpc-2300	143	4	.	.	PUNCT
dpc-2300	144	1	6	6	NUM
dpc-2300	144	2	.	.	X
dpc-2300	144	3	salimi	salimi	PROPN
dpc-2300	144	4	m	m	PROPN
dpc-2300	144	5	,	,	PUNCT
dpc-2300	144	6	barlow	barlow	PROPN
dpc-2300	144	7	jl	jl	PROPN
dpc-2300	144	8	,	,	PUNCT
dpc-2300	144	9	saunders	saunders	PROPN
dpc-2300	144	10	sp	sp	PROPN
dpc-2300	144	11	,	,	PUNCT
dpc-2300	144	12	et	et	PROPN
dpc-2300	144	13	al	al	PROPN
dpc-2300	144	14	.	.	PUNCT
dpc-2300	145	1	a	a	DET
dpc-2300	145	2	role	role	NOUN
dpc-2300	145	3	for	for	ADP
dpc-2300	145	4	il-25	il-25	NOUN
dpc-2300	145	5	and	and	CCONJ
dpc-2300	145	6	il33	il33	PROPN
dpc-2300	145	7	-	-	PUNCT
dpc-2300	145	8	driven	drive	VERB
dpc-2300	145	9	type-2	type-2	NUM
dpc-2300	145	10	innate	innate	ADJ
dpc-2300	145	11	lymphoid	lymphoid	NOUN
dpc-2300	145	12	cells	cell	NOUN
dpc-2300	145	13	in	in	ADP
dpc-2300	145	14	atopic	atopic	NOUN
dpc-2300	145	15	dermatitis	dermatitis	NOUN
dpc-2300	145	16	.	.	PUNCT
dpc-2300	146	1	j	j	PROPN
dpc-2300	146	2	exp	exp	NOUN
dpc-2300	146	3	med	med	PROPN
dpc-2300	146	4	.	.	PUNCT
dpc-2300	147	1	2013;210(13):2939	2013;210(13):2939	NUM
dpc-2300	147	2	-	-	SYM
dpc-2300	147	3	2950	2950	NUM
dpc-2300	147	4	.	.	PUNCT
dpc-2300	148	1	doi	doi	NOUN
dpc-2300	148	2	:	:	PUNCT
dpc-2300	148	3	10.1084	10.1084	NUM
dpc-2300	148	4	/	/	SYM
dpc-2300	148	5	jem.20130351	jem.20130351	PROPN
dpc-2300	148	6	.	.	PUNCT
dpc-2300	149	1	pmid	pmid	NOUN
dpc-2300	149	2	:	:	PUNCT
dpc-2300	149	3	24323357	24323357	NUM
dpc-2300	149	4	.	.	PUNCT
dpc-2300	150	1	pmcid	pmcid	NOUN
dpc-2300	150	2	:	:	PUNCT
dpc-2300	150	3	pmc3865470	pmc3865470	ADJ
dpc-2300	150	4	.	.	PUNCT
dpc-2300	151	1	7	7	X
dpc-2300	151	2	.	.	X
dpc-2300	151	3	bieber	bieber	PROPN
dpc-2300	151	4	t.	t.	PROPN
dpc-2300	151	5	interleukin-13	interleukin-13	PROPN
dpc-2300	151	6	:	:	PUNCT
dpc-2300	151	7	targeting	target	VERB
dpc-2300	151	8	an	an	DET
dpc-2300	151	9	underestimated	underestimated	ADJ
dpc-2300	151	10	cytokine	cytokine	NOUN
dpc-2300	151	11	in	in	ADP
dpc-2300	151	12	atopic	atopic	NOUN
dpc-2300	151	13	dermatitis	dermatitis	NOUN
dpc-2300	151	14	.	.	PUNCT
dpc-2300	152	1	allergy	allergy	NOUN
dpc-2300	152	2	.	.	PUNCT
dpc-2300	153	1	2020;75(1):54	2020;75(1):54	X
dpc-2300	153	2	-	-	SYM
dpc-2300	153	3	62	62	NUM
dpc-2300	153	4	.	.	PUNCT
dpc-2300	154	1	doi	doi	NOUN
dpc-2300	154	2	:	:	PUNCT
dpc-2300	154	3	10.1111/	10.1111/	NUM
dpc-2300	154	4	all.13954	all.13954	ADP
dpc-2300	154	5	.	.	PUNCT
dpc-2300	155	1	pmid	pmid	NOUN
dpc-2300	155	2	:	:	PUNCT
dpc-2300	155	3	31230370	31230370	NUM
dpc-2300	155	4	.	.	PUNCT
dpc-2300	156	1	8	8	NUM
dpc-2300	156	2	.	.	X
dpc-2300	156	3	bieber	bieber	PROPN
dpc-2300	156	4	t.	t.	PROPN
dpc-2300	156	5	atopic	atopic	PROPN
dpc-2300	156	6	dermatitis	dermatitis	PROPN
dpc-2300	156	7	:	:	PUNCT
dpc-2300	156	8	an	an	DET
dpc-2300	156	9	expanding	expand	VERB
dpc-2300	156	10	therapeutic	therapeutic	ADJ
dpc-2300	156	11	pipeline	pipeline	NOUN
dpc-2300	156	12	for	for	ADP
dpc-2300	156	13	a	a	DET
dpc-2300	156	14	complex	complex	ADJ
dpc-2300	156	15	disease	disease	NOUN
dpc-2300	156	16	.	.	PUNCT
dpc-2300	157	1	nat	nat	PROPN
dpc-2300	157	2	rev	rev	VERB
dpc-2300	157	3	drug	drug	NOUN
dpc-2300	157	4	discov	discov	NOUN
dpc-2300	157	5	.	.	PUNCT
dpc-2300	158	1	2022;21(1):21	2022;21(1):21	NUM
dpc-2300	158	2	-	-	SYM
dpc-2300	158	3	40	40	NUM
dpc-2300	158	4	.	.	PUNCT
dpc-2300	159	1	doi	doi	NOUN
dpc-2300	159	2	:	:	PUNCT
dpc-2300	159	3	10.1038	10.1038	NUM
dpc-2300	159	4	/	/	SYM
dpc-2300	159	5	s41573	s41573	PROPN
dpc-2300	159	6	-	-	PUNCT
dpc-2300	159	7	021	021	NUM
dpc-2300	159	8	-	-	PUNCT
dpc-2300	159	9	00266	00266	NUM
dpc-2300	159	10	-	-	SYM
dpc-2300	159	11	6	6	NUM
dpc-2300	159	12	.	.	PUNCT
dpc-2300	160	1	pmid	pmid	NOUN
dpc-2300	160	2	:	:	PUNCT
dpc-2300	160	3	34417579	34417579	NUM
dpc-2300	160	4	.	.	PUNCT
dpc-2300	161	1	pmcid	pmcid	NOUN
dpc-2300	161	2	:	:	PUNCT
dpc-2300	161	3	pmc8377708	pmc8377708	PROPN
dpc-2300	161	4	.	.	PUNCT
dpc-2300	162	1	9	9	X
dpc-2300	162	2	.	.	X
dpc-2300	162	3	tamari	tamari	PROPN
dpc-2300	162	4	m	m	NOUN
dpc-2300	162	5	,	,	PUNCT
dpc-2300	162	6	trier	tri	ADJ
dpc-2300	162	7	am	am	PROPN
dpc-2300	162	8	,	,	PUNCT
dpc-2300	162	9	kim	kim	PROPN
dpc-2300	162	10	bs	bs	PROPN
dpc-2300	162	11	.	.	PUNCT
dpc-2300	163	1	emerging	emerge	VERB
dpc-2300	163	2	targeted	target	VERB
dpc-2300	163	3	therapeutics	therapeutic	NOUN
dpc-2300	163	4	underscore	underscore	VERB
dpc-2300	163	5	immunologic	immunologic	ADJ
dpc-2300	163	6	heterogeneity	heterogeneity	NOUN
dpc-2300	163	7	of	of	ADP
dpc-2300	163	8	asthma	asthma	NOUN
dpc-2300	163	9	.	.	PUNCT
dpc-2300	164	1	j	j	PROPN
dpc-2300	164	2	allergy	allergy	PROPN
dpc-2300	164	3	clin	clin	PROPN
dpc-2300	164	4	immunol	immunol	PROPN
dpc-2300	164	5	.	.	PUNCT
dpc-2300	165	1	2021;148(3):719	2021;148(3):719	NUM
dpc-2300	165	2	-	-	SYM
dpc-2300	165	3	721	721	NUM
dpc-2300	165	4	.	.	PUNCT
dpc-2300	166	1	doi	doi	NOUN
dpc-2300	166	2	:	:	PUNCT
dpc-2300	166	3	10.1016	10.1016	NUM
dpc-2300	166	4	/	/	SYM
dpc-2300	166	5	j.jaci.2021.07.008	j.jaci.2021.07.008	PROPN
dpc-2300	166	6	.	.	PUNCT
dpc-2300	167	1	pmid	pmid	NOUN
dpc-2300	167	2	:	:	PUNCT
dpc-2300	167	3	34310926	34310926	NUM
dpc-2300	167	4	.	.	PUNCT
dpc-2300	168	1	10	10	NUM
dpc-2300	168	2	.	.	PUNCT
dpc-2300	169	1	guttman	guttman	ADJ
dpc-2300	169	2	-	-	PUNCT
dpc-2300	169	3	yassky	yassky	NOUN
dpc-2300	169	4	e	e	NOUN
dpc-2300	169	5	,	,	PUNCT
dpc-2300	169	6	pavel	pavel	PROPN
dpc-2300	169	7	ab	ab	PROPN
dpc-2300	169	8	,	,	PUNCT
dpc-2300	169	9	zhou	zhou	PROPN
dpc-2300	169	10	l	l	PROPN
dpc-2300	169	11	,	,	PUNCT
dpc-2300	169	12	et	et	PROPN
dpc-2300	169	13	al	al	PROPN
dpc-2300	169	14	.	.	PUNCT
dpc-2300	170	1	gbr	gbr	PROPN
dpc-2300	170	2	830	830	NUM
dpc-2300	170	3	,	,	PUNCT
dpc-2300	170	4	an	an	DET
dpc-2300	170	5	anti	anti	NOUN
dpc-2300	170	6	-	-	ADJ
dpc-2300	170	7	ox40	ox40	ADJ
dpc-2300	170	8	,	,	PUNCT
dpc-2300	170	9	improves	improve	VERB
dpc-2300	170	10	skin	skin	NOUN
dpc-2300	170	11	gene	gene	NOUN
dpc-2300	170	12	signatures	signature	NOUN
dpc-2300	170	13	and	and	CCONJ
dpc-2300	170	14	clinical	clinical	ADJ
dpc-2300	170	15	scores	score	NOUN
dpc-2300	170	16	in	in	ADP
dpc-2300	170	17	patients	patient	NOUN
dpc-2300	170	18	with	with	ADP
dpc-2300	170	19	atopic	atopic	NOUN
dpc-2300	170	20	dermatitis	dermatitis	NOUN
dpc-2300	170	21	.	.	PUNCT
dpc-2300	171	1	j	j	PROPN
dpc-2300	171	2	allergy	allergy	PROPN
dpc-2300	171	3	clin	clin	PROPN
dpc-2300	171	4	immunol	immunol	PROPN
dpc-2300	171	5	.	.	PUNCT
dpc-2300	172	1	2019;144(2):482	2019;144(2):482	NUM
dpc-2300	172	2	-	-	PUNCT
dpc-2300	172	3	493.e7	493.e7	PROPN
dpc-2300	172	4	.	.	PUNCT
dpc-2300	173	1	doi	doi	NOUN
dpc-2300	173	2	:	:	PUNCT
dpc-2300	173	3	10.1016	10.1016	NUM
dpc-2300	173	4	/	/	SYM
dpc-2300	173	5	j.jaci.2018.11.053	j.jaci.2018.11.053	PROPN
dpc-2300	173	6	.	.	PUNCT
dpc-2300	174	1	pmid	pmid	NOUN
dpc-2300	174	2	:	:	PUNCT
dpc-2300	174	3	30738171	30738171	NUM
dpc-2300	174	4	.	.	PUNCT
dpc-2300	175	1	11	11	NUM
dpc-2300	175	2	.	.	PUNCT
dpc-2300	176	1	tsoi	tsoi	PROPN
dpc-2300	176	2	lc	lc	PROPN
dpc-2300	176	3	,	,	PUNCT
dpc-2300	176	4	rodriguez	rodriguez	PROPN
dpc-2300	176	5	e	e	PROPN
dpc-2300	176	6	,	,	PUNCT
dpc-2300	176	7	degenhardt	degenhardt	ADJ
dpc-2300	176	8	f	f	PROPN
dpc-2300	176	9	,	,	PUNCT
dpc-2300	176	10	et	et	PROPN
dpc-2300	176	11	al	al	PROPN
dpc-2300	176	12	.	.	PUNCT
dpc-2300	176	13	atopic	atopic	PROPN
dpc-2300	176	14	dermatitis	dermatitis	NOUN
dpc-2300	176	15	is	be	AUX
dpc-2300	176	16	an	an	DET
dpc-2300	176	17	il-13	il-13	PRON
dpc-2300	176	18	–	–	PUNCT
dpc-2300	176	19	dominant	dominant	ADJ
dpc-2300	176	20	disease	disease	NOUN
dpc-2300	176	21	with	with	ADP
dpc-2300	176	22	greater	great	ADJ
dpc-2300	176	23	molecular	molecular	ADJ
dpc-2300	176	24	heterogeneity	heterogeneity	NOUN
dpc-2300	176	25	compared	compare	VERB
dpc-2300	176	26	to	to	ADP
dpc-2300	176	27	psoriasis	psoriasis	NOUN
dpc-2300	176	28	.	.	PUNCT
dpc-2300	177	1	j	j	PROPN
dpc-2300	177	2	invest	invest	VERB
dpc-2300	177	3	dermatol	dermatol	NOUN
dpc-2300	177	4	.	.	PUNCT
dpc-2300	178	1	2019;139(7):14801489	2019;139(7):14801489	NUM
dpc-2300	178	2	.	.	PUNCT
dpc-2300	178	3	doi	doi	PROPN
dpc-2300	178	4	:	:	PUNCT
dpc-2300	178	5	10.1016	10.1016	NUM
dpc-2300	178	6	/	/	SYM
dpc-2300	178	7	j.jid.2018.12.018	j.jid.2018.12.018	NOUN
dpc-2300	178	8	.	.	PUNCT
dpc-2300	179	1	pmid	pmid	NOUN
dpc-2300	179	2	:	:	PUNCT
dpc-2300	179	3	30641038	30641038	NUM
dpc-2300	179	4	:	:	PUNCT
dpc-2300	180	1	pmcid	pmcid	ADJ
dpc-2300	180	2	:	:	PUNCT
dpc-2300	180	3	pmc6711380	pmc6711380	NOUN
dpc-2300	180	4	.	.	PUNCT
dpc-2300	181	1	12	12	NUM
dpc-2300	181	2	.	.	PUNCT
dpc-2300	181	3	möbus	möbus	PROPN
dpc-2300	181	4	l	l	PROPN
dpc-2300	181	5	,	,	PUNCT
dpc-2300	181	6	rodriguez	rodriguez	PROPN
dpc-2300	181	7	e	e	NOUN
dpc-2300	181	8	,	,	PUNCT
dpc-2300	181	9	harder	hard	ADJ
dpc-2300	181	10	i	i	PRON
dpc-2300	181	11	,	,	PUNCT
dpc-2300	181	12	et	et	PROPN
dpc-2300	181	13	al	al	PROPN
dpc-2300	181	14	.	.	PUNCT
dpc-2300	181	15	atopic	atopic	PROPN
dpc-2300	181	16	dermatitis	dermatitis	NOUN
dpc-2300	181	17	displays	display	VERB
dpc-2300	181	18	stable	stable	ADJ
dpc-2300	181	19	and	and	CCONJ
dpc-2300	181	20	dynamic	dynamic	ADJ
dpc-2300	181	21	skin	skin	NOUN
dpc-2300	181	22	transcriptome	transcriptome	NOUN
dpc-2300	181	23	signatures	signature	NOUN
dpc-2300	181	24	.	.	PUNCT
dpc-2300	182	1	j	j	PROPN
dpc-2300	182	2	allergy	allergy	PROPN
dpc-2300	182	3	clin	clin	PROPN
dpc-2300	182	4	immunol	immunol	PROPN
dpc-2300	182	5	.	.	PUNCT
dpc-2300	183	1	2021;147(1):213	2021;147(1):213	NUM
dpc-2300	183	2	-	-	SYM
dpc-2300	183	3	223	223	NUM
dpc-2300	183	4	.	.	PUNCT
dpc-2300	184	1	doi	doi	NOUN
dpc-2300	184	2	:	:	PUNCT
dpc-2300	184	3	10.1016	10.1016	NUM
dpc-2300	184	4	/	/	SYM
dpc-2300	184	5	j.	j.	PROPN
dpc-2300	184	6	jaci.2020.06.012	jaci.2020.06.012	PROPN
dpc-2300	184	7	.	.	PUNCT
dpc-2300	185	1	pmid	pmid	NOUN
dpc-2300	185	2	:	:	PUNCT
dpc-2300	185	3	32615169	32615169	NUM
dpc-2300	185	4	.	.	PUNCT
dpc-2300	186	1	13	13	NUM
dpc-2300	186	2	.	.	PUNCT
dpc-2300	186	3	weidinger	weidinger	PROPN
dpc-2300	186	4	s	s	PROPN
dpc-2300	186	5	,	,	PUNCT
dpc-2300	186	6	beck	beck	PROPN
dpc-2300	186	7	la	la	PROPN
dpc-2300	186	8	,	,	PUNCT
dpc-2300	186	9	bieber	bieber	PROPN
dpc-2300	186	10	t	t	PROPN
dpc-2300	186	11	,	,	PUNCT
dpc-2300	186	12	kabashima	kabashima	PROPN
dpc-2300	186	13	k	k	PROPN
dpc-2300	186	14	,	,	PUNCT
dpc-2300	186	15	irvine	irvine	PROPN
dpc-2300	186	16	ad	ad	NOUN
dpc-2300	186	17	.	.	PUNCT
dpc-2300	187	1	atopic	atopic	NOUN
dpc-2300	187	2	dermatitis	dermatitis	PROPN
dpc-2300	187	3	.	.	PUNCT
dpc-2300	188	1	nat	nat	PROPN
dpc-2300	188	2	rev	rev	VERB
dpc-2300	188	3	dis	dis	PROPN
dpc-2300	188	4	primers	primer	NOUN
dpc-2300	188	5	.	.	PUNCT
dpc-2300	189	1	2018;4(1):1	2018;4(1):1	NOUN
dpc-2300	189	2	.	.	PUNCT
dpc-2300	190	1	doi	doi	PROPN
dpc-2300	190	2	:	:	PUNCT
dpc-2300	190	3	10.1038/	10.1038/	NUM
dpc-2300	190	4	s41572	s41572	PROPN
dpc-2300	190	5	-	-	PUNCT
dpc-2300	190	6	018	018	NUM
dpc-2300	190	7	-	-	PUNCT
dpc-2300	190	8	0001	0001	NUM
dpc-2300	190	9	-	-	PUNCT
dpc-2300	190	10	z.	z.	NOUN
dpc-2300	190	11	pmid	pmid	PROPN
dpc-2300	190	12	:	:	PUNCT
dpc-2300	190	13	29930242	29930242	NUM
dpc-2300	190	14	.	.	PUNCT
dpc-2300	191	1	14	14	NUM
dpc-2300	191	2	.	.	PUNCT
dpc-2300	192	1	campbell	campbell	PROPN
dpc-2300	192	2	jj	jj	PROPN
dpc-2300	192	3	,	,	PUNCT
dpc-2300	192	4	haraldsen	haraldsen	VERB
dpc-2300	192	5	g	g	PROPN
dpc-2300	192	6	,	,	PUNCT
dpc-2300	192	7	pan	pan	PROPN
dpc-2300	192	8	j	j	PROPN
dpc-2300	192	9	,	,	PUNCT
dpc-2300	192	10	et	et	PROPN
dpc-2300	192	11	al	al	PROPN
dpc-2300	192	12	.	.	PUNCT
dpc-2300	193	1	the	the	DET
dpc-2300	193	2	chemokine	chemokine	ADJ
dpc-2300	193	3	receptor	receptor	NOUN
dpc-2300	193	4	ccr4	ccr4	NOUN
dpc-2300	193	5	in	in	ADP
dpc-2300	193	6	vascular	vascular	ADJ
dpc-2300	193	7	recognition	recognition	NOUN
dpc-2300	193	8	by	by	ADP
dpc-2300	193	9	cutaneous	cutaneous	ADJ
dpc-2300	193	10	but	but	CCONJ
dpc-2300	193	11	not	not	PART
dpc-2300	193	12	intestinal	intestinal	ADJ
dpc-2300	193	13	memory	memory	NOUN
dpc-2300	193	14	t	t	NOUN
dpc-2300	193	15	cells	cell	NOUN
dpc-2300	193	16	.	.	PUNCT
dpc-2300	194	1	nature	nature	NOUN
dpc-2300	194	2	.	.	PUNCT
dpc-2300	195	1	1999;400(6746):776	1999;400(6746):776	NUM
dpc-2300	195	2	-	-	SYM
dpc-2300	195	3	780	780	NUM
dpc-2300	195	4	.	.	PUNCT
dpc-2300	196	1	doi	doi	NOUN
dpc-2300	196	2	:	:	PUNCT
dpc-2300	196	3	10.1038/23495	10.1038/23495	NUM
dpc-2300	196	4	.	.	PUNCT
dpc-2300	197	1	pmid	pmid	NOUN
dpc-2300	197	2	:	:	PUNCT
dpc-2300	197	3	10466728	10466728	NUM
dpc-2300	197	4	.	.	PUNCT
dpc-2300	198	1	15	15	NUM
dpc-2300	198	2	.	.	PUNCT
dpc-2300	199	1	vestergaard	vestergaard	PROPN
dpc-2300	199	2	c	c	PROPN
dpc-2300	199	3	,	,	PUNCT
dpc-2300	199	4	bang	bang	PROPN
dpc-2300	199	5	k	k	PROPN
dpc-2300	199	6	,	,	PUNCT
dpc-2300	199	7	gesser	gesser	PROPN
dpc-2300	199	8	b	b	PROPN
dpc-2300	199	9	,	,	PUNCT
dpc-2300	199	10	yoneyama	yoneyama	NOUN
dpc-2300	199	11	h	h	NOUN
dpc-2300	199	12	,	,	PUNCT
dpc-2300	199	13	matsushima	matsushima	PROPN
dpc-2300	199	14	k	k	PROPN
dpc-2300	199	15	,	,	PUNCT
dpc-2300	199	16	larsen	larsen	PROPN
dpc-2300	199	17	cg	cg	PROPN
dpc-2300	199	18	.	.	PUNCT
dpc-2300	200	1	a	a	DET
dpc-2300	200	2	th2	th2	PROPN
dpc-2300	200	3	chemokine	chemokine	PROPN
dpc-2300	200	4	,	,	PUNCT
dpc-2300	200	5	tarc	tarc	PROPN
dpc-2300	200	6	,	,	PUNCT
dpc-2300	200	7	produced	produce	VERB
dpc-2300	200	8	by	by	ADP
dpc-2300	200	9	keratinocytes	keratinocyte	NOUN
dpc-2300	200	10	may	may	AUX
dpc-2300	200	11	recruit	recruit	VERB
dpc-2300	200	12	cla+ccr4	cla+ccr4	PROPN
dpc-2300	200	13	+	+	PRON
dpc-2300	200	14	lymphocytes	lymphocyte	VERB
dpc-2300	200	15	into	into	ADP
dpc-2300	200	16	lesional	lesional	ADJ
dpc-2300	200	17	atopic	atopic	NOUN
dpc-2300	200	18	dermatitis	dermatitis	NOUN
dpc-2300	200	19	skin	skin	NOUN
dpc-2300	200	20	.	.	PUNCT
dpc-2300	201	1	j	j	PROPN
dpc-2300	201	2	invest	invest	VERB
dpc-2300	201	3	dermatol	dermatol	NOUN
dpc-2300	201	4	.	.	PUNCT
dpc-2300	202	1	2000;115(4):640	2000;115(4):640	NUM
dpc-2300	202	2	-	-	SYM
dpc-2300	202	3	646	646	NUM
dpc-2300	202	4	.	.	PUNCT
dpc-2300	203	1	doi	doi	NOUN
dpc-2300	203	2	:	:	PUNCT
dpc-2300	203	3	10.1046	10.1046	NUM
dpc-2300	203	4	/	/	SYM
dpc-2300	203	5	j.1523	j.1523	NOUN
dpc-2300	203	6	-	-	PUNCT
dpc-2300	203	7	1747.2000.00115.x	1747.2000.00115.x	NUM
dpc-2300	203	8	.	.	PUNCT
dpc-2300	204	1	pmid	pmid	NOUN
dpc-2300	204	2	:	:	PUNCT
dpc-2300	204	3	10998136	10998136	NUM
dpc-2300	204	4	.	.	PUNCT
dpc-2300	205	1	16	16	NUM
dpc-2300	205	2	.	.	PUNCT
dpc-2300	206	1	renert	renert	NOUN
dpc-2300	206	2	-	-	PUNCT
dpc-2300	206	3	yuval	yuval	PROPN
dpc-2300	206	4	y	y	PROPN
dpc-2300	206	5	,	,	PUNCT
dpc-2300	206	6	thyssen	thyssen	PROPN
dpc-2300	206	7	jp	jp	PROPN
dpc-2300	206	8	,	,	PUNCT
dpc-2300	206	9	bissonnette	bissonnette	NOUN
dpc-2300	206	10	r	r	NOUN
dpc-2300	206	11	,	,	PUNCT
dpc-2300	206	12	et	et	PROPN
dpc-2300	206	13	al	al	PROPN
dpc-2300	206	14	.	.	PUNCT
dpc-2300	206	15	biomarkers	biomarker	NOUN
dpc-2300	206	16	in	in	ADP
dpc-2300	206	17	atopic	atopic	NOUN
dpc-2300	206	18	dermatitis	dermatitis	NOUN
dpc-2300	206	19	—	—	PUNCT
dpc-2300	206	20	a	a	DET
dpc-2300	206	21	review	review	NOUN
dpc-2300	206	22	on	on	ADP
dpc-2300	206	23	behalf	behalf	NOUN
dpc-2300	206	24	of	of	ADP
dpc-2300	206	25	the	the	DET
dpc-2300	206	26	international	international	ADJ
dpc-2300	206	27	eczema	eczema	PROPN
dpc-2300	206	28	council	council	PROPN
dpc-2300	206	29	.	.	PUNCT
dpc-2300	207	1	j	j	PROPN
dpc-2300	207	2	allergy	allergy	PROPN
dpc-2300	207	3	clin	clin	PROPN
dpc-2300	207	4	immunol	immunol	NOUN
dpc-2300	207	5	.	.	PUNCT
dpc-2300	208	1	2021;147(4):1174	2021;147(4):1174	NUM
dpc-2300	208	2	-	-	SYM
dpc-2300	208	3	1190.e1	1190.e1	PROPN
dpc-2300	208	4	.	.	PUNCT
dpc-2300	208	5	doi	doi	NOUN
dpc-2300	208	6	:	:	PUNCT
dpc-2300	208	7	10.1016	10.1016	NUM
dpc-2300	208	8	/	/	SYM
dpc-2300	208	9	j.jaci.2021.01.013	j.jaci.2021.01.013	PROPN
dpc-2300	208	10	.	.	PUNCT
dpc-2300	209	1	pmid	pmid	NOUN
dpc-2300	209	2	:	:	PUNCT
dpc-2300	209	3	33516871	33516871	NUM
dpc-2300	209	4	.	.	PUNCT
dpc-2300	210	1	17	17	NUM
dpc-2300	210	2	.	.	PUNCT
dpc-2300	211	1	bissonnette	bissonnette	NOUN
dpc-2300	211	2	r	r	PROPN
dpc-2300	211	3	,	,	PUNCT
dpc-2300	211	4	rulloda	rulloda	PROPN
dpc-2300	211	5	j	j	PROPN
dpc-2300	211	6	,	,	PUNCT
dpc-2300	211	7	nadine	nadine	PROPN
dpc-2300	211	8	lee	lee	PROPN
dpc-2300	211	9	n	n	PROPN
dpc-2300	211	10	,	,	PUNCT
dpc-2300	211	11	et	et	PROPN
dpc-2300	211	12	al	al	PROPN
dpc-2300	211	13	.	.	PROPN
dpc-2300	211	14	rpt193	rpt193	PROPN
dpc-2300	211	15	,	,	PUNCT
dpc-2300	211	16	an	an	DET
dpc-2300	211	17	oral	oral	ADJ
dpc-2300	211	18	ccr4	ccr4	NOUN
dpc-2300	211	19	inhibitor	inhibitor	NOUN
dpc-2300	211	20	:	:	PUNCT
dpc-2300	211	21	efficacy	efficacy	NOUN
dpc-2300	211	22	results	result	NOUN
dpc-2300	211	23	from	from	ADP
dpc-2300	211	24	a	a	DET
dpc-2300	211	25	randomized	randomized	ADJ
dpc-2300	211	26	,	,	PUNCT
dpc-2300	211	27	placebo	placebo	NOUN
dpc-2300	211	28	-	-	PUNCT
dpc-2300	211	29	controlled	control	VERB
dpc-2300	211	30	phase	phase	NOUN
dpc-2300	211	31	1b	1b	NUM
dpc-2300	211	32	monotherapy	monotherapy	NOUN
dpc-2300	211	33	trial	trial	NOUN
dpc-2300	211	34	in	in	ADP
dpc-2300	211	35	patients	patient	NOUN
dpc-2300	211	36	with	with	ADP
dpc-2300	211	37	moderate	moderate	ADJ
dpc-2300	211	38	-	-	PUNCT
dpc-2300	211	39	to	to	ADP
dpc-2300	211	40	severe	severe	ADJ
dpc-2300	211	41	atopic	atopic	NOUN
dpc-2300	211	42	dermatitis	dermatitis	NOUN
dpc-2300	211	43	.	.	PUNCT
dpc-2300	212	1	isds	isds	ADJ
dpc-2300	212	2	2021	2021	NUM
dpc-2300	212	3	.	.	PUNCT
dpc-2300	213	1	abstract	abstract	ADJ
dpc-2300	213	2	88	88	NUM
dpc-2300	213	3	.	.	PUNCT
dpc-2300	214	1	18	18	NUM
dpc-2300	214	2	.	.	X
dpc-2300	215	1	kim	kim	PROPN
dpc-2300	215	2	be	be	PROPN
dpc-2300	215	3	,	,	PUNCT
dpc-2300	215	4	leung	leung	PROPN
dpc-2300	215	5	dym	dym	PROPN
dpc-2300	215	6	,	,	PUNCT
dpc-2300	215	7	boguniewicz	boguniewicz	PROPN
dpc-2300	215	8	m	m	PROPN
dpc-2300	215	9	,	,	PUNCT
dpc-2300	215	10	howell	howell	PROPN
dpc-2300	215	11	md	md	PROPN
dpc-2300	215	12	.	.	PROPN
dpc-2300	215	13	loricrin	loricrin	PROPN
dpc-2300	215	14	and	and	CCONJ
dpc-2300	215	15	involucrin	involucrin	ADJ
dpc-2300	215	16	expression	expression	NOUN
dpc-2300	215	17	is	be	AUX
dpc-2300	215	18	down	down	ADV
dpc-2300	215	19	-	-	PUNCT
dpc-2300	215	20	regulated	regulate	VERB
dpc-2300	215	21	by	by	ADP
dpc-2300	215	22	th2	th2	PROPN
dpc-2300	215	23	cytokines	cytokine	NOUN
dpc-2300	215	24	through	through	ADP
dpc-2300	215	25	stat-6	stat-6	NUM
dpc-2300	215	26	.	.	PUNCT
dpc-2300	215	27	clin	clin	PROPN
dpc-2300	215	28	immunol	immunol	NOUN
dpc-2300	215	29	.	.	PUNCT
dpc-2300	216	1	2008;126(3):332	2008;126(3):332	X
dpc-2300	216	2	-	-	SYM
dpc-2300	216	3	337	337	NUM
dpc-2300	216	4	.	.	PUNCT
dpc-2300	217	1	doi	doi	NOUN
dpc-2300	217	2	:	:	PUNCT
dpc-2300	217	3	10.1016	10.1016	NUM
dpc-2300	217	4	/	/	SYM
dpc-2300	217	5	j.	j.	PROPN
dpc-2300	217	6	clim.2007.11.006	clim.2007.11.006	PROPN
dpc-2300	217	7	.	.	PUNCT
dpc-2300	218	1	pmid	pmid	NOUN
dpc-2300	218	2	:	:	PUNCT
dpc-2300	218	3	18166499	18166499	NUM
dpc-2300	218	4	:	:	PUNCT
dpc-2300	218	5	pmcid	pmcid	ADJ
dpc-2300	218	6	:	:	PUNCT
dpc-2300	218	7	pmc2275206	pmc2275206	NOUN
dpc-2300	218	8	.	.	PUNCT
dpc-2300	219	1	19	19	NUM
dpc-2300	219	2	.	.	PUNCT
dpc-2300	220	1	howell	howell	PROPN
dpc-2300	220	2	md	md	PROPN
dpc-2300	220	3	,	,	PUNCT
dpc-2300	220	4	kim	kim	PROPN
dpc-2300	220	5	be	be	PROPN
dpc-2300	220	6	,	,	PUNCT
dpc-2300	220	7	gao	gao	PROPN
dpc-2300	220	8	p	p	X
dpc-2300	220	9	,	,	PUNCT
dpc-2300	220	10	et	et	PROPN
dpc-2300	220	11	al	al	PROPN
dpc-2300	220	12	.	.	PROPN
dpc-2300	220	13	cytokine	cytokine	ADJ
dpc-2300	220	14	modulation	modulation	NOUN
dpc-2300	220	15	of	of	ADP
dpc-2300	220	16	atopic	atopic	NOUN
dpc-2300	220	17	dermatitis	dermatitis	NOUN
dpc-2300	220	18	filaggrin	filaggrin	NOUN
dpc-2300	220	19	skin	skin	NOUN
dpc-2300	220	20	expression	expression	NOUN
dpc-2300	220	21	.	.	PUNCT
dpc-2300	221	1	j	j	PROPN
dpc-2300	221	2	allergy	allergy	PROPN
dpc-2300	221	3	clin	clin	PROPN
dpc-2300	221	4	immunol	immunol	PROPN
dpc-2300	221	5	.	.	PUNCT
dpc-2300	222	1	2009;124(3	2009;124(3	NUM
dpc-2300	222	2	suppl	suppl	PROPN
dpc-2300	222	3	2):r7	2):r7	NUM
dpc-2300	222	4	-	-	PUNCT
dpc-2300	222	5	r12	r12	NOUN
dpc-2300	222	6	.	.	PUNCT
dpc-2300	223	1	doi	doi	NOUN
dpc-2300	223	2	:	:	PUNCT
dpc-2300	223	3	10.1016	10.1016	NUM
dpc-2300	223	4	/	/	SYM
dpc-2300	223	5	j.jaci.2009.07.012	j.jaci.2009.07.012	PROPN
dpc-2300	223	6	.	.	PUNCT
dpc-2300	224	1	pmid	pmid	NOUN
dpc-2300	224	2	:	:	PUNCT
dpc-2300	224	3	19720210	19720210	NUM
dpc-2300	224	4	.	.	PUNCT
dpc-2300	225	1	20	20	NUM
dpc-2300	225	2	.	.	PUNCT
dpc-2300	226	1	kim	kim	PROPN
dpc-2300	226	2	j	j	PROPN
dpc-2300	226	3	,	,	PUNCT
dpc-2300	226	4	kim	kim	PROPN
dpc-2300	226	5	be	be	PROPN
dpc-2300	226	6	,	,	PUNCT
dpc-2300	226	7	ahn	ahn	PROPN
dpc-2300	226	8	k	k	PROPN
dpc-2300	226	9	,	,	PUNCT
dpc-2300	226	10	leung	leung	PROPN
dpc-2300	226	11	dym	dym	PROPN
dpc-2300	226	12	.	.	PUNCT
dpc-2300	227	1	interactions	interaction	NOUN
dpc-2300	227	2	between	between	ADP
dpc-2300	227	3	atopic	atopic	NOUN
dpc-2300	227	4	dermatitis	dermatitis	NOUN
dpc-2300	227	5	and	and	CCONJ
dpc-2300	227	6	staphylococcus	staphylococcus	NOUN
dpc-2300	227	7	aureus	aureus	NOUN
dpc-2300	227	8	infection	infection	NOUN
dpc-2300	227	9	:	:	PUNCT
dpc-2300	227	10	clinical	clinical	ADJ
dpc-2300	227	11	implications	implication	NOUN
dpc-2300	227	12	.	.	PUNCT
dpc-2300	228	1	allergy	allergy	NOUN
dpc-2300	228	2	asthma	asthma	PROPN
dpc-2300	228	3	immunol	immunol	PROPN
dpc-2300	228	4	res	re	NOUN
dpc-2300	228	5	.	.	PUNCT
dpc-2300	229	1	2019;11(5):593	2019;11(5):593	PROPN
dpc-2300	229	2	-	-	PUNCT
dpc-2300	229	3	603	603	NUM
dpc-2300	229	4	.	.	PUNCT
dpc-2300	230	1	doi	doi	NOUN
dpc-2300	230	2	:	:	PUNCT
dpc-2300	230	3	10.4168	10.4168	NUM
dpc-2300	230	4	/	/	SYM
dpc-2300	230	5	aair.2019.11.5.593	aair.2019.11.5.593	NOUN
dpc-2300	230	6	.	.	PUNCT
dpc-2300	231	1	pmid	pmid	NOUN
dpc-2300	231	2	:	:	PUNCT
dpc-2300	231	3	31332972	31332972	NUM
dpc-2300	231	4	.	.	PUNCT
dpc-2300	232	1	pmcid	pmcid	NOUN
dpc-2300	232	2	:	:	PUNCT
dpc-2300	232	3	pmc6658404	pmc6658404	NOUN
dpc-2300	232	4	.	.	PUNCT
dpc-2300	233	1	21	21	NUM
dpc-2300	233	2	.	.	PUNCT
dpc-2300	233	3	simpson	simpson	PROPN
dpc-2300	233	4	el	el	PROPN
dpc-2300	233	5	,	,	PUNCT
dpc-2300	233	6	villarreal	villarreal	NOUN
dpc-2300	233	7	m	m	PROPN
dpc-2300	233	8	,	,	PUNCT
dpc-2300	233	9	jepson	jepson	PROPN
dpc-2300	233	10	b	b	PROPN
dpc-2300	233	11	,	,	PUNCT
dpc-2300	233	12	et	et	PROPN
dpc-2300	233	13	al	al	PROPN
dpc-2300	233	14	.	.	PUNCT
dpc-2300	234	1	patients	patient	NOUN
dpc-2300	234	2	with	with	ADP
dpc-2300	234	3	atopic	atopic	NOUN
dpc-2300	234	4	dermatitis	dermatitis	NOUN
dpc-2300	234	5	colonized	colonize	VERB
dpc-2300	234	6	with	with	ADP
dpc-2300	234	7	staphylococcus	staphylococcus	NOUN
dpc-2300	234	8	aureus	aureus	NOUN
dpc-2300	234	9	have	have	VERB
dpc-2300	234	10	a	a	DET
dpc-2300	234	11	distinct	distinct	ADJ
dpc-2300	234	12	phenotype	phenotype	NOUN
dpc-2300	234	13	and	and	CCONJ
dpc-2300	234	14	endotype	endotype	NOUN
dpc-2300	234	15	.	.	PUNCT
dpc-2300	235	1	j	j	PROPN
dpc-2300	235	2	invest	invest	VERB
dpc-2300	235	3	dermatol	dermatol	NOUN
dpc-2300	235	4	.	.	PUNCT
dpc-2300	236	1	2018;138(10):22242233	2018;138(10):22242233	X
dpc-2300	236	2	.	.	PUNCT
dpc-2300	236	3	doi	doi	NOUN
dpc-2300	236	4	:	:	PUNCT
dpc-2300	236	5	10.1016	10.1016	NUM
dpc-2300	236	6	/	/	SYM
dpc-2300	236	7	j.jid.2018.03.1517	j.jid.2018.03.1517	PROPN
dpc-2300	236	8	.	.	PUNCT
dpc-2300	237	1	pmid	pmid	NOUN
dpc-2300	237	2	:	:	PUNCT
dpc-2300	237	3	29604251	29604251	NUM
dpc-2300	237	4	.	.	PUNCT
dpc-2300	238	1	pmcid	pmcid	NOUN
dpc-2300	238	2	:	:	PUNCT
dpc-2300	238	3	pmc6153055	pmc6153055	NOUN
dpc-2300	238	4	.	.	PUNCT
dpc-2300	239	1	22	22	NUM
dpc-2300	239	2	.	.	PUNCT
dpc-2300	240	1	mack	mack	PROPN
dpc-2300	240	2	mr	mr	PROPN
dpc-2300	240	3	,	,	PUNCT
dpc-2300	240	4	kim	kim	PROPN
dpc-2300	240	5	bs	bs	PROPN
dpc-2300	240	6	.	.	PUNCT
dpc-2300	241	1	the	the	DET
dpc-2300	241	2	itch	itch	NOUN
dpc-2300	241	3	-	-	PUNCT
dpc-2300	241	4	scratch	scratch	NOUN
dpc-2300	241	5	cycle	cycle	NOUN
dpc-2300	241	6	:	:	PUNCT
dpc-2300	241	7	a	a	DET
dpc-2300	241	8	neuroimmune	neuroimmune	NOUN
dpc-2300	241	9	perspective	perspective	NOUN
dpc-2300	241	10	.	.	PUNCT
dpc-2300	242	1	trends	trend	NOUN
dpc-2300	242	2	immunol	immunol	NOUN
dpc-2300	242	3	.	.	PUNCT
dpc-2300	243	1	2018;39(12):980	2018;39(12):980	NUM
dpc-2300	243	2	-	-	PUNCT
dpc-2300	243	3	991	991	NUM
dpc-2300	243	4	.	.	PUNCT
dpc-2300	244	1	doi	doi	NOUN
dpc-2300	244	2	:	:	PUNCT
dpc-2300	244	3	10.1016	10.1016	NUM
dpc-2300	244	4	/	/	SYM
dpc-2300	244	5	j.	j.	PROPN
dpc-2300	244	6	it.2018.10.001	it.2018.10.001	PROPN
dpc-2300	244	7	.	.	PUNCT
dpc-2300	245	1	pmid	pmid	NOUN
dpc-2300	245	2	:	:	PUNCT
dpc-2300	245	3	30471983	30471983	NUM
dpc-2300	245	4	.	.	PUNCT
dpc-2300	246	1	23	23	NUM
dpc-2300	246	2	.	.	PUNCT
dpc-2300	247	1	oetjen	oetjen	PROPN
dpc-2300	247	2	lk	lk	PROPN
dpc-2300	247	3	,	,	PUNCT
dpc-2300	247	4	mack	mack	PROPN
dpc-2300	247	5	mr	mr	PROPN
dpc-2300	247	6	,	,	PUNCT
dpc-2300	247	7	feng	feng	PROPN
dpc-2300	247	8	j	j	PROPN
dpc-2300	247	9	,	,	PUNCT
dpc-2300	247	10	et	et	PROPN
dpc-2300	247	11	al	al	PROPN
dpc-2300	247	12	.	.	PUNCT
dpc-2300	248	1	sensory	sensory	ADJ
dpc-2300	248	2	neurons	neuron	NOUN
dpc-2300	248	3	co	co	ADJ
dpc-2300	248	4	-	-	ADJ
dpc-2300	248	5	opt	opt	ADJ
dpc-2300	248	6	classical	classical	ADJ
dpc-2300	248	7	immune	immune	NOUN
dpc-2300	248	8	signaling	signal	VERB
dpc-2300	248	9	pathways	pathway	NOUN
dpc-2300	248	10	to	to	PART
dpc-2300	248	11	mediate	mediate	VERB
dpc-2300	248	12	chronic	chronic	ADJ
dpc-2300	248	13	itch	itch	NOUN
dpc-2300	248	14	.	.	PUNCT
dpc-2300	249	1	cell	cell	NOUN
dpc-2300	249	2	.	.	PUNCT
dpc-2300	250	1	2017;171(1):217	2017;171(1):217	X
dpc-2300	250	2	-	-	PUNCT
dpc-2300	250	3	228.e13	228.e13	NUM
dpc-2300	250	4	.	.	PUNCT
dpc-2300	251	1	doi	doi	NOUN
dpc-2300	251	2	:	:	PUNCT
dpc-2300	251	3	10.1016	10.1016	NUM
dpc-2300	251	4	/	/	SYM
dpc-2300	251	5	j.cell.2017.08.006	j.cell.2017.08.006	PROPN
dpc-2300	251	6	.	.	PUNCT
dpc-2300	252	1	pmid	pmid	NOUN
dpc-2300	252	2	:	:	PUNCT
dpc-2300	252	3	28890086	28890086	NUM
dpc-2300	252	4	.	.	PUNCT
dpc-2300	253	1	pmcid	pmcid	NOUN
dpc-2300	253	2	:	:	PUNCT
dpc-2300	253	3	pmc5658016	pmc5658016	NOUN
dpc-2300	253	4	.	.	PUNCT
dpc-2300	254	1	24	24	NUM
dpc-2300	254	2	.	.	PUNCT
dpc-2300	255	1	bilsborough	bilsborough	PROPN
dpc-2300	255	2	j	j	PROPN
dpc-2300	255	3	,	,	PUNCT
dpc-2300	255	4	leung	leung	PROPN
dpc-2300	255	5	dym	dym	PROPN
dpc-2300	255	6	,	,	PUNCT
dpc-2300	255	7	maurer	maurer	PROPN
dpc-2300	255	8	m	m	PROPN
dpc-2300	255	9	,	,	PUNCT
dpc-2300	255	10	et	et	PROPN
dpc-2300	255	11	al	al	PROPN
dpc-2300	255	12	.	.	PROPN
dpc-2300	255	13	il-31	il-31	PUNCT
dpc-2300	255	14	is	be	AUX
dpc-2300	255	15	associated	associate	VERB
dpc-2300	255	16	with	with	ADP
dpc-2300	255	17	cutaneous	cutaneous	ADJ
dpc-2300	255	18	lymphocyte	lymphocyte	ADJ
dpc-2300	255	19	antigen	antigen	ADJ
dpc-2300	255	20	-	-	PUNCT
dpc-2300	255	21	positive	positive	ADJ
dpc-2300	255	22	skin	skin	NOUN
dpc-2300	255	23	homing	home	VERB
dpc-2300	255	24	t	t	NOUN
dpc-2300	255	25	cells	cell	NOUN
dpc-2300	255	26	in	in	ADP
dpc-2300	255	27	patients	patient	NOUN
dpc-2300	255	28	with	with	ADP
dpc-2300	255	29	atopic	atopic	NOUN
dpc-2300	255	30	dermatitis	dermatitis	NOUN
dpc-2300	255	31	.	.	PUNCT
dpc-2300	256	1	j	j	PROPN
dpc-2300	256	2	allergy	allergy	PROPN
dpc-2300	256	3	clin	clin	PROPN
dpc-2300	256	4	immunol	immunol	PROPN
dpc-2300	256	5	.	.	PUNCT
dpc-2300	257	1	2006;117(2):418	2006;117(2):418	NUM
dpc-2300	257	2	-	-	SYM
dpc-2300	257	3	425	425	NUM
dpc-2300	257	4	.	.	PUNCT
dpc-2300	258	1	doi	doi	NOUN
dpc-2300	258	2	:	:	PUNCT
dpc-2300	258	3	10.1016	10.1016	NUM
dpc-2300	258	4	/	/	SYM
dpc-2300	258	5	j.jaci.2005.10.046	j.jaci.2005.10.046	PROPN
dpc-2300	258	6	.	.	PUNCT
dpc-2300	259	1	pmid	pmid	NOUN
dpc-2300	259	2	:	:	PUNCT
dpc-2300	259	3	16461143	16461143	NUM
dpc-2300	259	4	.	.	PUNCT
dpc-2300	260	1	25	25	NUM
dpc-2300	260	2	.	.	PUNCT
dpc-2300	261	1	silverberg	silverberg	PROPN
dpc-2300	261	2	ji	ji	PROPN
dpc-2300	261	3	,	,	PUNCT
dpc-2300	261	4	pinter	pinter	VERB
dpc-2300	261	5	a	a	PRON
dpc-2300	261	6	,	,	PUNCT
dpc-2300	261	7	alavi	alavi	NOUN
dpc-2300	261	8	a	a	PRON
dpc-2300	261	9	,	,	PUNCT
dpc-2300	261	10	et	et	PROPN
dpc-2300	261	11	al	al	PROPN
dpc-2300	261	12	.	.	PROPN
dpc-2300	261	13	nemolizumab	nemolizumab	PROPN
dpc-2300	261	14	is	be	AUX
dpc-2300	261	15	associated	associate	VERB
dpc-2300	261	16	with	with	ADP
dpc-2300	261	17	a	a	DET
dpc-2300	261	18	rapid	rapid	ADJ
dpc-2300	261	19	improvement	improvement	NOUN
dpc-2300	261	20	in	in	ADP
dpc-2300	261	21	atopic	atopic	NOUN
dpc-2300	261	22	dermatitis	dermatitis	NOUN
dpc-2300	261	23	signs	sign	NOUN
dpc-2300	261	24	and	and	CCONJ
dpc-2300	261	25	symptoms	symptom	NOUN
dpc-2300	261	26	:	:	PUNCT
dpc-2300	261	27	subpopulation	subpopulation	NOUN
dpc-2300	261	28	(	(	PUNCT
dpc-2300	261	29	easi	easi	NOUN
dpc-2300	261	30	≥	≥	NUM
dpc-2300	261	31	16	16	NUM
dpc-2300	261	32	)	)	PUNCT
dpc-2300	261	33	analysis	analysis	NOUN
dpc-2300	261	34	of	of	ADP
dpc-2300	261	35	randomized	randomized	ADJ
dpc-2300	261	36	phase	phase	NOUN
dpc-2300	261	37	2b	2b	NUM
dpc-2300	261	38	study	study	NOUN
dpc-2300	261	39	.	.	PUNCT
dpc-2300	262	1	j	j	PROPN
dpc-2300	262	2	eur	eur	PROPN
dpc-2300	262	3	acad	acad	PROPN
dpc-2300	262	4	dermatol	dermatol	NOUN
dpc-2300	262	5	venereol	venereol	NOUN
dpc-2300	262	6	.	.	PUNCT
dpc-2300	263	1	2021;35(7):1562	2021;35(7):1562	NUM
dpc-2300	263	2	-	-	SYM
dpc-2300	263	3	1568	1568	NUM
dpc-2300	263	4	.	.	PUNCT
dpc-2300	264	1	doi	doi	NOUN
dpc-2300	264	2	:	:	PUNCT
dpc-2300	264	3	10.1111	10.1111	NUM
dpc-2300	264	4	/	/	SYM
dpc-2300	264	5	jdv.17218	jdv.17218	PROPN
dpc-2300	264	6	.	.	PUNCT
dpc-2300	265	1	pmid	pmid	NOUN
dpc-2300	265	2	:	:	PUNCT
dpc-2300	265	3	33711179	33711179	NUM
dpc-2300	265	4	.	.	PUNCT
dpc-2300	266	1	26	26	NUM
dpc-2300	266	2	.	.	PUNCT
dpc-2300	266	3	gittler	gittler	PROPN
dpc-2300	266	4	jk	jk	PROPN
dpc-2300	266	5	,	,	PUNCT
dpc-2300	266	6	shemer	shemer	PROPN
dpc-2300	266	7	a	a	PRON
dpc-2300	266	8	,	,	PUNCT
dpc-2300	266	9	suárez	suárez	NOUN
dpc-2300	266	10	-	-	PUNCT
dpc-2300	266	11	fariñas	fariñas	NOUN
dpc-2300	266	12	m	m	PROPN
dpc-2300	266	13	,	,	PUNCT
dpc-2300	266	14	et	et	PROPN
dpc-2300	266	15	al	al	PROPN
dpc-2300	266	16	.	.	PROPN
dpc-2300	266	17	progressive	progressive	ADJ
dpc-2300	266	18	activation	activation	NOUN
dpc-2300	266	19	of	of	ADP
dpc-2300	266	20	th2	th2	PROPN
dpc-2300	266	21	/	/	SYM
dpc-2300	266	22	th22	th22	PROPN
dpc-2300	266	23	cytokines	cytokine	NOUN
dpc-2300	266	24	and	and	CCONJ
dpc-2300	266	25	selective	selective	ADJ
dpc-2300	266	26	epidermal	epidermal	ADJ
dpc-2300	266	27	proteins	protein	NOUN
dpc-2300	266	28	characterizes	characterize	VERB
dpc-2300	266	29	acute	acute	ADJ
dpc-2300	266	30	and	and	CCONJ
dpc-2300	266	31	chronic	chronic	ADJ
dpc-2300	266	32	atopic	atopic	NOUN
dpc-2300	266	33	dermatitis	dermatitis	NOUN
dpc-2300	266	34	.	.	PUNCT
dpc-2300	267	1	j	j	PROPN
dpc-2300	267	2	allergy	allergy	PROPN
dpc-2300	267	3	clin	clin	PROPN
dpc-2300	267	4	immunol	immunol	NOUN
dpc-2300	267	5	.	.	PUNCT
dpc-2300	268	1	2012;130(6):1344	2012;130(6):1344	NUM
dpc-2300	268	2	-	-	SYM
dpc-2300	268	3	1354	1354	NUM
dpc-2300	268	4	.	.	PUNCT
dpc-2300	269	1	doi	doi	NOUN
dpc-2300	269	2	:	:	PUNCT
dpc-2300	269	3	10.1016	10.1016	NUM
dpc-2300	269	4	/	/	SYM
dpc-2300	269	5	j.	j.	PROPN
dpc-2300	269	6	jaci.2012.07.012	jaci.2012.07.012	PROPN
dpc-2300	269	7	.	.	PUNCT
dpc-2300	270	1	pmid	pmid	NOUN
dpc-2300	270	2	:	:	PUNCT
dpc-2300	270	3	22951056	22951056	NUM
dpc-2300	270	4	.	.	PUNCT
dpc-2300	271	1	pmcid	pmcid	NOUN
dpc-2300	271	2	:	:	PUNCT
dpc-2300	271	3	pmc3991245	pmc3991245	PROPN
dpc-2300	271	4	.	.	PUNCT
dpc-2300	272	1	27	27	NUM
dpc-2300	272	2	.	.	PUNCT
dpc-2300	273	1	brunner	brunner	PROPN
dpc-2300	273	2	pm	pm	PROPN
dpc-2300	273	3	,	,	PUNCT
dpc-2300	273	4	pavel	pavel	PROPN
dpc-2300	273	5	ab	ab	PROPN
dpc-2300	273	6	,	,	PUNCT
dpc-2300	273	7	khattri	khattri	PROPN
dpc-2300	273	8	s	s	PROPN
dpc-2300	273	9	,	,	PUNCT
dpc-2300	273	10	et	et	PROPN
dpc-2300	273	11	al	al	PROPN
dpc-2300	273	12	.	.	PROPN
dpc-2300	273	13	baseline	baseline	PROPN
dpc-2300	273	14	il-22	il-22	NOUN
dpc-2300	273	15	expression	expression	NOUN
dpc-2300	273	16	in	in	ADP
dpc-2300	273	17	patients	patient	NOUN
dpc-2300	273	18	with	with	ADP
dpc-2300	273	19	atopic	atopic	NOUN
dpc-2300	273	20	dermatitis	dermatitis	NOUN
dpc-2300	273	21	stratifies	stratify	VERB
dpc-2300	273	22	tissue	tissue	NOUN
dpc-2300	273	23	responses	response	NOUN
dpc-2300	273	24	to	to	AUX
dpc-2300	273	25	fezakinumab	fezakinumab	VERB
dpc-2300	273	26	.	.	PUNCT
dpc-2300	274	1	j	j	PROPN
dpc-2300	274	2	allergy	allergy	PROPN
dpc-2300	274	3	clin	clin	PROPN
dpc-2300	274	4	immunol	immunol	PROPN
dpc-2300	274	5	.	.	PUNCT
dpc-2300	275	1	2019;143(1):142	2019;143(1):142	NUM
dpc-2300	275	2	-	-	SYM
dpc-2300	275	3	154	154	NUM
dpc-2300	275	4	.	.	PUNCT
dpc-2300	276	1	doi	doi	NOUN
dpc-2300	276	2	:	:	PUNCT
dpc-2300	276	3	10.1016	10.1016	NUM
dpc-2300	276	4	/	/	SYM
dpc-2300	276	5	j.jaci.2018.07.028	j.jaci.2018.07.028	PROPN
dpc-2300	276	6	.	.	PUNCT
dpc-2300	277	1	pmid	pmid	NOUN
dpc-2300	277	2	:	:	PUNCT
dpc-2300	277	3	30121291	30121291	NUM
dpc-2300	277	4	.	.	PUNCT
dpc-2300	278	1	28	28	NUM
dpc-2300	278	2	.	.	PUNCT
dpc-2300	279	1	bakker	bakker	PROPN
dpc-2300	279	2	ds	ds	PROPN
dpc-2300	279	3	,	,	PUNCT
dpc-2300	279	4	nierkens	nierkens	PROPN
dpc-2300	279	5	s	s	PART
dpc-2300	279	6	,	,	PUNCT
dpc-2300	279	7	knol	knol	PROPN
dpc-2300	279	8	ef	ef	PROPN
dpc-2300	279	9	,	,	PUNCT
dpc-2300	279	10	et	et	PROPN
dpc-2300	279	11	al	al	PROPN
dpc-2300	279	12	.	.	PUNCT
dpc-2300	280	1	confirmation	confirmation	NOUN
dpc-2300	280	2	of	of	ADP
dpc-2300	280	3	multiple	multiple	ADJ
dpc-2300	280	4	endotypes	endotype	NOUN
dpc-2300	280	5	in	in	ADP
dpc-2300	280	6	atopic	atopic	NOUN
dpc-2300	280	7	dermatitis	dermatitis	NOUN
dpc-2300	280	8	based	base	VERB
dpc-2300	280	9	on	on	ADP
dpc-2300	280	10	serum	serum	NOUN
dpc-2300	280	11	biomarkers	biomarker	NOUN
dpc-2300	280	12	.	.	PUNCT
dpc-2300	281	1	j	j	PROPN
dpc-2300	281	2	allergy	allergy	PROPN
dpc-2300	281	3	clin	clin	PROPN
dpc-2300	281	4	immunol	immunol	NOUN
dpc-2300	281	5	.	.	PUNCT
dpc-2300	282	1	2021;147(1):189	2021;147(1):189	PROPN
dpc-2300	282	2	-	-	SYM
dpc-2300	282	3	198	198	NUM
dpc-2300	282	4	.	.	PUNCT
dpc-2300	283	1	doi	doi	NOUN
dpc-2300	283	2	:	:	PUNCT
dpc-2300	283	3	10.1016	10.1016	NUM
dpc-2300	283	4	/	/	SYM
dpc-2300	283	5	j.	j.	PROPN
dpc-2300	283	6	jaci.2020.04.062	jaci.2020.04.062	PROPN
dpc-2300	283	7	.	.	PUNCT
dpc-2300	284	1	pmid	pmid	NOUN
dpc-2300	284	2	:	:	PUNCT
dpc-2300	284	3	32526312	32526312	NUM
dpc-2300	284	4	.	.	PUNCT
dpc-2300	285	1	29	29	NUM
dpc-2300	285	2	.	.	X
dpc-2300	285	3	de	de	X
dpc-2300	285	4	jesús	jesús	ADV
dpc-2300	285	5	-	-	PUNCT
dpc-2300	285	6	gil	gil	NOUN
dpc-2300	285	7	c	c	PROPN
dpc-2300	285	8	,	,	PUNCT
dpc-2300	285	9	sans	san	NOUN
dpc-2300	285	10	-	-	PUNCT
dpc-2300	285	11	de	de	X
dpc-2300	285	12	sannicolàs	sannicolàs	PROPN
dpc-2300	285	13	l	l	NOUN
dpc-2300	285	14	,	,	PUNCT
dpc-2300	285	15	garcía	garcía	NOUN
dpc-2300	285	16	-	-	PUNCT
dpc-2300	285	17	jiménez	jiménez	NOUN
dpc-2300	286	1	i	i	PROPN
dpc-2300	286	2	,	,	PUNCT
dpc-2300	286	3	et	et	PROPN
dpc-2300	286	4	al	al	PROPN
dpc-2300	286	5	.	.	PUNCT
dpc-2300	287	1	the	the	DET
dpc-2300	287	2	translational	translational	ADJ
dpc-2300	287	3	relevance	relevance	NOUN
dpc-2300	287	4	of	of	ADP
dpc-2300	287	5	human	human	ADJ
dpc-2300	287	6	circulating	circulate	VERB
dpc-2300	287	7	memory	memory	NOUN
dpc-2300	287	8	6	6	NUM
dpc-2300	287	9	review	review	NOUN
dpc-2300	287	10	|	|	ADV
dpc-2300	287	11	dermatol	dermatol	ADJ
dpc-2300	287	12	pract	pract	NOUN
dpc-2300	287	13	concept	concept	NOUN
dpc-2300	287	14	.	.	PUNCT
dpc-2300	288	1	2022;12(1):e2022152	2022;12(1):e2022152	NUM
dpc-2300	288	2	cutaneous	cutaneous	ADJ
dpc-2300	288	3	lymphocyte	lymphocyte	NOUN
dpc-2300	288	4	-	-	PUNCT
dpc-2300	288	5	associated	associate	VERB
dpc-2300	288	6	antigen	antigen	ADP
dpc-2300	288	7	positive	positive	ADJ
dpc-2300	288	8	t	t	NOUN
dpc-2300	288	9	cells	cell	NOUN
dpc-2300	288	10	in	in	ADP
dpc-2300	288	11	inflammatory	inflammatory	ADJ
dpc-2300	288	12	skin	skin	NOUN
dpc-2300	288	13	disorders	disorder	NOUN
dpc-2300	288	14	.	.	PUNCT
dpc-2300	289	1	front	front	ADJ
dpc-2300	289	2	immunol	immunol	NOUN
dpc-2300	289	3	.	.	PUNCT
dpc-2300	290	1	2021;12:652613	2021;12:652613	NUM
dpc-2300	290	2	.	.	PUNCT
dpc-2300	290	3	doi	doi	NOUN
dpc-2300	290	4	:	:	PUNCT
dpc-2300	290	5	10.3389	10.3389	NUM
dpc-2300	290	6	/	/	SYM
dpc-2300	290	7	fimmu.2021.652613	fimmu.2021.652613	PROPN
dpc-2300	290	8	.	.	PUNCT
dpc-2300	291	1	pmid	pmid	NOUN
dpc-2300	291	2	:	:	PUNCT
dpc-2300	291	3	33833765	33833765	NUM
dpc-2300	291	4	.	.	PUNCT
dpc-2300	292	1	pmcid	pmcid	NOUN
dpc-2300	292	2	:	:	PUNCT
dpc-2300	292	3	pmc8021783	pmc8021783	NOUN
dpc-2300	292	4	.	.	PUNCT
dpc-2300	293	1	30	30	NUM
dpc-2300	293	2	.	.	PUNCT
dpc-2300	294	1	ferran	ferran	PROPN
dpc-2300	294	2	m	m	PROPN
dpc-2300	294	3	,	,	PUNCT
dpc-2300	294	4	santamaria	santamaria	PROPN
dpc-2300	294	5	-	-	PUNCT
dpc-2300	294	6	babi	babi	PROPN
dpc-2300	294	7	lf	lf	PROPN
dpc-2300	294	8	.	.	PROPN
dpc-2300	294	9	pathological	pathological	ADJ
dpc-2300	294	10	mechanisms	mechanism	NOUN
dpc-2300	294	11	of	of	ADP
dpc-2300	294	12	skin	skin	NOUN
dpc-2300	294	13	homing	home	VERB
dpc-2300	294	14	t	t	NOUN
dpc-2300	294	15	cells	cell	NOUN
dpc-2300	294	16	in	in	ADP
dpc-2300	294	17	atopic	atopic	NOUN
dpc-2300	294	18	dermatitis	dermatitis	NOUN
dpc-2300	294	19	.	.	PUNCT
dpc-2300	295	1	world	world	PROPN
dpc-2300	295	2	allergy	allergy	PROPN
dpc-2300	295	3	organ	organ	PROPN
dpc-2300	295	4	j.	j.	PROPN
dpc-2300	295	5	2010;3(3):44	2010;3(3):44	PROPN
dpc-2300	295	6	-	-	SYM
dpc-2300	295	7	47	47	NUM
dpc-2300	295	8	.	.	PUNCT
dpc-2300	296	1	doi	doi	NOUN
dpc-2300	296	2	:	:	PUNCT
dpc-2300	296	3	10.1097	10.1097	NUM
dpc-2300	296	4	/	/	SYM
dpc-2300	296	5	wox.0b013e3181d675f8	wox.0b013e3181d675f8	PROPN
dpc-2300	296	6	.	.	PUNCT
dpc-2300	297	1	pmid	pmid	NOUN
dpc-2300	297	2	:	:	PUNCT
dpc-2300	297	3	23282416	23282416	NUM
dpc-2300	297	4	.	.	PUNCT
dpc-2300	298	1	pmcid	pmcid	NOUN
dpc-2300	298	2	:	:	PUNCT
dpc-2300	298	3	pmc3651146	pmc3651146	ADJ
dpc-2300	298	4	.	.	PUNCT
dpc-2300	299	1	31	31	NUM
dpc-2300	299	2	.	.	PUNCT
dpc-2300	300	1	czarnowicki	czarnowicki	PROPN
dpc-2300	300	2	t	t	PROPN
dpc-2300	300	3	,	,	PUNCT
dpc-2300	300	4	santamaria	santamaria	PROPN
dpc-2300	300	5	-	-	PUNCT
dpc-2300	300	6	babí	babí	NOUN
dpc-2300	300	7	lf	lf	PROPN
dpc-2300	300	8	,	,	PUNCT
dpc-2300	300	9	guttman	guttman	ADJ
dpc-2300	300	10	-	-	PUNCT
dpc-2300	300	11	yassky	yassky	NOUN
dpc-2300	300	12	e.	e.	PROPN
dpc-2300	300	13	circulating	circulating	PROPN
dpc-2300	300	14	cla+	cla+	NOUN
dpc-2300	300	15	t	t	NOUN
dpc-2300	300	16	cells	cell	NOUN
dpc-2300	300	17	in	in	ADP
dpc-2300	300	18	atopic	atopic	NOUN
dpc-2300	300	19	dermatitis	dermatitis	NOUN
dpc-2300	300	20	and	and	CCONJ
dpc-2300	300	21	their	their	PRON
dpc-2300	300	22	possible	possible	ADJ
dpc-2300	300	23	role	role	NOUN
dpc-2300	300	24	as	as	ADP
dpc-2300	300	25	peripheral	peripheral	ADJ
dpc-2300	300	26	biomarkers	biomarker	NOUN
dpc-2300	300	27	.	.	PUNCT
dpc-2300	301	1	allergy	allergy	NOUN
dpc-2300	301	2	.	.	PUNCT
dpc-2300	302	1	2017;72(3):366	2017;72(3):366	NUM
dpc-2300	302	2	-	-	PUNCT
dpc-2300	302	3	372	372	NUM
dpc-2300	302	4	.	.	PUNCT
dpc-2300	302	5	doi	doi	NOUN
dpc-2300	302	6	:	:	PUNCT
dpc-2300	302	7	10.1111	10.1111	NUM
dpc-2300	302	8	/	/	SYM
dpc-2300	302	9	all.13080	all.13080	NOUN
dpc-2300	302	10	.	.	PUNCT
dpc-2300	303	1	pmid	pmid	NOUN
dpc-2300	303	2	:	:	PUNCT
dpc-2300	303	3	27861978	27861978	NUM
dpc-2300	303	4	.	.	PUNCT
dpc-2300	304	1	32	32	NUM
dpc-2300	304	2	.	.	X
dpc-2300	305	1	strobl	strobl	NOUN
dpc-2300	305	2	j	j	PROPN
dpc-2300	305	3	,	,	PUNCT
dpc-2300	305	4	gail	gail	PROPN
dpc-2300	305	5	l	l	PROPN
dpc-2300	305	6	,	,	PUNCT
dpc-2300	305	7	kleissl	kleissl	PROPN
dpc-2300	305	8	l	l	PROPN
dpc-2300	305	9	,	,	PUNCT
dpc-2300	305	10	et	et	PROPN
dpc-2300	305	11	al	al	PROPN
dpc-2300	305	12	.	.	PROPN
dpc-2300	305	13	human	human	ADJ
dpc-2300	305	14	resident	resident	PROPN
dpc-2300	305	15	memory	memory	NOUN
dpc-2300	305	16	t	t	PROPN
dpc-2300	305	17	cells	cell	NOUN
dpc-2300	305	18	exit	exit	VERB
dpc-2300	305	19	the	the	DET
dpc-2300	305	20	skin	skin	NOUN
dpc-2300	305	21	and	and	CCONJ
dpc-2300	305	22	mediate	mediate	VERB
dpc-2300	305	23	systemic	systemic	ADJ
dpc-2300	305	24	th2	th2	PROPN
dpc-2300	305	25	-	-	PUNCT
dpc-2300	305	26	driven	drive	VERB
dpc-2300	305	27	inflammation	inflammation	NOUN
dpc-2300	305	28	.	.	PUNCT
dpc-2300	306	1	j	j	PROPN
dpc-2300	306	2	exp	exp	NOUN
dpc-2300	306	3	med	med	PROPN
dpc-2300	306	4	.	.	PUNCT
dpc-2300	307	1	2021;218(11):e20210417	2021;218(11):e20210417	NUM
dpc-2300	307	2	.	.	PUNCT
dpc-2300	308	1	doi	doi	NOUN
dpc-2300	308	2	:	:	PUNCT
dpc-2300	308	3	10.1084/	10.1084/	NUM
dpc-2300	308	4	jem.20210417	jem.20210417	NUM
dpc-2300	308	5	.	.	PUNCT
dpc-2300	309	1	pmid	pmid	NOUN
dpc-2300	309	2	:	:	PUNCT
dpc-2300	309	3	34643646	34643646	NUM
dpc-2300	309	4	.	.	PUNCT
dpc-2300	310	1	pmcid	pmcid	ADJ
dpc-2300	310	2	:	:	PUNCT
dpc-2300	310	3	pmc8563284	pmc8563284	NOUN
dpc-2300	310	4	.	.	PUNCT
dpc-2300	311	1	33	33	NUM
dpc-2300	311	2	.	.	PUNCT
dpc-2300	311	3	bakker	bakker	PROPN
dpc-2300	311	4	ds	ds	PROPN
dpc-2300	311	5	,	,	PUNCT
dpc-2300	311	6	van	van	PROPN
dpc-2300	311	7	der	der	NOUN
dpc-2300	311	8	wal	wal	PROPN
dpc-2300	311	9	mm	mm	PROPN
dpc-2300	311	10	,	,	PUNCT
dpc-2300	311	11	heeb	heeb	PROPN
dpc-2300	311	12	lem	lem	PROPN
dpc-2300	311	13	,	,	PUNCT
dpc-2300	311	14	et	et	PROPN
dpc-2300	311	15	al	al	PROPN
dpc-2300	311	16	.	.	PROPN
dpc-2300	312	1	early	early	ADJ
dpc-2300	312	2	and	and	CCONJ
dpc-2300	312	3	longterm	longterm	ADJ
dpc-2300	312	4	effects	effect	NOUN
dpc-2300	312	5	of	of	ADP
dpc-2300	312	6	dupilumab	dupilumab	NOUN
dpc-2300	312	7	treatment	treatment	NOUN
dpc-2300	312	8	on	on	ADP
dpc-2300	312	9	circulating	circulate	VERB
dpc-2300	312	10	t	t	PROPN
dpc-2300	312	11	-	-	PUNCT
dpc-2300	312	12	cell	cell	NOUN
dpc-2300	312	13	functions	function	NOUN
dpc-2300	312	14	in	in	ADP
dpc-2300	312	15	patients	patient	NOUN
dpc-2300	312	16	with	with	ADP
dpc-2300	312	17	moderate	moderate	ADJ
dpc-2300	312	18	-	-	PUNCT
dpc-2300	312	19	to	to	ADP
dpc-2300	312	20	-	-	PUNCT
dpc-2300	312	21	severe	severe	ADJ
dpc-2300	312	22	atopic	atopic	NOUN
dpc-2300	312	23	dermatitis	dermatitis	NOUN
dpc-2300	312	24	.	.	PUNCT
dpc-2300	313	1	j	j	PROPN
dpc-2300	313	2	invest	invest	VERB
dpc-2300	313	3	dermatol	dermatol	NOUN
dpc-2300	313	4	.	.	PUNCT
dpc-2300	314	1	2021;141(8):1943	2021;141(8):1943	NUM
dpc-2300	314	2	-	-	SYM
dpc-2300	314	3	1953.e13	1953.e13	NUM
dpc-2300	314	4	.	.	PUNCT
dpc-2300	315	1	doi	doi	NOUN
dpc-2300	315	2	:	:	PUNCT
dpc-2300	315	3	10.1016	10.1016	NUM
dpc-2300	315	4	/	/	SYM
dpc-2300	315	5	j.	j.	PROPN
dpc-2300	315	6	jid.2021.01.022	jid.2021.01.022	PROPN
dpc-2300	315	7	.	.	PUNCT
dpc-2300	316	1	pmid	pmid	NOUN
dpc-2300	316	2	:	:	PUNCT
dpc-2300	316	3	33610558	33610558	NUM
dpc-2300	316	4	.	.	PUNCT
dpc-2300	317	1	34	34	NUM
dpc-2300	317	2	.	.	PUNCT
dpc-2300	317	3	roesner	roesner	PROPN
dpc-2300	317	4	lm	lm	PROPN
dpc-2300	317	5	,	,	PUNCT
dpc-2300	317	6	bridgewood	bridgewood	PROPN
dpc-2300	317	7	c	c	NOUN
dpc-2300	317	8	,	,	PUNCT
dpc-2300	317	9	mcgonagle	mcgonagle	NOUN
dpc-2300	317	10	d	d	NOUN
dpc-2300	317	11	,	,	PUNCT
dpc-2300	317	12	wittmann	wittmann	PROPN
dpc-2300	317	13	m.	m.	NOUN
dpc-2300	317	14	dupilumab	dupilumab	PROPN
dpc-2300	317	15	:	:	PUNCT
dpc-2300	317	16	an	an	DET
dpc-2300	317	17	opportunity	opportunity	NOUN
dpc-2300	317	18	to	to	PART
dpc-2300	317	19	unravel	unravel	VERB
dpc-2300	317	20	in	in	ADP
dpc-2300	317	21	vivo	vivo	ADJ
dpc-2300	317	22	actions	action	NOUN
dpc-2300	317	23	of	of	ADP
dpc-2300	317	24	il-4	il-4	NOUN
dpc-2300	317	25	and	and	CCONJ
dpc-2300	317	26	il-13	il-13	ADP
dpc-2300	317	27	in	in	ADP
dpc-2300	317	28	humans	human	NOUN
dpc-2300	317	29	.	.	PUNCT
dpc-2300	318	1	j	j	PROPN
dpc-2300	318	2	invest	invest	VERB
dpc-2300	318	3	dermatol	dermatol	NOUN
dpc-2300	318	4	.	.	PUNCT
dpc-2300	319	1	2021;141(8):1879	2021;141(8):1879	NUM
dpc-2300	319	2	-	-	SYM
dpc-2300	319	3	1881	1881	NUM
dpc-2300	319	4	.	.	PUNCT
dpc-2300	320	1	doi	doi	NOUN
dpc-2300	320	2	:	:	PUNCT
dpc-2300	320	3	10.1016	10.1016	NUM
dpc-2300	320	4	/	/	SYM
dpc-2300	320	5	j.jid.2021.02.007	j.jid.2021.02.007	NOUN
dpc-2300	320	6	.	.	PUNCT
dpc-2300	321	1	pmid	pmid	NOUN
dpc-2300	321	2	:	:	PUNCT
dpc-2300	321	3	34303467	34303467	NUM
dpc-2300	321	4	.	.	PUNCT
dpc-2300	321	5	  	  	SPACE